+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 53613

Chapter 53613 contains a list of PDF Full Texts available from EurekaMag.

Valea, F.A., 2007:
Human papillomavirus testing for precancerous lesions of the cervix

Grce, M.; Davies, P., 2008:
Human papillomavirus testing for primary cervical cancer screening

Feldman, S., 2015:
Human papillomavirus testing for primary cervical cancer screening: is it time to abandon Papanicolaou testing?

Ghosh, S.K.; Choudhury, B.; Hansa, J.; Mondal, R.; Singh, M.; Singh, M.; Duttagupta, S.; Das, A.; Kumar, R.; Laskar, R.S.; Kannan, R.; Ghosh, P.R., 2011:
Human papillomavirus testing for suspected cervical cancer patients from Southern Assam by fast-PCR

Coupé, V.M.H.; Berkhof, J., 2009:
Human papillomavirus testing improves follow-up after treatment for cervical intraepithelial neoplasia

Castle, P.E.; Cremer, M., 2014:
Human papillomavirus testing in cervical cancer screening

Schache, A.; Croud, J.; Robinson, M.; Thavaraj, S., 2015:
Human papillomavirus testing in head and neck squamous cell carcinoma: best practice for diagnosis

McGinley, K.F.; Hey, W.; Sussman, D.O.; Brown, G.A., 2011:
Human papillomavirus testing in men

Rebolj, M.; Bonde, J.; Njor, S.Helle.; Lynge, E., 2011:
Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review

Schiffman, M.; Wentzensen, N.; Wacholder, S.; Kinney, W.; Gage, J.C.; Castle, P.E., 2011:
Human papillomavirus testing in the prevention of cervical cancer

McKenna, M.; McMenamin, M.M., 2014:
Human papillomavirus testing in young women: clinical outcomes of human papillomavirus triage in a UK cervical screening program

Kulasingam, S.L.; Rajan, R.; St Pierre, Y.; Atwood, C.Victoria.; Myers, E.R.; Franco, E.L., 2009:
Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis

Herbert, A.; Best, J.M.; Chana, P.; Ktori, E.; Nowicki, M.; Dunsmore, H.; Culora, G.; Arbyn, M.; Kubba, A.A., 2007:
Human papillomavirus testing with conventional Pap smear screening in three inner London community clinics

Covell, J.L.; Stoler, M.H., 2007:
Human papillomavirus testing, vaccination, and gynecologic screening: fight or flight?

Badaracco, G.; Venuti, A., 2007:
Human papillomavirus therapeutic vaccines in head and neck tumors

Morrow, M.P.; Yan, J.; Sardesai, N.Y., 2013:
Human papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer

Olsen, J.; Jepsen, M.Rudbeck., 2010:
Human papillomavirus transmission and cost-effectiveness of introducing quadrivalent HPV vaccination in Denmark

Rittà, M.; Landolfo, V.; Mazibrada, J.; De Andrea, M.; Dell'Oste, V.; Caneparo, V.; Peretti, A.; Giordano, C.; Pecorari, G.; Garzaro, M.; Landolfo, S., 2013:
Human papillomavirus tumor-infiltrating T-regulatory lymphocytes and P53 codon 72 polymorphisms correlate with clinical staging and prognosis of oropharyngeal cancer

Prescott, E.L.; Brimacombe, C.L.; Hartley, M.; Bell, I.; Graham, S.; Roberts, S., 2015:
Human papillomavirus type 1 E1^E4 protein is a potent inhibitor of the serine-arginine (SR) protein kinase SRPK1 and inhibits phosphorylation of host SR proteins and of the viral transcription and replication regulator E2

Lace, M.J.; Anson, J.R.; Klussmann, J.P.; Wang, D.Hong.; Smith, E.M.; Haugen, T.H.; Turek, L.P., 2011:
Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers

Bellone, S.; El-Sahwi, K.; Cocco, E.; Casagrande, F.; Cargnelutti, M.; Palmieri, M.; Bignotti, E.; Romani, C.; Silasi, D-Arin.; Azodi, M.; Schwartz, P.E.; Rutherford, T.J.; Pecorelli, S.; Santin, A.D., 2009:
Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines

Mole, S.; Milligan, S.G.; Graham, S.V., 2008:
Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF

Kim, M-Kyung.; Kim, H.Seung.; Kim, S-Hyeong.; Oh, J-Min.; Han, J.Yong.; Lim, J.Mook.; Juhnn, Y-Sung.; Song, Y-Sang., 2010:
Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment

Muto, V.; Stellacci, E.; Lamberti, A.Giuseppe.; Perrotti, E.; Carrabba, A.; Matera, G.; Sgarbanti, M.; Battistini, A.; Liberto, M.Carla.; Focà, A., 2011:
Human papillomavirus type 16 E5 protein induces expression of beta interferon through interferon regulatory factor 1 in human keratinocytes

Oh, J-Min.; Kim, S-Hyeong.; Cho, E-Ah.; Song, Y-Sang.; Kim, W-Ho.; Juhnn, Y-Sung., 2010:
Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells

Hao, M.; Wu, X-zhou.; Wang, X-li.; Bian, M-lu.; Liu, H-tu., 2010:
Human papillomavirus type 16 E5 sequence evolution analysis

Jabbar, S.; Strati, K.; Shin, M.Kyun.; Pitot, H.C.; Lambert, P.F., 2010:
Human papillomavirus type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in mice

Cai, H.B.; Chen, C.C.; Ding, X.H., 2010:
Human papillomavirus type 16 E6 gene variations in Chinese population

Parroche, P.; Touka, M.; Mansour, M.; Bouvard, Véronique.; Thépot, Aélie.; Accardi, R.; Carreira, C.; Roblot, G.G.; Sylla, B.S.; Hasan, U.; Tommasino, M., 2011:
Human papillomavirus type 16 E6 inhibits p21(WAF1) transcription independently of p53 by inactivating p150(Sal2)

Jong, J.Eun.; Jeong, K.Wan.; Shin, H.; Hwang, L.Rang.; Lee, D.; Seo, T., 2012:
Human papillomavirus type 16 E6 protein inhibits DNA fragmentation via interaction with DNA fragmentation factor 40

Williams, V.M.; Filippova, M.; Filippov, V.; Payne, K.J.; Duerksen-Hughes, P., 2014:
Human papillomavirus type 16 E6* induces oxidative stress and DNA damage

Lee, T-Young.; Kim, Y-Hyun.; Lee, K-Soon.; Kim, J-Ki.; Lee, I-Han.; Yang, J-Myung.; Sung, M-Hee.; Park, J-Sup.; Poo, H., 2010:
Human papillomavirus type 16 E6-specific antitumor immunity is induced by oral administration of HPV16 E6-expressing Lactobacillus casei in C57BL/6 mice

McCloskey, R.; Menges, C.; Friedman, A.; Patel, D.; McCance, D.J., 2010:
Human papillomavirus type 16 E6/E7 upregulation of nucleophosmin is important for proliferation and inhibition of differentiation

Ramos, C.A.; Narala, N.; Vyas, G.M.; Leen, A.M.; Gerdemann, U.; Sturgis, E.M.; Anderson, M.L.; Savoldo, B.; Heslop, H.E.; Brenner, M.K.; Rooney, C.M., 2013:
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies

McLaughlin-Drubin, M.E.; Huh, K-Won.; Münger, K., 2008:
Human papillomavirus type 16 E7 oncoprotein associates with E2F6

Park, J.Wook.; Nickel, K.P.; Torres, A.D.; Lee, D.; Lambert, P.F.; Kimple, R.J., 2015:
Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damage

Yu, Y.; Munger, K., 2013:
Human papillomavirus type 16 E7 oncoprotein inhibits the anaphase promoting complex/cyclosome activity by dysregulating EMI1 expression in mitosis

Srinivasan, M.; Taioli, E.; Ragin, C.C., 2009:
Human papillomavirus type 16 and 18 in primary lung cancers--a meta-analysis

Wang, Y.; Wang, A.; Jiang, R.; Pan, H.; Huang, B.; Lu, Y.; Wu, C., 2008:
Human papillomavirus type 16 and 18 infection is associated with lung cancer patients from the central part of China

Nam, K.; Kwak, J.; Kim, J.; Jeon, S., 2013:
Human papillomavirus type 16 causes larger colposcopic lesions than other HPV types in patients with grade 3 cervical intraepithelial neoplasia

La Placa, M.; Venturoli, S.; Dika, E.; Saccani, E.; Rech, G.; Fanti, P.A., 2009:
Human papillomavirus type 16 detected in four periungual squamous cell carcinomas from the same patient

Hu, Y.; Zhu, Y-Ying.; Zhang, S-Hui.; Zhu, H.; Shuai, C-Xia., 2011:
Human papillomavirus type 16 e6 gene variations in young Chinese women with cervical squamous cell carcinoma

Schelhaas, M.; Ewers, H.; Rajamäki, M-Liisa.; Day, P.M.; Schiller, J.T.; Helenius, A., 2008:
Human papillomavirus type 16 entry: retrograde cell surface transport along actin-rich protrusions

Ma, Z.; Liu, L.; Zhang, F.; Yu, M.; Wang, K.; Luo, J.; Liu, K.; Chen, B.; Xu, L., 2009:
Human papillomavirus type 16 exists in bacteria isolated from cervical cancer biopsies

Laniosz, V.; Dabydeen, S.A.; Havens, M.A.; Meneses, P.I., 2009:
Human papillomavirus type 16 infection of human keratinocytes requires clathrin and caveolin-1 and is brefeldin a sensitive

Hao, M.; Wang, X-Li.; Bian, M-Lu.; Liu, H-Tu., 2010:
Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia

Marongiu, L.; Godi, A.; Parry, J.V.; Beddows, S., 2016:
Human papillomavirus type 16 long control region and E6 variants stratified by cervical disease stage

Yuan, H.; Ito, S.; Senga, T.; Hyodo, T.; Kiyono, T.; Kikkawa, F.; Hamaguchi, M., 2009:
Human papillomavirus type 16 oncoprotein E7 suppresses cadherin-mediated cell adhesion via ERK and AP-1 signaling

Fleury, M.J.J.; Touzé, A.; Coursaget, P., 2014:
Human papillomavirus type 16 pseudovirions with few point mutations in L1 major capsid protein FG loop could escape actual or future vaccination for potential use in gene therapy

Shang, Q.; Wang, Y.; Fang, Y.; Wei, L.; Chen, S.; Sun, Y.; Li, B.; Zhang, F.; Gu, H., 2011:
Human papillomavirus type 16 variant analysis of E6, E7, and L1 [corrected] genes and long control region in [corrected] cervical carcinomas in patients in northeast China

Xiong, G-Wu.; Yuan, Y.; Li, M.; Guo, H-Yan.; Zhang, X-Wei., 2010:
Human papillomavirus type 16 variant analysis of upstream regulatory region and E6, E7 oncogene from cervical cancer patients in Beijing

Junes-Gill, K.; Sichero, L.; Maciag, P.Cesar.; Mello, W.; Noronha, Vânia.; Villa, L.Lina., 2008:
Human papillomavirus type 16 variants in cervical cancer from an admixtured population in Brazil

López-Revilla, Rén.; Pineda, M.A.; Ortiz-Valdez, J.; Sánchez-Garza, M.; Riego, L., 2009:
Human papillomavirus type 16 variants in cervical intraepithelial neoplasia and invasive carcinoma in San Luis Potosí City, Mexico

Xi, L.Fu.; Koutsky, L.A.; Castle, P.E.; Edelstein, Z.R.; Hulbert, A.; Schiffman, M.; Kiviat, N.B., 2010:
Human papillomavirus type 16 variants in paired enrollment and follow-up cervical samples: implications for a proper understanding of type-specific persistent infections

Hanisch, R.A.; Cherne, S.L.; Sow, P.Salif.; Winer, R.L.; Hughes, J.P.; Feng, Q.; Gottlieb, G.S.; Toure, M.; Dem, A.; Kiviat, N.B.; Hawes, S.E., 2015:
Human papillomavirus type 16 viral load in relation to HIV infection, cervical neoplasia and cancer in Senegal

Custodio, A.; Ortega, L.; Sanz, G.; Sastre, J., 2011:
Human papillomavirus type 16- associated primary squamous cell carcinoma of the rectum following cervical intraepithelial neoplasia

Croci-Torti, A.; Tamalet, C.; Segondy, M.; Dandurand, M.; Meunier, L.; Stoebner, P-E., 2014:
Human papillomavirus type 16-induced skin squamous cell carcinoma located on the groin of immunocompetent patients

Zhang, E-Ying.; Tang, X-Dong., 2013:
Human papillomavirus type 16/18 oncoproteins: potential therapeutic targets in non-smoking associated lung cancer

Cheng, Y-Wen.; Lee, H.; Shiau, M-Yuh.; Wu, T-Chin.; Huang, T-Teng.; Chang, Y-Hsin., 2008:
Human papillomavirus type 16/18 up-regulates the expression of interleukin-6 and antiapoptotic Mcl-1 in non-small cell lung cancer

Xi, L.Fu.; Koutsky, L.A.; Castle, P.E.; Wheeler, C.M.; Galloway, D.A.; Mao, C.; Ho, J.; Kiviat, N.B., 2009:
Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3

Ma, T.; Su, Z.; Chen, L.; Liu, S.; Zhu, N.; Wen, L.; Yuan, Y.; Lv, L.; Chen, X.; Huang, J.; Chen, H., 2012:
Human papillomavirus type 18 E6 and E7 genes integrate into human hepatoma derived cell line Hep G2

Arroyo Mühr, L.Sara.; Hultin, E.; Bzhalava, D.; Eklund, C.; Lagheden, C.; Ekström, J.; Johansson, H.; Forslund, O.; Dillner, J., 2015:
Human papillomavirus type 197 is commonly present in skin tumors

Handisurya, A.; Rieger, A.; Bankier, A.; Koller, A.; Salat, A.; Stingl, G.; Kirnbauer, R., 2007:
Human papillomavirus type 26 infection causing multiple invasive squamous cell carcinomas of the fingernails in an AIDS patient under highly active antiretroviral therapy

Wanat, K.A.; Tyring, S.; Rady, P.; Kovarik, C.L., 2015:
Human papillomavirus type 27 associated with multiple verruca within a tattoo: report of a case and review of the literature

Smith, J.L.; Campos, S.K.; Ozbun, M.A., 2007:
Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytes

Morandell, D.; Rostek, U.; Bouvard, V.; Campo-Fernández, B.; Fiedler, M.; Jansen-Dürr, P.; Zwerschke, W., 2008:
Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression

Rodrigues-Coutlée, C.; Archambault, J.; Money, D.; Ramanakumar, A.V.; Raboud, J.; Hankins, C.; Koushik, A.; Richardson, H.; Brassard, P.; Franco, E.L.; Coutlée, F.; Conners, J.; Grimshaw, R.; Haase, D.; Johnston, L.; Schlech, W.; Yuzicappi-Fayant, A.; Landis, S.; Smaill, F.; Wobeser, W.; Austin, T.; Hammerberg, O.; Ralph, T.; Coutlee, F.; Falutz, J.; Ferenczy, A.; Hankins, C.; Klein, M.; Labrecque, L.; Lapointe, N.; Lalonde, R.; Macleod, J.; Noel, G.; Perron, C.; Routy, J-Pierre.; Toma, E.; To, 2014:
Human papillomavirus type 56 polymorphism in Canadian women with and without cervical lesions

Shimizu, A.; Tamura, A.; Abe, M.; Amano, H.; Motegi, S.; Nakatani, Y.; Hoshino, H.; Ishikawa, O., 2013:
Human papillomavirus type 56-associated Bowen disease

Mendes Araújo, F.; dos Santos Gon, A.; Sichero, L.; Simão Sobrinho, Jão., 2013:
Human papillomavirus type 57 in generalized verrucosis without immunodeficiency

Danielewski, J.A.; Garland, S.M.; McCloskey, J.; Hillman, R.J.; Tabrizi, S.N., 2013:
Human papillomavirus type 6 and 11 genetic variants found in 71 oral and anogenital epithelial samples from Australia

Matsukura, T.; Mitsuishi, T.; Sugase, M.; Kawashima, M., 2010:
Human papillomavirus type 7-associated condyloma

Introcaso, C.E.; Rady, P.L.; He, Q.; Tyring, S.K.; Kovarik, C.L., 2012:
Human papillomavirus type 73 associated with multiple cutaneous squamous cell carcinomas in an immunosuppressed patient

Guldbakke, K.K.; Brodsky, J.; Liang, M.; Schanbacher, C.F., 2008:
Human papillomavirus type 73 in primary and recurrent periungual squamous cell carcinoma

Oldak, M.; Maksym, R.B.; Sperling, T.; Yaniv, M.; Smola, H.; Pfister, H.J.; Malejczyk, J.; Smola, S., 2010:
Human papillomavirus type 8 E2 protein unravels JunB/Fra-1 as an activator of the beta4-integrin gene in human keratinocytes

Sperling, T.; Ołdak, M.; Walch-Rückheim, B.; Wickenhauser, C.; Doorbar, J.; Pfister, H.; Malejczyk, M.; Majewski, Sławomir.; Keates, A.C.; Smola, S., 2013:
Human papillomavirus type 8 interferes with a novel C/EBPβ-mediated mechanism of keratinocyte CCL20 chemokine expression and Langerhans cell migration

Wang, K-Liahng.; Wang, T-Yeuan.; Huang, Y-Chuen.; Lai, J.Cheng-Yen.; Chang, T-Chang.; Yen, M-Shyen., 2009:
Human papillomavirus type and clinical manifestation in seven cases of large-cell neuroendocrine cervical carcinoma

Abalos, A.T.; Harris, R.B.; Nyitray, A.G.; Mitchell, A.; Thompson, P.A.; Giuliano, A.R.; Garcia, F., 2012:
Human papillomavirus type distribution among heterosexual couples

Bekele, A.; Baay, M.; Mekonnen, Z.; Suleman, S.; Chatterjee, S., 2010:
Human papillomavirus type distribution among women with cervical pathology - a study over 4 years at Jimma Hospital, southwest Ethiopia

Menegazzi, P.; Barzon, L.; Palù, G.; Reho, E.; Tagliaferro, L., 2010:
Human papillomavirus type distribution and correlation with cyto-histological patterns in women from the South of Italy

Li, N.; Franceschi, S.; Howell-Jones, R.; Snijders, P.J.F.; Clifford, G.M., 2011:
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication

Hoots, B.E.; Palefsky, J.M.; Pimenta, J.M.; Smith, J.S., 2009:
Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions

Pista, A.; de Oliveira, C.Freire.; Lopes, C.; Cunha, M.João.; Tavares, A.; Dias, M.; Rocha, Eénia.; Telhado, M.da.Conceição.; Afonso, A.; Loureiro, M.; Horgan, C.; Marques, I.; Cortes, E.; Alegra, S.; Serra, M.do.Carmo.; Lima, J.; Afonso, E.; Ladeíra, A.Paula.; Gonçalves, L.; Sobral, N.; Reforço, A.Sofia.; Pacheco, M.Amália.; Enriquez, Jé.Luis.; Lagoa, Aónia.; Ribeiro, V.; Ferreira, L.; Cadilla, Aónio.Jesús.; Furtado, Jé.Manuel.; Rodrigues, J.; de Castro, P.Vieira.; e Silva, Aónio., 2013:
Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study

Quek, S.Chong.; Lim, B.Kiong.; Domingo, E.; Soon, R.; Park, J-Sup.; Vu, T.Nhung.; Tay, E.Hseon.; Le, Q.Thanh.; Kim, Y-Tak.; Vu, B.Quyet.; Cao, N.Thanh.; Limson, G.; Pham, V.Thanh.; Molijn, A.; Ramakrishnan, G.; Chen, J., 2013:
Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia

Munjal, K.; Adamson, C.S-C.; Rajendran, V.; Nandedkar, S.; Cooper, K.; Evans, M.F., 2015:
Human papillomavirus type distribution in invasive cervical cancers from Madhya Pradesh: implications for vaccination programs in central India

Bryant, D.; Rai, N.; Rowlands, G.; Hibbitts, S.; Jones, J.; Tristram, A.; Fiander, A.; Powell, N., 2011:
Human papillomavirus type distribution in vulval intraepithelial neoplasia determined using PapilloCheck DNA Microarray

Bao, Y-P.; Li, N.; Smith, J.S.; Qiao, Y-L., 2007:
Human papillomavirus type distribution in women from Asia: a meta-analysis

Chen, A.Che-Ha.; McMillan, N.A.J.; Antonsson, A., 2008:
Human papillomavirus type spectrum in normal skin of individuals with or without a history of frequent sun exposure

Yam, Y.; Chew, E.; Yang, L.; Chengchew, S.; Ding, M., 1995:
Human papillomavirus type-16 DNA integration in nuclear matrix and chromosome scaffold associated DNA in a cervical-carcinoma cell-line

Chen, W.; Zhang, X.; Molijn, A.; Jenkins, D.; Shi, J-Fang.; Quint, W.; Schmidt, J.E.; Wang, P.; Liu, Y-Ling.; Li, L-Kun.; Shi, H.; Liu, J-Hong.; Xie, X.; Niyazi, M.; Yang, P.; Wei, L-Hui.; Li, L-Yu.; Li, J.; Liu, J-Feng.; Zhou, Q.; Hong, Y.; Li, L.; Li, Q.; Zhou, H-Lin.; Bian, M-Lu.; Chen, J.; Qiao, Y-Lin.; Smith, J.S., 2010:
Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18

Wang, H.; Qiao, Y.L., 2008:
Human papillomavirus type-distribution in condylomata acuminata of mainland China: a meta-analysis

Smith, J.S.; Backes, D.M.; Hoots, B.E.; Kurman, R.J.; Pimenta, J.M., 2009:
Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors

Söderlund-Strand, A.; Kjellberg, L.; Dillner, J., 2014 :
Human papillomavirus type-specific persistence and recurrence after treatment for cervical dysplasia

Tachezy, R.; Smahelova, J.; Kaspirkova, J.; Salakova, M., 2014:
Human papillomavirus type-specific prevalence in the cervical cancer screening population of Czech women

Ding, X.; Liu, Z.; Su, J.; Yan, D.; Sun, W.; Zeng, Z., 2015:
Human papillomavirus type-specific prevalence in women referred for colposcopic examination in Beijing

Park, J-J.; Kim, S-H.; Lee, J.H.; Lee, J-B.; Yun, S.J., 2012:
Human papillomavirus types 1, 16 and 18 detected in a lesion of verrucous carcinoma of the cheek

Xi, L.Fu.; Edelstein, Z.R.; Meyers, C.; Ho, J.; Cherne, S.L.; Schiffman, M., 2009:
Human papillomavirus types 16 and 18 DNA load in relation to coexistence of other types, particularly those in the same species

Zampronha, R.de.Araújo.Catão.; Freitas-Junior, R.; Murta, E.Fernando.Candido.; Michelin, Márcia.Antoniazi.; Barbaresco, A.Almeida.; Adad, S.Jorge.; Oliveira, A.Monteiro.de.; Rassi, A.B.; Oton, Gória.Jabur.Bittar., 2014:
Human papillomavirus types 16 and 18 and the prognosis of patients with stage I cervical cancer

Jayaprakash, V.; Reid, M.; Hatton, E.; Merzianu, M.; Rigual, N.; Marshall, J.; Gill, S.; Frustino, J.; Wilding, G.; Loree, T.; Popat, S.; Sullivan, M., 2012:
Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010

Gnanamony, M.; Peedicayil, A.; Subhashini, J.; Ram, T.Samuel.; Christopher, S.; Gravitt, P.; Abraham, P., 2010:
Human papillomavirus types 16 and 18 mRNA levels and not DNA levels may be associated with advancing stages of cervical cancer

Keam, S.J.; Harper, D.M., 2008:
Human papillomavirus types 16 and 18 vaccine (recombinant, AS04 adjuvanted, adsorbed) [Cervarix

Keam, S.J.; Harper, D.M., 2008:
Human papillomavirus types 16 and 18 vaccine (recombinant, AS04 adjuvanted, adsorbed) [Cervarix]: profile report

Sutcliffe, S.; Viscidi, R.P.; Till, C.; Goodman, P.J.; Hoque, A.M.; Hsing, A.W.; Thompson, I.M.; Zenilman, J.M.; De Marzo, A.M.; Platz, E.A., 2010:
Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial

King, C.M.; Johnston, J.S.; Ofili, K.; Tam, M.; Palefsky, J.; Da Costa, M.; Mathur, Y.; Barbosa, P., 2016:
Human papillomavirus types 2, 27, and 57 Identified in plantar verrucae from HIV-positive and HIV-negative individuals

Takehara, K.; Toda, T.; Nishimura, T.; Sakane, J.; Kawakami, Y.; Mizunoe, T.; Nishiwaki, M.; Taniyama, K., 2011:
Human papillomavirus types 52 and 58 are prevalent in uterine cervical squamous lesions from Japanese women

Poynten, I.Mary.; Waterboer, T.; Jin, F.; Templeton, D.J.; Prestage, G.; Donovan, B.; Pawlita, M.; Fairley, C.K.; Garland, S.M.; Grulich, A.E., 2014:
Human papillomavirus types 6 and 11 seropositivity: risk factors and association with ano-genital warts among homosexual men

Wang, H.; Qiao, Y-lin., 2007:
Human papillomavirus types and their related diseases

Porras, C.; Rodríguez, A.Cecilia.; Hildesheim, A.; Herrero, R.; González, P.; Wacholder, S.; Burk, R.D.; Schiffman, M., 2009:
Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young women

Heard, I.; Tondeur, L.; Arowas, L.; Falguières, M.; Demazoin, M-Christine.; Favre, M., 2014:
Human papillomavirus types distribution in organised cervical cancer screening in France

Firnhaber, C.; Sello, M.; Maskew, M.; Williams, S.; Schulze, D.; Williamson, A-L.; Allan, B.; Lewis, D., 2011 :
Human papillomavirus types in HIV seropositive men with penile warts in Johannesburg, South Africa

Guan, P.; Clifford, G.M.; Franceschi, S., 2013:
Human papillomavirus types in glandular lesions of the cervix: a meta-analysis of published studies

Usubütün, A.; Alemany, L.; Küçükali, Türkan.; Ayhan, A.; Yüce, K.; de Sanjosé, S.; Font, R.; Lloveras, B.; Klaustermeier, J.; Quint, W.; Muñoz, N.; Bosch, F.Xavier., 2010:
Human papillomavirus types in invasive cervical cancer specimens from Turkey

Siegler, E.; Lahat, N.; Shiner, M.; Mackuli, L.; Aroudi, Y.; Shapiro, S.; Auslander, R.; Lavie, O., 2012:
Human papillomavirus types in women with cervical cancer in Haifa District

Arioz, D.Tolga.; Altindis, M.; Tokyol, C.; Kalayci, R.; Saylan, A.; Yilmazer, M., 2009:
Human papillomavirus typing and soluble interleukin-2 receptor levels in female sex workers with a negative cervical smear result

Antonishyn, N.A.; Horsman, G.B.; Kelln, R.A.; Severini, A., 2009:
Human papillomavirus typing and viral gene expression analysis for the triage of women with abnormal results from papanicolaou test smears to colposcopy

Sturegård, E.; Johansson, H.; Ekström, J.; Hansson, B-Göran.; Johnsson, A.; Gustafsson, E.; Dillner, J.; Forslund, O., 2013:
Human papillomavirus typing in reporting of condyloma

Palm, M.D.; Tyring, S.K.; Rady, P.L.; Tharp, M.D., 2010:
Human papillomavirus typing of verrucae in a patient with WHIM syndrome

Tomson, N.; Sterling, J.; Ahmed, I.; Hague, J.; Berth-Jones, J., 2011:
Human papillomavirus typing of warts and response to cryotherapy

Lin, C-Yu.; Chao, A.; Yang, Y-Cheng.; Chou, H-Hsueh.; Ho, C-Ming.; Lin, R-Wen.; Chang, T-Chang.; Chiou, J-Yia.; Chao, F-Yu.; Wang, K-Liahng.; Chien, T-Yen.; Hsueh, S.; Huang, C-Chun.; Chen, C-Jen.; Lai, C-Huey., 2008:
Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR

Shiau, M-Yuh.; Fan, L-Ching.; Yang, S-Chun.; Tsao, C-Hui.; Lee, H.; Cheng, Y-Wen.; Lai, L-Chuan.; Chang, Y-Hsin., 2013:
Human papillomavirus up-regulates MMP-2 and MMP-9 expression and activity by inducing interleukin-8 in lung adenocarcinomas

Brotherton, J.Ml., 2014:
Human papillomavirus vaccination

Kliewer, E.V.; Mahmud, S.M.; Demers, A.A.; Lambert, P., 2014:
Human papillomavirus vaccination and Pap testing profile in Manitoba, Canada

Barbaro, B.; Brotherton, J.M.L.; Gertig, D.M., 2012:
Human papillomavirus vaccination and cervical cancer screening by socioeconomic status, Victoria

Brogly, S.B.; Perkins, R.B.; Zepf, D.; Longtine, J.; Yang, S., 2015:
Human papillomavirus vaccination and cervical cytology in young minority women

Mammas, I.; Stewart, J.; Hughes, A., 2010:
Human papillomavirus vaccination and school nurses: a British survey

Rysavy, M.B.; Kresowik, J.D.K.; Liu, D.; Mains, L.; Lessard, M.; Ryan, G.L., 2014:
Human papillomavirus vaccination and sexual behavior in young women

Forster, A.S.; Marlow, L.A.V.; Stephenson, J.; Wardle, J.; Waller, J., 2012:
Human papillomavirus vaccination and sexual behaviour: cross-sectional and longitudinal surveys conducted in England

Roberts, S.A.; Brabin, L.; Stretch, R.; Baxter, D.; Elton, P.; Kitchener, H.; McCann, R., 2011:
Human papillomavirus vaccination and social inequality: results from a prospective cohort study

Klosky, J.L.; Foster, R.H.; Hodges, J.; Peasant, C.; Gamble, H.; McDermott, M.J.; Rao, P., 2013:
Human papillomavirus vaccination and the primary prevention of cancer: implications for survivors of childhood cancer

Anonymous, 2013:
Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013 - United States

Stokley, S.; Jeyarajah, J.; Yankey, D.; Cano, M.; Gee, J.; Roark, J.; Curtis, R.C.; Markowitz, L., 2014:
Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States

Ache, K.A.; Wallace, L.S., 2008:
Human papillomavirus vaccination coverage on YouTube

Hayashi, Y.; Mitsushita, J.; Netsu, S.; Konno, R., 2011:
Human papillomavirus vaccination for prevention of cervical cancer

Skinner, S.Rachel.; Garland, S.M.; Stanley, M.A.; Pitts, M.; Quinn, M.A., 2008:
Human papillomavirus vaccination for the prevention of cervical neoplasia: is it appropriate to vaccinate women older than 26?

Mehta, N.R.; Julian, P.J.; Meek, J.I.; Sosa, L.E.; Bilinski, A.; Hariri, S.; Markowitz, L.E.; Hadler, J.L.; Niccolai, L.M., 2012:
Human papillomavirus vaccination history among women with precancerous cervical lesions: disparities and barriers

Ouedraogo, N.; Müller, O.; Jahn, A.; Gerhardus, A., 2011:
Human papillomavirus vaccination in Africa

Svane, D., 2009 :
Human papillomavirus vaccination in Denmark

Russell, M.; Raheja, V.; Jaiyesimi, R., 2014:
Human papillomavirus vaccination in adolescence

Barroso, L.F.; Wilkin, T., 2011:
Human papillomavirus vaccination in males: the state of the science

Klosky, J.L.; Gamble, H.L.; Spunt, S.L.; Randolph, M.E.; Green, D.M.; Hudson, M.M., 2010:
Human papillomavirus vaccination in survivors of childhood cancer

Kim, J.J., 2008:
Human papillomavirus vaccination in the UK

Astbury, K.; Turner, M.J., 2010:
Human papillomavirus vaccination in the prevention of cervical neoplasia

Juntasopeepun, P.; Davidson, P.M.; Suwan, N.; Phianmongkhol, Y.; Srisomboon, J., 2012:
Human papillomavirus vaccination intention among young women in Thailand

Krawczyk, A.L.; Perez, S.; Lau, E.; Holcroft, C.A.; Amsel, R.; Knäuper, Bärbel.; Rosberger, Z., 2013:
Human papillomavirus vaccination intentions and uptake in college women

Capone, A.; Favato, G., 2012:
Human papillomavirus vaccination is not exclusively a matter of price

Weiss, T.W.; Zimet, G.D.; Rosenthal, S.L.; Brenneman, S.K.; Klein, J.D., 2010:
Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females

Jim, C.C.; Lee, J.Wai-Yin.; Groom, A.V.; Espey, D.K.; Saraiya, M.; Holve, S.; Bullock, A.; Howe, J.; Thierry, J., 2012:
Human papillomavirus vaccination practices among providers in Indian health service, tribal and urban Indian healthcare facilities

Daley, M.F.; Crane, L.A.; Markowitz, L.E.; Black, S.R.; Beaty, B.L.; Barrow, J.; Babbel, C.; Gottlieb, S.L.; Liddon, N.; Stokley, S.; Dickinson, L.Miriam.; Kempe, A., 2010:
Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure

Sauvageau, C.; Kiely, M., 2010:
Human papillomavirus vaccination program

Lo, B., 2007:
Human papillomavirus vaccination programmes

Yasmin, S.; Gerberry, D.J.; Blower, S., 2014:
Human papillomavirus vaccination programs and human immunodeficiency virus epidemics

Dempsey, A.F.; Schaffer, S.E., 2011:
Human papillomavirus vaccination rates and state mandates for tetanus-containing vaccines

Dorell, C.G.; Yankey, D.; Santibanez, T.A.; Markowitz, L.E., 2012:
Human papillomavirus vaccination series initiation and completion, 2008-2009

Pérez Cachafeiro, S., 2008:
Human papillomavirus vaccination strategies

Haug, C.J., 2008:
Human papillomavirus vaccination--reasons for caution

Bartolozzi, G.; Bona, G.; Ciofi, M.; D.M.rtino, M.; D.P.etro, P.; Duse, M.; Esposito, S.; Gasparini, R.; Mariani, L.; Marostica, G.; Paravati, F.; Plebani, A.; Principi, N.; Zuccotti, G.V.; Tovo, P.A., 2007:
Human papillomavirus vaccination. Consensus Conference in pediatric age

Klein, K.; Luedtke, S., 2008:
Human papillomavirus vaccination: a case for mandatory immunization?

Palmer, A.K.; Harris, A.L.; Jacobson, R.M., 2015:
Human papillomavirus vaccination: a case study in translational science

Alameda González, César.; de Lorenzo-Cáceres Ascanio, A., 2008:
Human papillomavirus vaccination: attitude to a consultation on a therapeutic novelty

Schim van der Loeff, M.F.; Giuliano, A.R., 2013:
Human papillomavirus vaccination: component of an integrated HIV prevention program?

Gattoc, L.; Nair, N.; Ault, K., 2014:
Human papillomavirus vaccination: current indications and future directions

Peigue-Lafeuille, H., 2007:
Human papillomavirus vaccination: differing views and issues at stake

Markowitz, L.E.; Dunne, E.F.; Saraiya, M.; Chesson, H.W.; Curtis, C.Robinette.; Gee, J.; Bocchini, J.A.; Unger, E.R., 2014:
Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP)

Leyland, E., 2008:
Human papillomavirus vaccination: stabbing in the dark?

Howell-Jones, R., 2007:
Human papillomavirus vaccination: the United Kingdom s recommendation and update on European licensure and efficacy data

Pernas, S.; Tolaney, S.M.; Winer, E.P.; Goel, S., 2018:
CDK4/6 inhibition in breast cancer: current practice and future directions

Brotherton, J.M.L., 2016:
Human papillomavirus vaccination: where are we now?

Garland, S.M., 2012:
Human papillomavirus vaccination: where to now?

Stupiansky, N.W.; Rosenthal, S.L.; Wiehe, S.E.; Zimet, G.D., 2010:
Human papillomavirus vaccine acceptability among a national sample of adult women in the USA

Madhivanan, P.; Li, T.; Srinivas, V.; Marlow, L.; Mukherjee, S.; Krupp, K., 2015:
Human papillomavirus vaccine acceptability among parents of adolescent girls: obstacles and challenges in Mysore, India

Gerend, M.A.; Barley, J., 2008:
Human papillomavirus vaccine acceptability among young adult men

Bodurka, D.C.; Schlumbrecht, M.P., 2010:
Human papillomavirus vaccine acceptability: is multimedia education ready for prime time?

Belani, H.Kumar.; Sekar, P.; Guhaniyogi, R.; Abraham, A.; Bohjanen, P.R.; Bohjanen, K., 2015:
Human papillomavirus vaccine acceptance among young men in Bangalore, India

Malo, T.L.; Staras, S.A.S.; Bynum, S.A.; Giuliano, A.R.; Shenkman, E.A.; Vadaparampil, S.T., 2014:
Human papillomavirus vaccine administration among Medicaid providers who consistently recommended vaccination

Cui, Y.; Baldwin, S.B.; Wiley, D.J.; Fielding, J.E., 2011:
Human papillomavirus vaccine among adult women: disparities in awareness and acceptance

Dempsey, A.F.; Zimet, G.D., 2008:
Human papillomavirus vaccine and adolescents

Oaknin, A.; Barretina, M.Pilar., 2008:
Human papillomavirus vaccine and cervical cancer prevention

McIntosh, J.; Sturpe, D.A.; Khanna, N., 2008:
Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists

Stupiansky, N.W.; Alexander, A.B.; Zimet, G.D., 2012:
Human papillomavirus vaccine and men: what are the obstacles and challenges?

Narducci, A.; Einarson, A.; Bozzo, P., 2012:
Human papillomavirus vaccine and pregnancy

Liddon, N.C.; Leichliter, J.S.; Markowitz, L.E., 2012:
Human papillomavirus vaccine and sexual behavior among adolescent and young women

Wang, S-Ming.; Zhang, S-Kai.; Pan, X-Fei.; Ren, Z-Fang.; Yang, C-Xia.; Wang, Z-Zhen.; Gao, X-Hong.; Li, M.; Zheng, Q-Qing.; Ma, W.; Zhao, F-Hui.; Qiao, Y-Lin.; Sivasubramaniam, P., 2015:
Human papillomavirus vaccine awareness, acceptability, and decision-making factors among Chinese college students

Bhatta, M.P.; Phillips, L., 2016:
Human papillomavirus vaccine awareness, uptake, and parental and health care provider communication among 11- to 18-year-old adolescents in a rural Appalachian Ohio county in the United States

Mullins, T.L.Kowalczyk.; Griffioen, A.M.; Glynn, S.; Zimet, G.D.; Rosenthal, S.L.; Fortenberry, J.Dennis.; Kahn, J.A., 2014:
Human papillomavirus vaccine communication: perspectives of 11-12 year-old girls, mothers, and clinicians

Yuji, K.; Matsumura, T.; Miyano, S.; Tsuchiya, R.; Kami, M., 2010:
Human papillomavirus vaccine coverage

Brotherton, J.M.L.; Murray, S.L.; Hall, M.A.; Andrewartha, L.K.; Banks, C.A.; Meijer, D.; Pitcher, H.C.; Scully, M.M.; Molchanoff, L., 2014:
Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach

Eberth, J.M.; Hossain, M.Monir.; Tiro, J.A.; Zhang, X.; Holt, J.B.; Vernon, S.W., 2013:
Human papillomavirus vaccine coverage among females aged 11 to 17 in Texas counties: an application of multilevel, small area estimation

Taylor, L'shan.D.; Hariri, S.; Sternberg, M.; Dunne, E.F.; Markowitz, L.E., 2011:
Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008

Breitkopf, C.Radecki.; Pearson, H.C.; Dinh, T.A.; Tran, B-Chieu.T.; Vu, T.; Phan, G.A.Bao.; Ngo, Q.V.; Tran, V.D.; Rosenthal, S.L., 2009:
Human papillomavirus vaccine decision-making in Da Nang, Vietnam: perceived spousal and adolescent-parent concordance

LaMontagne, D.Scott.; Barge, S.; Le, N.Thi.; Mugisha, E.; Penny, M.E.; Gandhi, S.; Janmohamed, A.; Kumakech, E.; Mosqueira, N.Rocio.; Nguyen, N.Quy.; Paul, P.; Tang, Y.; Minh, T.Hung.; Uttekar, B.Patel.; Jumaan, A.O., 2012:
Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries

McRee, A-Laurie.; Gottlieb, S.L.; Reiter, P.L.; Dittus, P.J.; Tucker Halpern, C.; Brewer, N.T., 2012:
Human papillomavirus vaccine discussions: an opportunity for mothers to talk with their daughters about sexual health

Smith-McCune, K.K., 2008:
Human papillomavirus vaccine efficacy: aligning expectations with reality

Finn, O.J.; Edwards, R.P., 2009 :
Human papillomavirus vaccine for cancer prevention

Anonymous, 2008:
Human papillomavirus vaccine for children and adolescents

Anonymous, 2007:
Human papillomavirus vaccine for genotypes 6, 11, 16 and 18: new drug. Cervical cancer prevention: high hopes...

Mayer, A.P.; Vegunta, S.; Files, J.A., 2012:
Human papillomavirus vaccine for women over forty: it's not just for kids

Etter, D.J.; Zimet, G.D.; Rickert, V.I., 2012:
Human papillomavirus vaccine in adolescent women: a 2012 update

Clothier, H.J.; Lee, K.J.; Sundararajan, V.; Buttery, J.P.; Crawford, N.W., 2013:
Human papillomavirus vaccine in boys: background rates of potential adverse events

Goldstein, M.A., 2008:
Human papillomavirus vaccine in males

Pellegrino, P.; Carnovale, C.; Perrone, V.; Salvati, D.; Gentili, M.; Antoniazzi, S.; Clementi, E.; Radice, S., 2014:
Human papillomavirus vaccine in patients with systemic lupus erythematosus

Tsu, V.Davis.; LaMontagne, D.Scott., 2012:
Human papillomavirus vaccine inaccuracies

Ratanasiripong, N.T., 2016:
Human papillomavirus vaccine increases high-risk sexual behaviors: a myth or valid concern

Guerry, S.L.; De Rosa, C.J.; Markowitz, L.E.; Walker, S.; Liddon, N.; Kerndt, P.R.; Gottlieb, S.L., 2011 :
Human papillomavirus vaccine initiation among adolescent girls in high-risk communities

Lu, P-jun.; Williams, W.W.; Li, J.; Dorell, C.; Yankey, D.; Kepka, D.; Dunne, E.F., 2013:
Human papillomavirus vaccine initiation and awareness: U.S. young men in the 2010 National Health Interview Survey

Gottlieb, S.L.; Brewer, N.T.; Sternberg, M.R.; Smith, J.S.; Ziarnowski, K.; Liddon, N.; Markowitz, L.E., 2010:
Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer

Patel, D.A.; Zochowski, M.; Peterman, S.; Dempsey, A.F.; Ernst, S.; Dalton, V.K., 2012:
Human papillomavirus vaccine intent and uptake among female college students

Crosby, R.A.; DiClemente, R.J.; Salazar, L.F.; Nash, R.; Younge, S.; Head, S., 2012:
Human papillomavirus vaccine intention among college men: what's oral sex got to do with it?

Wheldon, C.W.; Buhi, E.R.; Daley, E.M.; Hernandez, N.D.; Anstey, E.Hesch.; Kolar, S.; Giuliano, A.R., 2016:
Human papillomavirus vaccine intentions among males: a test of the Parallel Processing Model

Daley, E.M.; Marhefka, S.L.; Buhi, E.R.; Vamos, C.A.; Hernandez, N.D.; Giuliano, A.R., 2011:
Human papillomavirus vaccine intentions among men participating in a human papillomavirus natural history study versus a comparison sample

Nghi, N.Quy.; Lamontagne, D.Scott.; Bingham, A.; Rafiq, M.; Mai, L.Thi.Phuong.; Lien, N.Thi.Phuong.; Khanh, N.Cong.; Hong, D.Thi.; Huyen, D.Thi.Thanh.; Tho, N.Thi.Thi.; Hien, N.Tran., 2010:
Human papillomavirus vaccine introduction in Vietnam: formative research findings

Jit, M.; Demarteau, N.; Elbasha, E.; Ginsberg, G.; Kim, J.; Praditsitthikorn, N.; Sinanovic, E.; Hutubessy, R., 2011:
Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models

Markowitz, L.E.; Tsu, V.; Deeks, S.L.; Cubie, H.; Wang, S.A.; Vicari, A.S.; Brotherton, J.M.L., 2013:
Human papillomavirus vaccine introduction--the first five years

Dekker, R.L., 2008:
Human papillomavirus vaccine legislation in Kentucky: a policy analysis

Anonymous, 2011:
Human papillomavirus vaccine misconception could mean women do not attend screening, putting them at risk of cervical cancer

Laemmle-Ruff, I.; Barbaro, B.; Brotherton, J., 2014:
Human papillomavirus vaccine national catch-up program - insights into under-notification

Kepka, D.; Berkowitz, Z.; Yabroff, K.Robin.; Roland, K.; Saraiya, M., 2013:
Human papillomavirus vaccine practices in the USA: do primary care providers use sexual history and cervical cancer screening results to make HPV vaccine recommendations?

Mudur, G., 2010:
Human papillomavirus vaccine project stirs controversy in India

Kahn, J.A.; Cooper, H.Paul.; Vadaparampil, S.T.; Pence, B.C.; Weinberg, A.D.; LoCoco, S.J.; Rosenthal, S.L., 2009:
Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians

Spila-Alegiani, S.; Da Cas, R.; Giambi, C.; Raschetti, R.; Salmaso, S., 2013:
Human papillomavirus vaccine register

MacDonald, N.; Stanbrook, M.B.; Hébert, P.C., 2008:
Human papillomavirus vaccine risk and reality

Gold, M.S.; McIntyre, P., 2010:
Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance

Borja-Hart, N.L.; Benavides, S.; Christensen, C., 2009:
Human papillomavirus vaccine safety in pediatric patients: an evaluation of the Vaccine Adverse Event Reporting System

Patel, D.A.; Grunzweig, K.A.; Zochowski, M.K.; Dempsey, A.F.; Carlos, R.C.; Dalton, V.K., 2014:
Human papillomavirus vaccine stages of change among male and female university students: ready or not?

Sengupta, A.; Shenoi, A.; Sarojini, N.B.; Madhavi, Y., 2011:
Human papillomavirus vaccine trials in India

Laz, T.H.; Rahman, M.; Berenson, A.B., 2013:
Human papillomavirus vaccine uptake among 18- to 26-year-old women in the United States: National Health Interview Survey, 2010

Wong, C.A.; Berkowitz, Z.; Dorell, C.G.; Anhang Price, R.; Lee, J.; Saraiya, M., 2012:
Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008

Laz, T.H.; Rahman, M.; Berenson, A.B., 2014:
Human papillomavirus vaccine uptake among 9-17 year old males in the United States: the National Health Interview Survey, 2010

Bednarczyk, R.A.; Birkhead, G.S.; Morse, D.L.; Doleyres, H.; McNutt, L-Anne., 2011:
Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010

Stöcker, P.; Dehnert, M.; Schuster, M.; Wichmann, O.; Deleré, Y., 2013:
Human papillomavirus vaccine uptake, knowledge and attitude among 10th grade students in Berlin, Germany, 2010

Conroy, K.; Rosenthal, S.L.; Zimet, G.D.; Jin, Y.; Bernstein, D.I.; Glynn, S.; Kahn, J.A., 2010:
Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination

Lavelanet, A.F.; Stampler, K.M.; Dunton, C.J., 2015:
Human papillomavirus vaccine uptake: what works and what can we do better?

Tiro, J.A.; Tsui, J.; Bauer, H.M.; Yamada, E.; Kobrin, S.; Breen, N., 2012:
Human papillomavirus vaccine use among adolescent girls and young adult women: an analysis of the 2007 California Health Interview Survey

Baden, L.R.; Curfman, G.D.; Morrissey, S.; Drazen, J.M., 2007:
Human papillomavirus vaccine--opportunity and challenge

Abarca, K.; Valenzuela, M.Teresa.; Vergara, R.; Luchsinger, V.; Muñoz, A.; Jiménez de la J, J.; Ripoll, E.; O'Ryan, M., 2009:
Human papillomavirus vaccine. Statement of the Advisory Committee of Immunizations on behalf of the Chilean Infectious Diseases Society. September 2008

Abarca V, K.; Valenzuela B, M.Teresa.; Vergara F, R.; Luchsinger F, V.; Muñoz M, A.; Jiménez de la Jara, J.; Ripoll M, E.; O'Ryan G, M., 2009:
Human papillomavirus vaccine. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society. September 2008

Savas, L.S.; Fernández, M.E.; Jobe, D.; Carmack, C.C., 2013:
Human papillomavirus vaccine: 2-1-1 helplines and minority parent decision-making

Shin, G.Yen., 2008:
Human papillomavirus vaccine: Effect of ethnic group should be clarified

Brown, E.C.F., 2008:
Human papillomavirus vaccine: Some issues around consent remain unresolved

Jenson, H.B., 2009 :
Human papillomavirus vaccine: a paradigm shift for pediatricians

Goel, S.; DeCristo, M.J.; McAllister, S.S.; Zhao, J.J., 2018:
CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest

Luedtke, S., 2008:
Human papillomavirus vaccine: are the concerns unfounded?

Jenson, H.B.; Baltimore, R.S., 2011:
Human papillomavirus vaccine: now for boys too?

Martínez-González, M.Angel.; Carlos, S.; de Irala, J., 2008:
Human papillomavirus vaccine: optimism versus prudence

Dinh, T.A.; Benoit, M.F., 2007:
Human papillomavirus vaccine: progress and the future

Fisher, R.; Darrow, D.H.; Tranter, M.; Williams, J.V., 2008:
Human papillomavirus vaccine: recommendations, issues and controversies

Bornstein, J., 2007:
Human papillomavirus vaccine: the beginning of the end for cervical cancer

MacDonald, N.; Hébert, P.C., 2007:
Human papillomavirus vaccine: waiting for a miracle

No, J.Hong.; Kim, M-Kyung.; Jeon, Y-Tark.; Kim, Y-Beom.; Song, Y-Sang., 2011:
Human papillomavirus vaccine: widening the scope for cancer prevention

Berer, M., 2007:
Human papillomavirus vaccines

Brun, J-L., 2008:
Human papillomavirus vaccines

Satyaprakash, A.; Creed, R.; Ravanfar, P.; Mendoza, N., 2009:
Human papillomavirus vaccines

Franceschi, S.; De Vuyst, H., 2009:
Human papillomavirus vaccines and anal carcinoma

Rathfisch, Gülay.; Güngör, İlkay.; Uzun, E.; Keskin, Özlem.; Tencere, Z., 2016:
Human papillomavirus vaccines and cervical cancer: awareness, knowledge, and risk perception among Turkish undergraduate students

Ault, K.A., 2008:
Human papillomavirus vaccines and the potential for cross-protection between related HPV types

de Sanjosé, S.; Alemany, L.; Castellsagué, X.; Bosch, F.Xavier., 2009:
Human papillomavirus vaccines and vaccine implementation

Sahasrabuddhe, V.V.; Sherman, M.E., 2013:
Human papillomavirus vaccines for cervical cancer prevention: translating possibility into reality

De Vuyst, H.; Franceschi, S., 2007:
Human papillomavirus vaccines in HIV-positive men and women

Ganry, O.; Bernin-Mereau, A-S.; Gignon, M.; Merlin-Brochard, J.; Schmit, J-L., 2014:
Human papillomavirus vaccines in Picardy, France: coverage and correlation with socioeconomic factors

Giorgi, C.; Franconi, R.; Rybicki, E.P., 2010:
Human papillomavirus vaccines in plants

Dawar, M.; Deeks, S.; Dobson, S., 2007:
Human papillomavirus vaccines launch a new era in cervical cancer prevention

Shaw, A.R., 2013:
Human papillomavirus vaccines six years after approval

Markman, M., 2007:
Human papillomavirus vaccines to prevent cervical cancer

Stanley, M., 2008:
Human papillomavirus vaccines versus cervical cancer screening

Stanley, M.; Pinto, L.A.; Trimble, C., 2013:
Human papillomavirus vaccines--immune responses

Who, 2010:
Human papillomavirus vaccines: WHO position paper

Anonymous, 2014:
Human papillomavirus vaccines: WHO position paper, October 2014

Singh, A.; Wong, T.; Howlett, R.I., 2009:
Human papillomavirus vaccines: Why the time is right to implement immunization and surveillance programs in Canada

Jenkins, D., 2008:
Human papillomavirus vaccines: a complex decision focused on cancer prevention and cost-effectiveness

Trollfors, B., 2008:
Human papillomavirus vaccines: an outsider's point of view

Ault, K.A., 2008 :
Human papillomavirus vaccines: an update for gynecologists

Kawana, K.; Yasugi, T.; Taketani, Y., 2010:
Human papillomavirus vaccines: current issues & future

Garland, S.M.; Smith, J.S., 2010:
Human papillomavirus vaccines: current status and future prospects

Isidean, S.D.; Tota, J.E.; Gagnon, J.A.; Franco, E.L., 2015:
Human papillomavirus vaccines: key factors in planning cost-effective vaccination programs

Luciani, S.; Jauregui, B.; Kieny, C.; Andrus, J.Kim., 2011:
Human papillomavirus vaccines: new tools for accelerating cervical cancer prevention in developing countries

Neels, P.; van Damme, P.; van Ranst, M.; Dogné, J-Michel., 2013:
Human papillomavirus vaccines: understanding the benefit-risk

Firnhaber, C.; Wilkin, T., 2012:
Human papillomavirus vaccines: where do they fit in HIV-infected individuals?

Freitas, A.C.; Mariz, F.C.; Silva, M.A.R.; Jesus, A.L.S., 2013:
Human papillomavirus vertical transmission: review of current data

Bencomo-Álvarez, A.E.; Limones-Perches, I.; Suárez-Rincón, A.E.; Ramírez-Jirano, L.J.; Borrayo-Carbajal, E.; Sánchez-Corona, J.; Montoya-Fuentes, H., 2013:
Human papillomavirus viral load in cervical intraepithelial neoplasia as a prognostic factor in a Mexican population

Labani, S.; Asthana, S., 2015:
Human papillomavirus viral load on careHPV testing of self-collected vaginal samples vs. clinician-collected cervical samples

Ingles, D.J.; Pierce Campbell, C.M.; Messina, J.A.; Stoler, M.H.; Lin, H-Yi.; Fulp, W.J.; Abrahamsen, M.; Sirak, B.A.; O'Keefe, M.T.; Papenfuss, M.; Gage, C.; Carvalho da Silva, R.; Gonzalez Sosa, R.; Rojas Juarez, O.; Villa, L.L.; Lazcano Ponce, E.; Giuliano, A.R., 2015:
Human papillomavirus virus (HPV) genotype- and age-specific analyses of external genital lesions among men in the HPV Infection in Men (HIM) Study

Feng, S.; Zheng, J.; Du, X.; Tan, Y.; Yang, H.; Zhang, H.; Zhang, Z., 2013:
Human papillomavirus was not detected by PCR using multiple consensus primer sets in esophageal adenocarcinomas in Chinese patients

Yanatatsaneejit, P.; Mutirangura, A.; Kitkumthorn, N., 2011:
Human papillomavirus's physical state and cyclin A1 promoter methylation in cervical cancer

Gilman, M.; Gilman, S.L.; Johns, M.M., 2009:
Human papillomavirus, abstinence, and the other risks

Cachay, E.R.; Mathews, W.Christopher., 2013:
Human papillomavirus, anal cancer, and screening considerations among HIV-infected individuals

Heard, I., 2011:
Human papillomavirus, cancer and vaccination

Lowy, D., 2008:
Human papillomavirus, cervical cancer prevention, and more

Tovar, J.M.; Bazaldua, O.V.; Vargas, L.; Reile, E., 2008:
Human papillomavirus, cervical cancer, and the vaccines

Teitelman, A.M.; Stringer, M.; Averbuch, T.; Witkoski, A., 2009:
Human papillomavirus, current vaccines, and cervical cancer prevention

Hsueh, P-Ren., 2009:
Human papillomavirus, genital warts, and vaccines

Brestovac, B.; Wong, M.E.; Tjendera, R.; Costantino, P.J.; Mamotte, C.; Witt, C.S., 2013:
Human papillomavirus, high-grade intraepithelial neoplasia and killer immunoglogulin-like receptors: a Western Australian cohort study

Denny, L.A.; Franceschi, S.; de Sanjosé, S.; Heard, I.; Moscicki, A.Barbara.; Palefsky, J., 2013:
Human papillomavirus, human immunodeficiency virus and immunosuppression

Smith, E.M.; Rubenstein, L.M.; Hoffman, H.; Haugen, T.H.; Turek, L.P., 2010:
Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer

Hoefling, N.L.; McHugh, J.B.; Light, E.; Kumar, B.; Walline, H.; Prince, M.; Bradford, C.; Carey, T.E.; Mukherji, S.K., 2013:
Human papillomavirus, p16, and epidermal growth factor receptor biomarkers and CT perfusion values in head and neck squamous cell carcinoma

Sinha, P.; Logan, H.L.; Mendenhall, W.M., 2012:
Human papillomavirus, smoking, and head and neck cancer

Lippman, A.; Melnychuk, R.; Shimmin, C.; Boscoe, M., 2007:
Human papillomavirus, vaccines and women's health: questions and cautions

Altinbas, S.K.; Tapisiz, O.L., 2013:
Human papillomavirus, vaccines, and protection from cervical cancer

Shepherd, L.J.; Bryson, S.C.Peter., 2009:
Human papillomavirus--lessons from history and challenges for the future

Mileo, A.M.; Abbruzzese, C.; Mattarocci, S.; Bellacchio, E.; Pisano, P.; Federico, A.; Maresca, V.; Picardo, M.; Giorgi, A.; Maras, B.; Schininà, M.Eugenia.; Paggi, M.G., 2010:
Human papillomavirus-16 E7 interacts with glutathione S-transferase P1 and enhances its role in cell survival

Kalantari, M.; Villa, L.L.; Calleja-Macias, I.E.; Bernard, H-Ulrich., 2008:
Human papillomavirus-16 and -18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation

Lee, L-Ang.; Huang, C-Guei.; Liao, C-Ta.; Lee, L-Yu.; Hsueh, C.; Chen, T-Ching.; Lin, C-Yu.; Fan, K-Hsing.; Wang, H-Ming.; Huang, S-Fu.; Chen, I-How.; Kang, C-Jan.; Ng, S-Hang.; Yang, S-Li.; Tsao, K-Chien.; Chang, Y-Liang.; Yen, T-Chen., 2013:
Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival

Heideman, Dëlle.A.M.; Waterboer, T.; Pawlita, M.; Delis-van Diemen, P.; Nindl, I.; Leijte, J.A.; Bonfrer, J.M.G.; Horenblas, S.; Meijer, C.J.L.M.; Snijders, P.J.F., 2007:
Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma

Meyer, M.S.; Applebaum, K.M.; Furniss, C.Sloane.; Peters, E.S.; Luckett, B.G.; Smith, J.F.; Bryan, J.; McClean, M.D.; Marsit, C.; Kelsey, K.T., 2008:
Human papillomavirus-16 modifies the association between fruit consumption and head and neck squamous cell carcinoma

Aguayo, F.; Anwar, M.; Koriyama, C.; Castillo, A.; Sun, Q.; Morewaya, J.; Eizuru, Y.; Akiba, S., 2010:
Human papillomavirus-16 presence and physical status in lung carcinomas from Asia

Horewicz, Vônica.V.; Feres, M.; Rapp, G.E.; Yasuda, V.; Cury, P.R., 2010:
Human papillomavirus-16 prevalence in gingival tissue and its association with periodontal destruction: a case-control study

Ngan, H.Y.S.; Cheung, A.N.Y.; Tam, K.F.; Chan, K.K.L.; Tang, H.W.; Bi, D.; Descamps, D.; Bock, H.L., 2010:
Human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine: immunogenicity and safety in healthy Chinese women from Hong Kong

Lyseng-Williamson, K.A., 2014:
Human papillomavirus-16/18 AS04-adjuvanted vaccine (cervarix®): a guide to its two-dose schedule in girls aged 9-14 years in the EU

Liu, N.; Wang, J.; Lei, L.; Li, Y.; Zhou, M.; Dan, H.; Zeng, X.; Chen, Q., 2015:
Human papillomavirus-32-associated focal epithelial hyperplasia accompanying HPV-16-positive papilloma-like lesions in oral mucosa

DePond, W.; Kure, K.; Lankachandra, K.; Gidwani, R.; Nelson, B.V.; Zimmerman, H.; Talboy, G.E.; Miranda, R.N., 2009:
Human papillomavirus-58 and -73-associated digital squamous cell carcinoma in a patient with aggressive digital papillary adenocarcinoma

Weinberger, P.M.; Merkley, M.A.; Khichi, S.S.; Lee, J.R.; Psyrri, A.; Jackson, L.L.; Dynan, W.S., 2010:
Human papillomavirus-active head and neck cancer and ethnic health disparities

Chang, A.Margaret.V.; Nikiforova, M.N.; Johnson, J.T.; Bauman, J.E.; Perez-Ordonez, B.; Seethala, R.R.; Krane, J.F.; Chiosea, S.I., 2015:
Human papillomavirus-associated adenocarcinoma of the base of tongue: potentially actionable genetic changes

Damato, S.; Thavaraj, S.; Winter, S.; Shah, K.A., 2014:
Human papillomavirus-associated adenocarcinoma of the palatine tonsil

Wikström, A.; Hedblad, M-Anne.; Syrjänen, S., 2014:
Human papillomavirus-associated balanoposthitis--a marker for penile intraepithelial neoplasia?

Anonymous, 2012:
Human papillomavirus-associated cancers - United States, 2004-2008

Grce, M.; Mravak-Stipetić, M., 2014:
Human papillomavirus-associated diseases

Kreuter, A.; Wieland, U., 2009:
Human papillomavirus-associated diseases in HIV-infected men who have sex with men

Gonçalves, A., 2018:
CDK4/6 inhibitors: biomarkers, mechanisms of resistance and interest of the study of the circulating tumor DNA

Salazar, C.R.; Smith, R.V.; Garg, M.K.; Haigentz, M.; Schiff, B.A.; Kawachi, N.; Anayannis, N.; Belbin, T.J.; Prystowsky, M.B.; Burk, R.D.; Schlecht, N.F., 2014:
Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment

Kreuter, A.; Skrygan, M.; Gambichler, T.; Brockmeyer, N.H.; Stücker, M.; Herzler, C.; Potthoff, A.; Altmeyer, P.; Pfister, H.; Wieland, U., 2009:
Human papillomavirus-associated induction of human beta-defensins in anal intraepithelial neoplasia

Nguyen, N.P.; Chi, A.; Nguyen, L.M.; Ly, B.H.; Karlsson, U.; Vinh-Hung, V., 2010:
Human papillomavirus-associated oropharyngeal cancer: a new clinical entity

Ukpo, O.C.; Pritchett, C.V.; Lewis, J.E.; Weaver, A.L.; Smith, D.I.; Moore, E.J., 2009:
Human papillomavirus-associated oropharyngeal squamous cell carcinomas: primary tumor burden and survival in surgical patients

Chau, N.G.; Rabinowits, G.; Haddad, R.I., 2015:
Human papillomavirus-associated oropharynx cancer (HPV-OPC): treatment options

Sato, Y.; Nozaki, T.; Matsusako, M.; Eto, H.; Matsui, M.; Ohtake, N.; Suzuki, K.; Starkey, J.; Saida, Y., 2014:
Human papillomavirus-associated plantar epidermoid cysts: MR and US imaging appearance

Jung, K-D.; Kim, P-S.; Lee, J-H.; Yang, J-M.; Lee, E-S.; Lee, D-Y.; Jang, K-T.; Kim, D-S., 2009:
Human papillomavirus-associated recurrent plantar epidermal cysts in a patient after organ transplantation

Turowski, C.Bansal.; Ross, A.S.; Cusack, C.Ann., 2009:
Human papillomavirus-associated squamous cell carcinoma of the nail bed in African-American patients

Stelow, E.B.; Jo, V.Y.; Stoler, M.H.; Mills, S.E., 2010:
Human papillomavirus-associated squamous cell carcinoma of the upper aerodigestive tract

Ojha, R.P.; Tota, J.E.; Offutt-Powell, T.N.; Klosky, J.L.; Minniear, T.D.; Jackson, B.E.; Gurney, J.G., 2014:
Human papillomavirus-associated subsequent malignancies among long-term survivors of pediatric and young adult cancers

Krüger-Corcoran, D.; Stockfleth, E.; Jürgensen, J.S.; Maltusch, A.; Nindl, I.; Sterry, W.; Lange-Asschenfeldt, B.; Ulrich, C., 2010:
Human papillomavirus-associated warts in organ transplant recipients. Incidence, risk factors, management

Denny, L.; Kuhn, L.; Hu, C-Chi.; Tsai, W-Yann.; Wright, T.C., 2010:
Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial

Arbyn, M.; Martin-Hirsch, P.; Wentzensen, N., 2010:
Human papillomavirus-based triage of women showing a cervical cytology result of borderline or mild dyskaryosis

Valerón-Almazán, P.; Bastida, Jús.; Rivero, P.; Vilar, J.; Dehesa, L.; Díaz-Cascajo, C.; Carretero, G., 2011:
Human papillomavirus-induced lesions on tattoos may show features of seborrheic keratosis

Ramirez-Fort, M.K., 2012:
Human papillomavirus-induced periungual pigmented Bowen's disease

Millán, A.Fernández-San.; Gómez-Sebastián, S.; Nuñez, Mía.C.; Veramendi, J.; Escribano, Jé.M., 2010:
Human papillomavirus-like particles vaccine efficiently produced in a non-fermentative system based on insect larva

Feller, L.; Wood, N.H.; Khammissa, R.A.G.; Lemmer, J., 2010:
Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 1: human papillomavirus-mediated carcinogenesis

Feller, L.; Wood, N.H.; Khammissa, R.A.G.; Lemmer, J., 2010:
Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma

Thariat, J.; Cecille, B.; Claire, F.; Pierre-yves, M.; Adrien, R.Christian., 2010:
Human papillomavirus-positive basaloid squamous cell carcinomas of the head and neck

Chernock, R.D.; Lewis, J.S.; Zhang, Q.; El-Mofty, S.K., 2010:
Human papillomavirus-positive basaloid squamous cell carcinomas of the upper aerodigestive tract: a distinct clinicopathologic and molecular subtype of basaloid squamous cell carcinoma

Sharma, A.; Méndez, E.; Yueh, B.; Lohavanichbutr, P.; Houck, J.; Doody, D.R.; Futran, N.D.; Upton, M.P.; Schwartz, S.M.; Chen, C., 2012:
Human papillomavirus-positive oral cavity and oropharyngeal cancer patients do not have better quality-of-life trajectories

Ginori, A.; Barone, A.; Santopietro, R.; Barbanti, G.; Cecconi, F.; Tripodi, S.Antonio., 2015:
Human papillomavirus-related basaloid squamous cell carcinoma of the bladder associated with genital tract human papillomavirus infection

Ortiz, A.Patricia.; Pérez-Irizarry, J.; Soto-Salgado, M.; Suárez, E.; Pérez, N.; Cruz, M.; Palefsky, J.; Tortolero-Luna, G.; Miranda, S.; Colón-López, V., 2015:
Human papillomavirus-related cancers among people living with AIDS in Puerto Rico

Hwang, S.Jin.; Ok, S.; Lee, H-Man.; Lee, E.; Park, I-Ho., 2015:
Human papillomavirus-related carcinoma with adenoid cystic-like features of the inferior turbinate: a case report

Bishop, J.A.; Ogawa, T.; Stelow, E.B.; Moskaluk, C.A.; Koch, W.M.; Pai, S.I.; Westra, W.H., 2013:
Human papillomavirus-related carcinoma with adenoid cystic-like features: a peculiar variant of head and neck cancer restricted to the sinonasal tract

Bishop, J.A.; Guo, T.W.; Smith, D.F.; Wang, H.; Ogawa, T.; Pai, S.I.; Westra, W.H., 2013:
Human papillomavirus-related carcinomas of the sinonasal tract

Ryu, C.Hwan.; Ryu, J.; Cho, K.Ho.; Moon, S.Ho.; Yun, T.; Lee, S-Hyun.; Choi, M.Kyung.; Park, W.Seo.; Jung, Y-S., 2014:
Human papillomavirus-related cell cycle markers can predict survival outcomes following a transoral lateral oropharyngectomy for tonsillar squamous cell carcinoma

Steele, C.Brooke.; Thomas, C.N.; Richardson, L.C., 2008:
Human papillomavirus-related content in state and tribal comprehensive cancer control plans

Palefsky, J.M., 2010:
Human papillomavirus-related disease in men: not just a women's issue

Palefsky, J., 2009:
Human papillomavirus-related disease in people with HIV

Stier, E.A.; Baranoski, A.S., 2009:
Human papillomavirus-related diseases in HIV-infected individuals

Zekan, J.; Skerlev, M.; Milić, L.; Karelović, D., 2014:
Human papillomavirus-related diseases of the female lower genital tract: oncogenic aspects and molecular interaction

Gillison, M.L., 2008:
Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination

Gormley, R.H.; Kovarik, C.L., 2012:
Human papillomavirus-related genital disease in the immunocompromised host: Part I

Gormley, R.H.; Kovarik, C.L., 2012:
Human papillomavirus-related genital disease in the immunocompromised host: Part II

Growdon, W.B.; Del Carmen, M., 2009:
Human papillomavirus-related gynecologic neoplasms: screening and prevention

Stelow, E.B., 2014:
Human papillomavirus-related head and neck squamous cell carcinoma

Psyrri, A.; Gouveris, P.; Vermorken, J.Baptist., 2009:
Human papillomavirus-related head and neck tumors: clinical and research implication

Vainshtein, J.; McHugh, J.B.; Spector, M.E.; Walline, H.M.; Komarck, C.M.; Stenmark, M.H.; Prince, M.E.; Worden, F.P.; Wolf, G.T.; Bradford, C.R.; Chepeha, D.B.; Carey, T.; Eisbruch, A., 2015:
Human papillomavirus-related oropharyngeal cancer: HPV and p16 status in the recurrent versus parent tumor

Qi, S-Zhen.; Wang, S-Ming.; Shi, J-Fang.; Wang, Q-Qiu.; Chen, X-Sheng.; Sun, L-Jun.; Liu, A.; Zhang, N.; Jiang, N.; Siva, P.; Xu, X-Lian.; Qiao, Y-Lin., 2015:
Human papillomavirus-related psychosocial impact of patients with genital warts in China: a hospital-based cross-sectional study

Dzeletovic, I.; Pasha, S.; Leighton, J.A., 2010:
Human papillomavirus-related rectal squamous cell carcinoma in a patient with ulcerative colitis diagnosed on narrow-band imaging

Bishop, J.A.; Westra, W.H., 2011:
Human papillomavirus-related small cell carcinoma of the oropharynx

Chernock, R.D.; Zhang, Q.; El-Mofty, S.K.; Thorstad, W.L.; Lewis, J.S., 2011:
Human papillomavirus-related squamous cell carcinoma of the oropharynx: a comparative study in whites and African Americans

Imko-Walczuk, B.; Cegielska, A.; Placek, W.; Kaszewski, S.; Fiedor, P., 2015:
Human papillomavirus-related verrucous carcinoma in a renal transplant patient after long-term immunosuppression: a case report

Rabelo-Santos, S.Helena.; Derchain, S.Françoise.Mauricette.; Villa, Lísa.Lina.; Costa, M.Cecília.; Sarian, L.Otávio.Zanatta.; do Amaral Westin, M.Cristina.; Kornegay, J.; Zeferino, L.Carlos., 2009:
Human papillomavirus-specific genotypes in cervical lesions of women referred for smears with atypical glandular cells or adenocarcinoma in situ

Nieto, K.; Gissmann, L.; Schädlich, L., 2011:
Human papillomavirus-specific immune therapy: failure and hope

Ko, Y.Ho.; Won, H.Sung.; Sun, D.Sheng.; An, H.Jung.; Jeon, E.Kyoung.; Kim, M.Sik.; Lee, H.Hong.; Kang, J.Hyoung.; Jung, C.Kwon., 2015:
Human papillomavirus-stratified analysis of the prognostic role of miR-21 in oral cavity and oropharyngeal squamous cell carcinoma

Dede, M.; Kubar, A.; Yenen, M.Cemal.; Alanbay, I.; Guven, S.; Mesten, Z.; Baser, I., 2007:
Human papillomavirus-type predict the clinical outcome of imiquimod therapy for women with vulvar condylomata acuminata

Chou, Y-Yu.; Lin, M-Chieh.; Huang, L-Wen., 2013:
Human papillomavirus-unrelated gastric type of cervical adenocarcinoma presenting with a metastatic ovarian tumor: report of a case

Anonymous, 2009:
Human papillomavirus: HPV information for clinicians

Nielsen, A.R.; Hayney, M.S., 2015:
Human papillomavirus: a brief overview and recommendations for pharmacists

Maher, H.K., 2007:
Human papillomavirus: a new vaccine

Gallegos-Hernández, Jé.Francisco.; Paredes-Hernández, E.; Flores-Díaz, R.; Minauro-Muñoz, G.; Apresa-García, T.; Hernández-Hernández, D.María., 2007:
Human papillomavirus: association with head and neck cancer

Adelstein, D.J.; Rodriguez, C.P., 2010:
Human papillomavirus: changing paradigms in oropharyngeal cancer

Juckett, G.; Hartman-Adams, H., 2011:
Human papillomavirus: clinical manifestations and prevention

Malik, H.; Khan, F.H.; Ahsan, H., 2014:
Human papillomavirus: current status and issues of vaccination

Weaver, B.A.; Cymet, T.C., 2011:
Human papillomavirus: every answer raises more questions

Graham, S.V., 2011:
Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies

Anonymous, 2007:
Human papillomavirus: often harmless but in some cases carcinogenic

Liu, H-tu., 2010:
Human papillomavirus: opportunities and challenges for us

de Aguiar, S.Regina.Vasconcellos.; Villanova, F.Elizabeth.; Martins, L.Carício.; dos Santos, M.Silva.; Maciel, J.de.Paula.; Falcão, L.Fábio.Magno.; Fuzii, H.Thais.; Quaresma, J.Antônio.Simões., 2015:
Human papillomavirus: prevalence and factors associated in women prisoners population from the Eastern Brazilian Amazon

Entiauspe, L.Gonçalves.; Teixeira, L.Ortiz.; Mendoza-Sassi, R.Andrés.; Gonçalves, C.Vitola.; Gonçalves, P.; Martinez, A.Maria.Barral.de., 2011:
Human papillomavirus: prevalence and genotypes found among HIV-positive and negative women at a reference center in the far south of Brazil

Bosch, F.Xavier., 2012:
Human papillomavirus: science and technologies for the elimination of cervical cancer

Ciarrocca, K.; Jackson, L.L.; De Rossi, S.S., 2013:
Human papillomavirus: the fundamentals of HPV for oral health care providers

Rajaram, S.; Mehta, S.; Goel, N., 2011:
Human papillomavirus: the silent intruder

Dempsey, A.F., 2008:
Human papillomavirus: the usefulness of risk factors in determining who should get vaccinated

Cho, N.Hoon., 2015:
Human papillomavirus: wearisome or awesome issue?

Barras, V.; Jacot-Guillarmod, M., 2014:
Human papillomavirus: what do young people really know about it?

Falter Ii, K.J.; Frimer, M.; Lavy, D.; Samuelson, R.; Shahabi, S., 2013:
Human papillomavirusassociated cancers as acquired immunodeficiency syndrome defining illnesses

Kane, M.A., 2008:
Human papillomaviruses (HPV) vaccines: implementation and communication issues

Sourvinos, G.; Mammas, I.N.; Derdas, S.; Spandidos, D.A., 2013:
Human papillomaviruses (HPVs) in lung cancer: a causative trigger or just a co-incidence?

Moody, C.A.; Laimins, L.A., 2009:
Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation

Fu, Y.L.; Hu, Y.X.; Ling, H.L.; Ye, Z.Z.; Liang, T.; Zhang, M.G.; Liu, Y.K.; Kang, B.; Luo, Y.J.; He, S.Y.; Lian, Y.J., 1994:
Human papillomaviruses and papillomatosis lesions of the female lower genital tract

Beglin, M.; Melar-New, M.; Laimins, L., 2010:
Human papillomaviruses and the interferon response

Alos, L.; Moyano, S.; Nadal, A.; Alobid, I.; Blanch, J.L.; Ayala, E.; Lloveras, Bén.; Quint, W.; Cardesa, A.; Ordi, J., 2009:
Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome

Skálová, A.; Kašpírková, J.; Andrle, P.; Hostička, L.; Vaneček, Táš., 2013:
Human papillomaviruses are not involved in the etiopathogenesis of salivary gland tumors

Mumba, E.; Ali, H.; Turton, D.; Cooper, K.; Grayson, W., 2008:
Human papillomaviruses do not play an aetiological role in Müllerian adenosarcomas of the uterine cervix

Kato, M.; Shimizu, A.; Takeuchi, Y.; Hattori, T.; Abe, M.; Amano, H.; Motegi, S-ichiro.; Tamura, A.; Ishikawa, O., 2015:
Human papillomaviruses in anogenital epithelial lesions

Al-Ahdal, M.N.; Al-Arnous, W.K.; Bohol, M.F.; Abuzaid, S.M.; Shoukri, M.M.; Elrady, K.S.; Firdous, N.; Aliyan, R.; Taseer, R.; Al-Hazzani, A.A.; Al-Qahtani, A.A., 2014:
Human papillomaviruses in cervical specimens of women residing in Riyadh, Saudi Arabia: a hospital-based study

Syrjänen, S., 2007:
Human papillomaviruses in head and neck carcinomas

Hoffmann, M.; Folz, B.J.; Niemann, A.M.; Gottschlich, S.; Lippert, B.M.; Mahnke, C.G.; Werner, J.A., 1998:
Human papillomaviruses in hypopharyngeal squamous cell carcinoma

Carrilho, C.; Gouveia, Pícia.; Yokohama, H.; Lopes, Jé.M.; Lunet, N.; Ferro, J.; Ismail, M.; Walboomers, J.; Sobrinho-Simões, M.; David, L., 2014:
Human papillomaviruses in intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva: a study from Mozambique

Syrjänen, S.; Lodi, G.; von Bültzingslöwen, I.; Aliko, A.; Arduino, P.; Campisi, G.; Challacombe, S.; Ficarra, G.; Flaitz, C.; Zhou, H.M.; Maeda, H.; Miller, C.; Jontell, M., 2011:
Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review

von Knebel Doeberitz, M.; Reuschenbach, M., 2010:
Human papillomaviruses in the pathogenesis of intraepithelial neoplasia (AIN) and carcinoma of the anus

Tolstov, Y.; Hadaschik, B.; Pahernik, S.; Hohenfellner, M.; Duensing, S., 2014:
Human papillomaviruses in urological malignancies: a critical assessment

Melar-New, M.; Laimins, L.A., 2010:
Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins

Sagna, T.; Djigma, F.; Zeba, M.; Bisseye, C.; Karou, S.D.; Ouermi, D.; Pietra, V.; Gnoula, C.; Sanogo, K.; Nikiema, J.B.; Simpore, J., 2011:
Human papillomaviruses prevalence and genital co-infections in HIV-seropositive women in Ouagadougou (Burkina Faso)

Al Moustafa, A-Eddin.; Al-Awadhi, R.; Missaoui, N.; Adam, I.; Durusoy, R.; Ghabreau, L.; Akil, N.; Ahmed, H.Gadelkarim.; Yasmeen, A.; Alsbeih, G., 2015:
Human papillomaviruses-related cancers. Presence and prevention strategies in the Middle east and north African regions

Galloway, D.A., 2009:
Human papillomaviruses: a growing field

Burk, R.D.; Chen, Z.; Van Doorslaer, K., 2009:
Human papillomaviruses: genetic basis of carcinogenicity

Anonymous, 2011:
Human papillomaviruses: some genital-mucosal types

Jones, S.H.; Younghusband, O.Z.; Evans, J.A., 1948:
Human parabiotic pygopagus twins with hypertension; report of a case with clinical, psychologic and endocrinologic observations

Anonymous, 2010:
Human paragonimiasis after eating raw or undercooked crayfish --- Missouri, July 2006-September 2010

Aka, N'Da.A.; Adoubryn, K.; Rondelaud, D.; Dreyfuss, G., 2009:
Human paragonimiasis in Africa

Lane, M.A.; Barsanti, M.C.; Santos, C.A.; Yeung, M.; Lubner, S.J.; Weil, G.J., 2009:
Human paragonimiasis in North America following ingestion of raw crayfish

Ford, W.R.; Blair, A.E.; Evans, R.L.; John, E.; Bugert, J.J.; Broadley, K.J.; Kidd, E.J., 2013:
Human parainfluenza type 3 virus impairs the efficacy of glucocorticoids to limit allergy-induced pulmonary inflammation in guinea-pigs

Villaran, M.V.; García, J.; Gomez, J.; Arango, A.E.; Gonzales, M.; Chicaiza, W.; Alemán, W.; Lorenzana de Rivera, I.; Sanchez, F.; Aguayo, N.; Kochel, T.J.; Halsey, E.S., 2014:
Human parainfluenza virus in patients with influenza-like illness from Central and South America during 2006-2010

Ustun, C.; Slabý, Jří.; Shanley, R.M.; Vydra, J.; Smith, A.R.; Wagner, J.E.; Weisdorf, D.J.; Young, J-Anne.H., 2013:
Human parainfluenza virus infection after hematopoietic stem cell transplantation: risk factors, management, mortality, and changes over time

Ruampunpong, H.; Payungporn, S.; Samransamruajkit, R.; Pratheepamornkul, T.; Theamboonlers, A.; Poovorawan, Y., 2014:
Human parainfluenza virus infection in Thai children with lower respiratory tract infection from 2010 to 2013

Palermo, L.M.; Porotto, M.; Yokoyama, C.C.; Palmer, S.G.; Mungall, B.A.; Greengard, O.; Niewiesk, S.; Moscona, A., 2009:
Human parainfluenza virus infection of the airway epithelium: viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity

Chen, Y.; Zhong, J-Yu.; Lin, T., 2010:
Human parainfluenza virus infections in children with acute respiratory infections in Guangzhou area in 2007

Zhao, L-qing.; Qian, Y.; Wang, F.; Zhu, R-nan.; Deng, J., 2007:
Human parainfluenza virus infections in infants and young children with acute respiratory infections in Beijing

Bartlett, E.J.; Cruz, A-Marie.; Esker, J.; Castaño, A.; Schomacker, H.; Surman, S.R.; Hennessey, M.; Boonyaratanakornkit, J.; Pickles, R.J.; Collins, P.L.; Murphy, B.R.; Schmidt, A.C., 2008:
Human parainfluenza virus type 1 C proteins are nonessential proteins that inhibit the host interferon and apoptotic responses and are required for efficient replication in nonhuman primates

Ma, G-Feng.; Miettinen, S.; Porola, P.; Hedman, K.; Salo, J.; Konttinen, Yö.T., 2009:
Human parainfluenza virus type 2 (HPIV2) induced host ADAM8 expression in human salivary adenocarcinoma cell line (HSY) during cell fusion

Nishio, M.; Tsurudome, M.; Garcin, D.; Komada, H.; Ito, M.; Le Mercier, P.; Nosaka, T.; Kolakofsky, D., 2011:
Human parainfluenza virus type 2 L protein regions required for interaction with other viral proteins and mRNA capping

Hara, K.; Fukumura, M.; Ohtsuka, J.; Kawano, M.; Nosaka, T., 2014:
Human parainfluenza virus type 2 vector induces dendritic cell maturation without viral RNA replication/transcription

Cunha, B.A.; Mickail, N.; Schoch, P., 2012:
Human parainfluenza virus type 3 (HPIV 3) community-acquired pneumonia (CAP) mimicking pertussis in an adult: the diagnostic importance of hoarseness and monocytosis

Cunha, B.A.; Corbett, M.; Mickail, N., 2011:
Human parainfluenza virus type 3 (HPIV 3) viral community-acquired pneumonia (CAP) mimicking swine influenza (H1N1) during the swine flu pandemic

Roth, J.P.; Li, J.K-K.; Barnard, D.L., 2010:
Human parainfluenza virus type 3 (HPIV-3): construction and rescue of an infectious, recombinant virus expressing the enhanced green fluorescent protein (EGFP)

Sasaki, M.; Ishii, A.; Orba, Y.; Thomas, Y.; Hang'ombe, B.M.; Moonga, L.; Mweene, A.S.; Ogawa, H.; Nakamura, I.; Kimura, T.; Sawa, H., 2014:
Human parainfluenza virus type 3 in wild nonhuman primates, Zambia

Mao, N.; Ji, Y.; Xie, Z.; Wang, H.; Wang, H.; An, J.; Zhang, X.; Zhang, Y.; Zhu, Z.; Cui, A.; Xu, S.; Shen, K.; Liu, C.; Yang, W.; Xu, W., 2013:
Human parainfluenza virus-associated respiratory tract infection among children and genetic analysis of HPIV-3 strains in Beijing, China

Amonsen, M.; Smith, D.F.; Cummings, R.D.; Air, G.M., 2007:
Human parainfluenza viruses hPIV1 and hPIV3 bind oligosaccharides with alpha2-3-linked sialic acids that are distinct from those bound by H5 avian influenza virus hemagglutinin

Fledelius, H.C.; Goldschmidt, E.; Haargaard, B.; Jensen, H., 2015:
Human parallels to experimental myopia? A literature review on visual deprivation

Gallup, A.C.; Hack, G.D., 2012:
Human paranasal sinuses and selective brain cooling: a ventilation system activated by yawning?

Bajaj, P.; Tripathy, R.K.; Aggarwal, G.; Pande, A.H., 2015:
Human paraoxonase 1 as a pharmacologic agent: limitations and perspectives

Coombes, R.Hunter.; Meek, E.C.; Dail, M.Beth.; Chambers, H.W.; Chambers, J.E., 2014:
Human paraoxonase 1 hydrolysis of nanomolar chlorpyrifos-oxon concentrations is unaffected by phenotype or Q192R genotype

She, Z-Gang.; Zheng, W.; Wei, Y-Sheng.; Chen, H-Zao.; Wang, A-Bing.; Li, H-Liang.; Liu, G.; Zhang, R.; Liu, J-Jing.; Stallcup, W.B.; Zhou, Z.; Liu, D-Pei.; Liang, C-Chuan., 2009:
Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice

Mendonça, M.Isabel.; Dos Reis, R.Palma.; Freitas, A.I.; Sousa, A.C.; Pereira, A.; Faria, P.; Gomes, S.; Silva, B.; Santos, N.; Serrão, M.; Ornelas, Iídio.; Freitas, Sónia.; Araújo, Jé.J.; Brehm, Aónio.; Cardoso, A.Almada., 2009:
Human paraoxonase gene polymorphisms and coronary artery disease risk

Koncsos, Péter.; Seres, Ió.; Harangi, M.; Illyés, Ián.; Józsa, L.; Gönczi, F.; Bajnok, László.; Paragh, Görgy., 2010:
Human paraoxonase-1 activity in childhood obesity and its relation to leptin and adiponectin levels

Maselli, L.Morganti.Ferreira.; da Cunha, J.; Gutierrez, E.Battaggia.; Maranhão, R.Cavalcante.; Spada, C.; Bydlowski, Sérgio.Paulo., 2015:
Human paraoxonase-1 activity is related to the number of CD4+ T-cells and is restored by antiretroviral therapy in HIV-1-infected individuals

Tsai, H-Chin.; Chen, Y-Shen.; Yen, C-Min., 2014:
Human parasitic meningitis caused by Angiostrongylus cantonensis infection in Taiwan

Yang, C.Y.; Meng, C.L.; Wong, P.Y., 1993:
Human parathyroid hormone fragment stimulates the de novo synthesis of prostaglandin endoperoxide synthase in chick calvaria

Lee, J-Hwa.; Hwang, K-Jung.; Kim, M-Yeon.; Lim, Y-Jung.; Seol, I-Joon.; Jin, H-Jin.; Jang, Y-Kyung.; Choi, S-Jin.; Oh, W.; Cho, Y-Hee.; Lee, Y-Ho., 2012:
Human parathyroid hormone increases the mRNA expression of the IGF system and hematopoietic growth factors in osteoblasts, but does not influence expression in mesenchymal stem cells

Adriaansen, J.; Perez, P.; Zheng, C.; Collins, M.T.; Baum, B.J., 2011:
Human parathyroid hormone is secreted primarily into the bloodstream after rat parotid gland gene transfer

Selvarangan, R.; Nzabi, M.; Selvaraju, S.B.; Ketter, P.; Carpenter, C.; Harrison, C.J., 2011:
Human parechovirus 3 causing sepsis-like illness in children from midwestern United States

Luo, L.; Zhu, R.; Zhao, L.; Deng, J.; Wang, F.; Sun, Y.; Song, Q.; Ding, Y.; Qian, Y., 2015:
Human parechovirus associated sepsis and central nervous system infections in hospitalized children

Verboon-Maciolek, M.A.; Groenendaal, F.; Hahn, C.D.; Hellmann, J.; van Loon, A.M.; Boivin, G.; de Vries, L.S., 2008:
Human parechovirus causes encephalitis with white matter injury in neonates

Felsenstein, S.; Yang, S.; Eubanks, N.; Sobrera, E.; Grimm, J.P.; Aldrovandi, G., 2015:
Human parechovirus central nervous system infections in southern California children

Alam, M.Masroor.; Khurshid, A.; Shaukat, S.; Rana, M.Suleman.; Sharif, S.; Angez, M.; Nisar, N.; Naeem, M.; Zahoor Zaidi, S.Sohail., 2014:
Human parechovirus genotypes -10, -13 and -15 in Pakistani children with acute dehydrating gastroenteritis

Sharp, J.; Bell, J.; Harrison, C.J.; Nix, W.Allan.; Oberste, M.Steven.; Selvarangan, R., 2013:
Human parechovirus in respiratory specimens from children in Kansas City, Missouri

Pham, N.Thi.Kim.; Takanashi, S.; Tran, D.Nguyen.; Trinh, Q.Duy.; Abeysekera, C.; Abeygunawardene, A.; Khamrin, P.; Okitsu, S.; Shimizu, H.; Mizuguchi, M.; Ushijima, H., 2011:
Human parechovirus infection in children hospitalized with acute gastroenteritis in Sri Lanka

Davis, J.; Fairley, D.; Christie, S.; Coyle, P.; Tubman, R.; Shields, M.D., 2015:
Human parechovirus infection in neonatal intensive care

Fischer, T.K.; Midgley, S.; Dalgaard, C.; Nielsen, A.Y., 2014:
Human parechovirus infection, Denmark

Shan, T.L.; Wang, C.M.; Cui, L.; Delwart, E.; Yuan, C.L.; Zhao, W.; Guo, W.; Dai, X.Q.; Yu, Y.; Hua, X.G., 2010:
Human parechovirus infections in monkeys with diarrhea, China

Piralla, A.; Furione, M.; Rovida, F.; Marchi, A.; Stronati, M.; Gerna, G.; Baldanti, F., 2012:
Human parechovirus infections in patients admitted to hospital in Northern Italy, 2008-2010

Schuffenecker, I.; Javouhey, E.; Gillet, Y.; Kugener, Béatrice.; Billaud, Gève.; Floret, D.; Lina, B.; Morfin, F., 2012:
Human parechovirus infections, Lyon, France, 2008-10: evidence for severe cases

de Vries, M.; Pyrc, K.; Berkhout, R.; Vermeulen-Oost, W.; Dijkman, R.; Jebbink, M.F.; Bruisten, S.; Berkhout, B.; van der Hoek, L., 2007:
Human parechovirus type 1, 3, 4, 5, and 6 detection in picornavirus cultures

Kolehmainen, P.; Jääskeläinen, A.; Blomqvist, S.; Kallio-Kokko, H.; Nuolivirta, K.; Helminen, M.; Roivainen, M.; Lappalainen, M.; Tauriainen, S., 2015:
Human parechovirus type 3 and 4 associated with severe infections in young children

Calvo, C.; García-García, M.L.; Arroyas, M.; Trallero, G.; Cabrerizo, M., 2015:
Human parechovirus-3 infection in a neonate with fever and suspected sepsis

Levorson, R.E.; Jantausch, B.A.; Wiedermann, B.L.; Spiegel, H.M.L.; Campos, J.M., 2009:
Human parechovirus-3 infection: emerging pathogen in neonatal sepsis

Piñeiro, L.; Vicente, D.; Montes, M.; Hernández-Dorronsoro, U.; Cilla, G., 2010:
Human parechoviruses in infants with systemic infection

Kokko, H., 2008:
Human parental age difference and offspring count: and we still do not know what men or women want

Kanai, R.; Bahrami, B.; Rees, G., 2011:
Human parietal cortex structure predicts individual differences in perceptual rivalry

Kouritas, V.K.; Hatzoglou, C.; Foroulis, C.N.; Gourgoulianis, K.I., 2008:
Human parietal pleura present electrophysiology variations according to location in pleural cavity

Molinari, E.; Baraldi, P.; Campanella, M.; Duzzi, D.; Nocetti, L.; Pagnoni, G.; Porro, C.A., 2013:
Human parietofrontal networks related to action observation detected at rest

Bräuer, L.; Möschter, S.; Beileke, S.; Jäger, K.; Garreis, F.; Paulsen, F.P., 2009:
Human parotid and submandibular glands express and secrete surfactant proteins A, B, C and D

Abdolhosseini, M.; Sotsky, J.B.; Shelar, A.P.; Joyce, P.B.M.; Gorr, S-Ulrik., 2012:
Human parotid secretory protein is a lipopolysaccharide-binding protein: identification of an anti-inflammatory peptide domain

Hao, J.; Zhu, W.; Sheng, C.; Yu, Y.; Zhou, Q., 2009:
Human parthenogenetic embryonic stem cells: one potential resource for cell therapy

Turovets, N.; D'Amour, K.A.; Agapov, V.; Turovets, I.; Kochetkova, O.; Janus, J.; Semechkin, A.; Moorman, M.A.; Agapova, L., 2011:
Human parthenogenetic stem cells produce enriched populations of definitive endoderm cells after trichostatin A pretreatment

Benjamin, L.A.; Lewthwaite, P.; Vasanthapuram, R.; Zhao, G.; Sharp, C.; Simmonds, P.; Wang, D.; Solomon, T., 2011:
Human parvovirus 4 as potential cause of encephalitis in children, India

Slavov, S.N.; Kashima, S.; Rocha-Junior, M.C.; Silva-Pinto, A.C.; Oliveira, L.C.; Eis-Hübinger, A.M.; Covas, D.T., 2015:
Human parvovirus 4 in Brazilian patients with haemophilia, beta-thalassaemia major and volunteer blood donors

Biagini, P.; Dussol, B.; Touinssi, M.; Brunet, P.; Picard, C.; Moal, Vérie.; Belhouchet, M.; Gallian, P.; Cantaloube, J-François.; Attoui, H.; Berland, Y.; de Micco, P., 2008:
Human parvovirus 4 in kidney transplant patients, France

Drexler, J.Felix.; Reber, U.; Muth, D.; Herzog, P.; Annan, A.; Ebach, F.; Sarpong, N.; Acquah, S.; Adlkofer, J.; Adu-Sarkodie, Y.; Panning, M.; Tannich, E.; May, Jürgen.; Drosten, C.; Eis-Hübinger, A.Maria., 2013:
Human parvovirus 4 in nasal and fecal specimens from children, Ghana

Servant-Delmas, A.; Laperche, S.; Mercier, Mélanie.; Elghouzzi, M-Hélène.; Lionnet, Fçois.; Stankovic, K.; Girot, R.; Lefrère, J-Jacques., 2011:
Human parvovirus 4 in recipients of cellular products and in blood donors: epidemiologic similarity with B19 parvovirus

Delwart, E., 2012:
Human parvovirus 4 in the blood supply and transmission by pooled plasma-derived clotting factors: does it matter?

Servant-Delmas, A.; Laperche, S.; Lionnet, Fçois.; Sharp, C.; Simmonds, P.; Lefrère, J-Jacques., 2014:
Human parvovirus 4 infection in low- and high-risk French individuals

Lavoie, M.; Sharp, C.P.; Pépin, J.; Pennington, C.; Foupouapouognigni, Y.; Pybus, O.G.; Njouom, R.; Simmonds, P., 2012:
Human parvovirus 4 infection, Cameroon

May, Jürgen.; Drexler, J.Felix.; Reber, U.; Sarpong, N.; Adjei, O.; Panning, M.; Drosten, C.; Eis-Hübinger, A.Maria., 2013:
Human parvovirus 4 viremia in young children, Ghana

Cefalo, M.G.; Arlotta, A.; Maurizi, P.; Russo, I.; Sani, I.; Battista, A.; Mastrangelo, S.; Ruggiero, A.; Riccardi, R., 2012:
Human parvovirus B 19 and Epstein-Barr virus co-infection in a child with hereditary spherocytosis

Zakrzewska, K.; Corcioli, F.; Carlsen, K.M.; Giuggioli, D.; Fanci, R.; Rinieri, A.; Ferri, C.; Azzi, A., 2009:
Human parvovirus B19 (B19V) infection in systemic sclerosis patients

Lou, S.; Luo, Y.; Cheng, F.; Huang, Q.; Shen, W.; Kleiboeker, S.; Tisdale, J.F.; Liu, Z.; Qiu, J., 2012:
Human parvovirus B19 DNA replication induces a DNA damage response that is dispensable for cell cycle arrest at phase G2/M

Tsai, C-Chou.; Chiu, C-Ching.; Hsu, J-Dong.; Hsu, H-Sheng.; Tzang, B-Show.; Hsu, T-Ching., 2014:
Human parvovirus B19 NS1 protein aggravates liver injury in NZB/W F1 mice

Jain, P.; Jain, A.; Khan, D.Nasar.; Kumar, M., 2014:
Human parvovirus B19 associated dilated cardiomyopathy

Wan, Z.; Zhi, N.; Wong, S.; Keyvanfar, K.; Liu, D.; Raghavachari, N.; Munson, P.J.; Su, S.; Malide, D.; Kajigaya, S.; Young, N.S., 2010:
Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors

Knoester, M.; von dem Borne, P.A.; Vossen, A.C.T.M.; Kroes, A.C.M.; Claas, E.C.J., 2012:
Human parvovirus B19 genotype 3 associated with chronic anemia after stem cell transplantation, missed by routine PCR testing

Khameneh, Z.Rostamzadeh.; Hanifian, H.; Barzegari, R.; Sepehrvand, N., 2015:
Human parvovirus B19 in Iranian pregnant women: a serologic survey

Ibrahem, W.Nazar.; Hasony, H.Jaber.; Hassan, J.Ghulam., 2014:
Human parvovirus B19 in childhood acute lymphoblastic leukaemia in Basrah

Eid, A.J.; Chen, S.F., 2013:
Human parvovirus B19 in solid organ transplantation

Thammasri, K.; Rauhamäki, S.; Wang, L.; Filippou, A.; Kivovich, V.; Marjomäki, V.; Naides, S.J.; Gilbert, L., 2014:
Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells

von Landenberg, P.; Lehmann, H.W.; Modrow, S., 2007:
Human parvovirus B19 infection and antiphospholipid antibodies

Luo, Y.; Kleiboeker, S.; Deng, X.; Qiu, J., 2014:
Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication

Nagai, Y.; Hara, N.; Maeda, T.; Iwata, M.; Domon, K.; Ishii, T.; Yoshizawa, S.; Akimoto, T.; Kato, H.; Urita, S.; Nakanishi, K.; Sugimoto, M., 2009:
Human parvovirus B19 infection in 15 adults--two-year Toho University Hospital study

Alves, M.Teodoro.; Vilaça, S.Simone.; Carvalho, M.das.Graças.; Fernandes, A.Paula.; Dusse, L.Maria.Sant'.Ana.; Gomes, K.Braga., 2013:
Human parvovirus B19 infection in a renal transplant recipient: a case report

Diallo, D-A.; Guindo, A.; Dorie, A.; Djibo, N.; Algiman, E.; Ouane, O-D.; Diakité, A-A.; Traoré, F-F.; Ag Baraika, M.; Dembélé, A-K.; Tchernia, G., 2012 :
Human parvovirus B19 infection in sickle cell anemia patient in Mali: a case-control study

Ignatovich, I.V.; Hobbs, J.A., 2013:
Human parvovirus B19 infection leads to downregulation of thyroid, estrogen, and retinoid hormone receptor expression

Saeki, T.; Shibuya, M.; Sawada, H.; Miyamura, S.; Nakano, M.; Gejyo, F.; Arakawa, M., 2001:
Human parvovirus B19 infection mimicking systemic lupus erythematosus

Tzang, B-Show.; Chen, D-Yuan.; Tsai, C-Chou.; Chiang, S-Yi.; Lin, T-Ming.; Hsu, T-Ching., 2010:
Human parvovirus B19 nonstructural protein NS1 enhanced the expression of cleavage of 70 kDa U1-snRNP autoantigen

Sánchez-Rodríguez, S.P.; Münch-Anguiano, Lía.; Echeverría, O.; Vázquez-Nin, G.; Mora-Pale, M.; Dordick, J.S.; Bustos-Jaimes, I., 2012:
Human parvovirus B19 virus-like particles: In vitro assembly and stability

Bock, C-Thomas.; Klingel, K.; Kandolf, R., 2010:
Human parvovirus B19-associated myocarditis

Shimohata, H.; Higuchi, T.; Ogawa, Y.; Fujita, S.; Nagai, M.; Imaizumi, M.; Maruyama, H.; Hirayama, K.; Kobayashi, M., 2013:
Human parvovirus B19-induced acute glomerulonephritis: a case report

Kobayashi, Y.; Hatta, Y.; Ishiwatari, Y.; Kanno, H.; Takei, M., 2014:
Human parvovirus B19-induced aplastic crisis in an adult patient with hereditary spherocytosis: a case report and review of the literature

Zhang, X., 2010:
Human parvovirus B19/PARV4 infection is probably associated with chronic hepatitis B/C

Rogo, L.D.; Mokhtari-Azad, T.; Kabir, M.H.; Rezaei, F., 2014:
Human parvovirus B19: a review

Slavov, S.N.; Kashima, S.; Pinto, A.Cristina.Silva.; Covas, D.Tadeu., 2011:
Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions

Corcioli, F.; Zakrzewska, K.; Fanci, R.; De Giorgi, V.; Innocenti, M.; Rotellini, M.; Di Lollo, S.; Azzi, A., 2010:
Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V)

Liu, S-Chi.; Tsai, C-Ti.; Wu, C-Kai.; Yu, M-Fen.; Wu, M-Zon.; Lin, L-In.; Wang, S-Shen.; Hwang, J-Jen.; Tseng, Y-Zu.; Chiang, F-Tien.; Tseng, C-Den., 2010:
Human parvovirus b19 infection in patients with coronary atherosclerosis

Bork, K., 2012:
Human pasteurized C1-inhibitor concentrate for the treatment of hereditary angioedema due to C1-inhibitor deficiency

Zhu, S-Cheng.; Shi, D-Peng.; Xuan, A., 2012:
Human patellar cartilage: echo planar diffusion-weighted MR imaging findings at 3.0 T

Reeves, N.D.; Maganaris, C.N.; Maffulli, N.; Rittweger, J., 2009:
Human patellar tendon stiffness is restored following graft harvest for anterior cruciate ligament surgery

Lippold, S.; Xu, H.; Ko, A.; Li, M.; Renaud, G.; Butthof, A.; Schröder, R.; Stoneking, M., 2014:
Human paternal and maternal demographic histories: insights from high-resolution Y chromosome and mtDNA sequences

Tarkhnishvili, D.; Gavashelishvili, A.; Murtskhvaladze, M.; Gabelaia, M.; Tevzadze, G., 2015:
Human paternal lineages, languages, and environment in the Caucasus

Barnett-Cowan, M.; Bülthoff, H.H., 2014:
Human path navigation in a three-dimensional world

Sutherland, K.Patterson.; Shaban, S.; Joyner, J.L.; Porter, J.W.; Lipp, E.K., 2012:
Human pathogen shown to cause disease in the threatened eklhorn coral Acropora palmata

Panayidou, S.; Ioannidou, E.; Apidianakis, Y., 2014:
Human pathogenic bacteria, fungi, and viruses in Drosophila: disease modeling, lessons, and shortcomings

Venclíková, Kýna.; Betášová, L.; Sikutová, S.; Jedličková, P.; Hubálek, Zěk.; Rudolf, I., 2015:
Human pathogenic borreliae in Ixodes ricinus ticks in natural and urban ecosystem (Czech Republic)

Wu, S.X.; Guo, N.R.; Li, X.F.; Liao, W.Q.; Chen, M.; Zhang, Q.Q.; Li, C.Y.; Li, R.Y.; Bulmer, G.S.; Li, D.M.; Xi, L.Y.; Lu, S.; Liu, B.; Zheng, Y.C.; Ran, Y.P.; Kuan, Y.Z., 2011:
Human pathogenic fungi in China--emerging trends from ongoing national survey for 1986, 1996, and 2006

Krüger, D.H.; Schönrich, Günther.; Klempa, B., 2011:
Human pathogenic hantaviruses and prevention of infection

Mazaheritehrani, E.; Sala, A.; Orsi, C.Francesca.; Neglia, R.Giovanna.; Morace, G.; Blasi, E.; Cermelli, C., 2014:
Human pathogenic viruses are retained in and released by Candida albicans biofilm in vitro

Sapkota, A.R.; Berger, S.; Vogel, T.M., 2011:
Human pathogens abundant in the bacterial metagenome of cigarettes

Létourneau, Vérie.; Nehmé, B.; Mériaux, A.; Massé, D.; Cormier, Y.; Duchaine, C., 2011:
Human pathogens and tetracycline-resistant bacteria in bioaerosols of swine confinement buildings and in nasal flora of hog producers

Sidhu, J.P.S.; Toze, S.G., 2008:
Human pathogens and their indicators in biosolids: a literature review

Tryland, M.; Nesbakken, T.; Robertson, L.; Grahek-Ogden, D.; Lunestad, B.T., 2015:
Human pathogens in marine mammal meat – a northern perspective

Cinquemani, C., 2011:
Human pathogens, nosocomial infections, heat-sensitive textile implants, and an innovative approach to deal with them

DeCOURSEY, E., 1948:
Human pathologic anatomy of ionizing radiation effects of the atomic bomb explosions

Nishihara, H., 2015:
Human pathological basis of blood vessels and stromal tissue for nanotechnology

Ivanova, M.M.; Borodachev, E.N.; Sazonova, M.A., 2013:
Human pathologies associated with mutations of mitochondrial genome

DeMaria, S.; Levine, A.I.; Cohen, L.B., 2008:
Human patient simulation and its role in endoscopic sedation training

McQueen, S.; Dickinson, M.; Pimblett, M., 2010:
Human patient simulation can aid staff training in non-invasive ventilation

Jansson, M.M.; Ala-Kokko, T.I.; Ohtonen, P.P.; Meriläinen, M.H.; Syrjälä, H.P.; Kyngäs, H.A., 2014:
Human patient simulation education in the nursing management of patients requiring mechanical ventilation: a randomized, controlled trial

Davis, A.H.; Kimble, L.P., 2012:
Human patient simulation evaluation rubrics for nursing education: measuring the Essentials of Baccalaureate Education for Professional Nursing Practice

Seybert, A.L.; Kobulinsky, L.R.; McKaveney, T.P., 2008:
Human patient simulation in a pharmacotherapy course

Roche, J., 2011:
Human patient simulation in critical care

Murray, W.Bosseau.; Wood, J.; Schwab, M.; Fritz, M.; Karpa, K.Dowhower., 2010:
Human patient simulation in pharmacology graduate education: bridging the bench-to-bedside gap

Shinnick, M.Ann.; Woo, M.A.; Mentes, J.C., 2011:
Human patient simulation: state of the science in prelicensure nursing education

Henneman, E.A.; Cunningham, H.; Roche, J.P.; Curnin, M.E., 2007:
Human patient simulation: teaching students to provide safe care

Hassan, Z-Udin.; D'Addario, M.; Sloan, P.A., 2007:
Human patient simulator for training oral and maxillofacial surgery residents in general anesthesia and airway management

Browne, H.; Cheetham, O.; Mason, J., 2012:
Human patient simulator-based training … for the olympics!

Howard, V.Michele.; Ross, C.; Mitchell, A.M.; Nelson, G.M., 2010:
Human patient simulators and interactive case studies: a comparative analysis of learning outcomes and student perceptions

El-Bahnasawy, M.M.; Abdel, F.Eman.Ebrahim.; Morsy, T.A., 2014:
Human pediculosis: a critical health problem and what about nursing policy?

Chowdhury, A.Y.; Tavis, J.E.; George, S.L., 2014:
Human pegivirus (GB virus C) NS3 protease activity inhibits induction of the type I interferon response and is not inhibited by HCV NS3 protease inhibitors

Chivero, E.T.; Bhattarai, N.; Rydze, R.T.; Winters, M.A.; Holodniy, M.; Stapleton, J.T., 2014:
Human pegivirus RNA is found in multiple blood mononuclear cells in vivo and serum-derived viral RNA-containing particles are infectious in vitro

Trinks, J.; Maestri, M.; Oliveto, Fán.; Del Pino, Ní.; Weissenbacher, M.; Torres, O.Walter.; Oubiña, Jé.Raúl., 2015:
Human pegivirus molecular epidemiology in Argentina: potential contribution of Latin American migration to genotype 3 circulation

Zanetti, E.M.; Bignardi, C.; Audenino, A.L., 2013:
Human pelvis loading rig for static and dynamic stress analysis

de Arruda, H.Oliveira.; de Lima, H.; Ortiz, V., 2007:
Human penile ossification: case report

Latif, B.; Omar, E.; Heo, C.Chin.; Othman, N.; Tappe, D., 2011:
Human pentastomiasis caused by Armillifer moniliformis in Malaysian Borneo

Yao, M.Hua.; Wu, F.; Tang, L.Fang., 2008:
Human pentastomiasis in China: case report and literature review

Lightowlers, R.N.; Chrzanowska-Lightowlers, Z.M.A., 2015:
Human pentatricopeptide proteins: only a few and what do they do?

Tamura, Y.; Ono, T.; Kuwana, M.; Inoue, K.; Takei, M.; Yamamoto, T.; Kawakami, T.; Fujita, J.; Kataoka, M.; Kimura, K.; Sano, M.; Daida, H.; Satoh, T.; Fukuda, K., 2013:
Human pentraxin 3 (PTX3) as a novel biomarker for the diagnosis of pulmonary arterial hypertension

Braunschweig, A.; Józsi, Mály., 2012:
Human pentraxin 3 binds to the complement regulator c4b-binding protein

Xu, J.; Sclabassi, R.J.; Liu, Q.; Chaparro, L.F.; Marchessault, R.; Sun, M., 2007:
Human perception based video preprocessing for telesurgery

Liu, M-Chieh.; Aquilino, S.A.; Lund, P.S.; Vargas, M.A.; Diaz-Arnold, A.M.; Gratton, D.G.; Qian, F., 2010:
Human perception of dental porcelain translucency correlated to spectrophotometric measurements

Wan, M.; Bolger, N.; Champagne, F.A., 2013:
Human perception of fear in dogs varies according to experience with dogs

Neznal, M.; Neznal, M., 2008:
Human perception of radon risk and radon mitigation: some remarks

Kappers, A.M.L., 2012:
Human perception of shape from touch

Tallet, Céline.; Spinka, M.; Maruscáková, I.; Simecek, P., 2010:
Human perception of vocalizations of domestic piglets and modulation by experience with domestic pigs (Sus scrofa)

Fleming, R.W., 2013:
Human perception: Visual heuristics in the perception of glossiness

Enns, J.T., 2015:
Human perception: a science of synergy

Cardoso-Leite, P.; Waszak, F.; Lepsien, Jöran., 2015:
Human perceptual decision making: disentangling task onset and stimulus onset

Tartaglia, E.M.; Bamert, L.; Mast, F.W.; Herzog, M.H., 2010:
Human perceptual learning by mental imagery

Praper, T.; Sonnen, A.; Viero, G.; Kladnik, A.; Froelich, C.J.; Anderluh, G.; Dalla Serra, M.; Gilbert, R.J.C., 2011:
Human perforin employs different avenues to damage membranes

Trapani, J.A.; Thia, K.Y.T.; Andrews, M.; Davis, I.D.; Gedye, C.; Parente, P.; Svobodova, S.; Chia, J.; Browne, K.; Campbell, I.G.; Phillips, W.A.; Voskoboinik, I.; Cebon, J.S., 2013:
Human perforin mutations and susceptibility to multiple primary cancers

Praper, T.; Besenicar, M.Podlesnik.; Istinic, H.; Podlesek, Z.; Metkar, S.S.; Froelich, C.J.; Anderluh, G., 2010:
Human perforin permeabilizing activity, but not binding to lipid membranes, is affected by pH

Borland, R.G.; Nicholson, A.N., 1974:
Human performance after a barbiturate (heptabarbitone)

Adams, O.S.; Chiles, W.D., 2014:
Human performance as a function of the work-rest ratio during prolonged confinement

Reichenbach, J.; Onnasch, L.; Manzey, D., 2012:
Human performance consequences of automated decision aids in states of sleep loss

Onnasch, L.; Wickens, C.D.; Li, H.; Manzey, D., 2014:
Human performance consequences of stages and levels of automation: an integrated meta-analysis

Clark, B.; Graybiel, A., 2018:
Human performance during adaptation to stress in the Pensacola Slow Rotation Room. (Res MR005. 13-6001 Subtask 1, Rep)

Rabbi, A.F.; Ivanca, K.; Putnam, A.V.; Musa, A.; Thaden, C.B.; Fazel-Rezai, R., 2010:
Human performance evaluation based on EEG signal analysis: a prospective review

Cullen, R.H.; Rogers, W.A.; Fisk, A.D., 2014:
Human performance in a multiple-task environment: effects of automation reliability on visual attention allocation

King, B.W.; Reisner, L.A.; Ellis, R.Darin.; Klein, M.D.; Auner, G.W.; Pandya, A.K., 2010:
Human performance in the task of port placement for biosensor use

Chang, Y-Hern.; Yeh, C-Hsing., 2010:
Human performance interfaces in air traffic control

Jia, D.; Bhatti, A.; Nahavandi, S.; Horan, B., 2015:
Human performance measures for interactive haptic-audio-visual interfaces

Kopec, C.D.; Brody, C.D., 2011:
Human performance on the temporal bisection task

Deuster, P.A.; O'Connor, F.G.; Henry, K.A.; Martindale, V.E.; Talbot, L.; Jonas, W.; Friedl, K., 2007:
Human performance optimization: an evolving charge to the Department of Defense

Carlson, L.D., 2014:
Human performance under different thermal loads

Walker, G.H.; Stanton, N.A.; Salmon, P.M.; Jenkins, D.P., 2014:
Human performance under two different command and control paradigms

Shibli, J.Awad.; Grassi, S.; de Figueiredo, L.Cristina.; Feres, M.; Iezzi, G.; Piattelli, A., 2007:
Human peri-implant bone response to turned and oxidized titanium implants inserted and retrieved after 2 months

Bae, W-Jung.; Chang, S-Woo.; Lee, S-Im.; Kum, K-Yeon.; Bae, K-Shik.; Kim, E-Cheol., 2010:
Human periodontal ligament cell response to a newly developed calcium phosphate-based root canal sealer

Adachi, K.; Amemiya, T.; Nakamura, T.; Honjyo, K.; Kumamoto, S.; Yamamoto, T.; Bentley, A.J.; Fullwood, N.J.; Kinoshita, S.; Kanamura, N., 2016:
Human periodontal ligament cell sheets cultured on amniotic membrane substrate

Yan, X-Zhen.; Both, S.K.; Yang, P-Shan.; Jansen, J.A.; van den Beucken, J.J.J.P.; Yang, F., 2015:
Human periodontal ligament derived progenitor cells: effect of STRO-1 cell sorting and Wnt3a treatment on cell behavior

Chowdhary, K.Yashwant.; George, J.Pauline.; Gowda, P.; Rao, J.A., 2014:
Human periodontal ligament fibroblast response to rhPDGF-BB application on periodontally diseased root surfaces-in vitro

El-Awady, A.R.; Lapp, C.A.; Gamal, A.Y.; Sharawy, M.M.; Wenger, K.H.; Cutler, C.W.; Messer, R.L.W., 2014:
Human periodontal ligament fibroblast responses to compression in chronic periodontitis

Kook, S-Ho.; Jang, Y-Suk.; Lee, J-Chae., 2012:
Human periodontal ligament fibroblasts stimulate osteoclastogenesis in response to compression force through TNF-α-mediated activation of CD4+ T cells

Li, B.; Jung, H-Jong.; Kim, S-Min.; Kim, M-Jin.; Jahng, J.Won.; Lee, J-Ho., 2014:
Human periodontal ligament stem cells repair mental nerve injury

Coura, G.S.; Garcez, R.C.; de Aguiar, C.B.N.Mendes.; Alvarez-Silva, M.; Magini, R.S.; Trentin, A.G., 2008:
Human periodontal ligament: a niche of neural crest stem cells

Sonnaert, M.; Papantoniou, I.; Bloemen, V.; Kerckhofs, G.; Luyten, F.P.; Schrooten, J., 2014:
Human periosteal-derived cell expansion in a perfusion bioreactor system: proliferation, differentiation and extracellular matrix formation

Ball, M.D.; Bonzani, I.C.; Bovis, M.J.; Williams, A.; Stevens, M.M., 2011:
Human periosteum is a source of cells for orthopaedic tissue engineering: a pilot study

Kawase, T.; Okuda, K.; Kogami, H.; Nakayama, H.; Nagata, M.; Sato, T.; Wolff, L.F.; Yoshie, H., 2010:
Human periosteum-derived cells combined with superporous hydroxyapatite blocks used as an osteogenic bone substitute for periodontal regenerative therapy: an animal implantation study using nude mice

Jansen, E.J.P.; Emans, P.J.; Guldemond, N.A.; van Rhijn, L.W.; Welting, T.J.M.; Bulstra, S.K.; Kuijer, R., 2008:
Human periosteum-derived cells from elderly patients as a source for cartilage tissue engineering?

Ferretti, C.; Borsari, V.; Falconi, M.; Gigante, A.; Lazzarini, R.; Fini, M.; Di Primio, R.; Mattioli-Belmonte, M., 2012:
Human periosteum-derived stem cells for tissue engineering applications: the role of VEGF

Perez-Andres, M.; Paiva, B.; Nieto, W.G.; Caraux, A.; Schmitz, A.; Almeida, J.; Vogt, R.F.; Marti, G.E.; Rawstron, A.C.; Van Zelm, M.C.; Van Dongen, J.J.M.; Johnsen, H.E.; Klein, B.; Orfao, A., 2010:
Human peripheral blood B-cell compartments: a crossroad in B-cell traffic

Nakamura, T.; Tsutsumi, V.; Torimura, T.; Naitou, M.; Iwamoto, H.; Masuda, H.; Hashimoto, O.; Koga, H.; Abe, M.; Ii, M.; Kawamoto, A.; Asahara, T.; Ueno, T.; Sata, M., 2012:
Human peripheral blood CD34-positive cells enhance therapeutic regeneration of chronically injured liver in nude rats

Covassin, L.; Laning, J.; Abdi, R.; Langevin, D.L.; Phillips, N.E.; Shultz, L.D.; Brehm, M.A., 2011:
Human peripheral blood CD4 T cell-engrafted non-obese diabetic-scid IL2rγ(null) H2-Ab1 (tm1Gru) Tg (human leucocyte antigen D-related 4) mice: a mouse model of human allogeneic graft-versus-host disease

Guerreiro, M.; Na, I-Kang.; Letsch, A.; Haase, D.; Bauer, S.; Meisel, C.; Roemhild, A.; Reinke, P.; Volk, H-Dieter.; Scheibenbogen, C., 2010:
Human peripheral blood and bone marrow Epstein-Barr virus-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsets

Briney, B.S.; Willis, J.R.; Crowe, J.E., 2012:
Human peripheral blood antibodies with long HCDR3s are established primarily at original recombination using a limited subset of germline genes

Di Stefano, R.; Barsotti, M.Chiara.; Armani, C.; Santoni, T.; Lorenzet, R.; Balbarini, A.; Celi, A., 2009:
Human peripheral blood endothelial progenitor cells synthesize and express functionally active tissue factor

King, M.A.; Covassin, L.; Brehm, M.A.; Racki, W.; Pearson, T.; Leif, J.; Laning, J.; Fodor, W.; Foreman, O.; Burzenski, L.; Chase, T.H.; Gott, B.; Rossini, A.A.; Bortell, R.; Shultz, L.D.; Greiner, D.L., 2009:
Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex

Di Maio, G.; Formichi, P.; Radi, E.; Bianchi, S.; Onnis, A.; Tarquini, E.; Leoncini, L.; Federico, A., 2012:
Human peripheral blood lymphocytes and fibroblasts as Notch3 expression models

Mavropoulos, A.; Smyk, D.; Rigopoulou, E.I.; Bogdanos, D.P., 2012:
Human peripheral blood mononuclear cell culture for flow cytometric analysis of phosphorylated mitogen-activated protein kinases

Rao, S.P.; Sancho, J.; Campos-Rivera, J.; Boutin, P.M.; Severy, P.B.; Weeden, T.; Shankara, S.; Roberts, B.L.; Kaplan, J.M., 2013:
Human peripheral blood mononuclear cells exhibit heterogeneous CD52 expression levels and show differential sensitivity to alemtuzumab mediated cytolysis

Kim, S-Whan.; Kim, H.; Cho, H-Jai.; Lee, J-Uek.; Levit, R.; Yoon, Y-sup., 2010:
Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease

Kühl, A.A.; Pawlowski, N.N.; Grollich, K.; Blessenohl, M.; Westermann, Jürgen.; Zeitz, M.; Loddenkemper, C.; Hoffmann, Jörg.C., 2010:
Human peripheral gammadelta T cells possess regulatory potential

Poliani, P.Luigi.; Kisand, K.; Marrella, V.; Ravanini, M.; Notarangelo, L.Daniele.; Villa, A.; Peterson, Pärt.; Facchetti, F., 2010:
Human peripheral lymphoid tissues contain autoimmune regulator-expressing dendritic cells

Yang, L-Min.; Liu, X-Lin.; Zhu, Q-Tang.; Zhang, Y.; Xi, T-Fei.; Hu, J.; He, C-Feng.; Jiang, L., 2011:
Human peripheral nerve-derived scaffold for tissue-engineered nerve grafts: histology and biocompatibility analysis

Takeda, Y.; Nara, H.; Araki, A.; Asao, H., 2015:
Human peripheral neutrophils express functional IL-21 receptors

Ribeiro, R.; Monteiro, Cátia.; Cunha, Vínia.; Oliveira, M.José.; Freitas, M.; Fraga, A.; Príncipe, P.; Lobato, C.; Lobo, F.; Morais, Aónio.; Silva, Vítor.; Sanches-Magalhães, Jé.; Oliveira, J.; Pina, F.; Mota-Pinto, A.; Lopes, C.; Medeiros, R., 2012:
Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro

Sacca, P.Alejandra.; Creydt, V.Pistone.; Choi, H.; Mazza, O.Néstor.; Fletcher, S.Johanna.; Vallone, V.Beatriz.Fernández.; Scorticati, C.; Chasseing, N.Alejandra.; Calvo, J.Carlos., 2012:
Human periprostatic adipose tissue: its influence on prostate cancer cells

Ribeiro, R.; Monteiro, Cátia.; Silvestre, R.; Castela, A.; Coutinho, H.; Fraga, A.; Príncipe, P.; Lobato, C.; Costa, C.; Cordeiro-da-Silva, A.; Lopes, Jé.Manuel.; Lopes, C.; Medeiros, R., 2013:
Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumor stroma

Chang, T.L.; Klepper, A.; Ding, J.; Garber, J.; Rapista, A.; Mosoian, A.; Hubner, W.; Gutierrez, J.; Walewski, J.; Abergel, J.; Schiano, T.; Branch, A., 2010:
Human peritoneal macrophages from ascitic fluid can be infected by a broad range of HIV-1 isolates

Xu, W.; Schlagwein, N.; Roos, A.; van den Berg, T.K.; Daha, M.R.; van Kooten, C., 2007:
Human peritoneal macrophages show functional characteristics of M-CSF-driven anti-inflammatory type 2 macrophages

Jin, J.; Voskerician, G.; Hunter, S.A.; McGee, M.F.; Cavazzola, L.T.; Schomisch, S.; Harth, K.; Rosen, M.J., 2009:
Human peritoneal membrane controls adhesion formation and host tissue response following intra-abdominal placement in a porcine model

Voskerician, G.; Jin, J.; Hunter, S.A.; Williams, C.P.; White, M.; Rosen, M.J., 2009:
Human peritoneal membrane reduces the formation of intra-abdominal adhesions in ventral hernia repair: experimental study in a chronic hernia rat model

Lv, Z-Dong.; Na, D.; Ma, X-Yang.; Zhao, C.; Zhao, W-Jun.; Xu, H-Mian., 2011:
Human peritoneal mesothelial cell transformation into myofibroblasts in response to TGF-ß1 in vitro

Tee, M.M.; Tesch, G.H.; Nikolic-Paterson, D.J.; Brown, F.G., 2007:
Human peritoneal mesothelial cells isolated from spent dialysate fluid maintain contaminating macrophages via production of macrophage colony stimulating factor

Askarinam, A.; James, A.W.; Zara, J.N.; Goyal, R.; Corselli, M.; Pan, A.; Liang, P.; Chang, L.; Rackohn, T.; Stoker, D.; Zhang, X.; Ting, K.; Péault, B.; Soo, C., 2013:
Human perivascular stem cells show enhanced osteogenesis and vasculogenesis with Nel-like molecule I protein

Pereira, E.A.C.; Wang, S.; Owen, S.L.F.; Aziz, T.Z.; Green, A.L., 2014:
Human periventricular grey somatosensory evoked potentials suggest rostrocaudally inverted somatotopy

Ha, B.; Kim, E-Kyung.; Kim, J-Hee.; Lee, H.Na.; Lee, K.Oh.; Lee, S.Yeol.; Jang, H.Hee., 2012:
Human peroxiredoxin 1 modulates TGF-β1-induced epithelial-mesenchymal transition through its peroxidase activity

Sgreccia, E., 2014:
Human person and personalism

Levin, S.A., 1997:
Human perspectives on the environment

Accetta, D.; Syverson, G.; Bonacci, B.; Reddy, S.; Bengtson, C.; Surfus, J.; Harbeck, R.; Huttenlocher, A.; Grossman, W.; Routes, J.; Verbsky, J., 2011:
Human phagocyte defect caused by a Rac2 mutation detected by means of neonatal screening for T-cell lymphopenia

Bobadilla, K.; Sada, E.; Jaime, M.E.; González, Y.; Ramachandra, L.; Rojas, R.E.; Pedraza-Sánchez, S.; Michalak, C.; González-Noriega, A.; Torres, M., 2013:
Human phagosome processing of Mycobacterium tuberculosis antigens is modulated by interferon-γ and interleukin-10

Taylor, D.; Senac, T., 2014:
Human pharmaceutical products in the environment - the "problem" in perspective

Khetan, S.K.; Collins, T.J., 2007:
Human pharmaceuticals in the aquatic environment: a challenge to Green Chemistry

Brausch, J.M.; Connors, K.A.; Brooks, B.W.; Rand, G.M., 2012:
Human pharmaceuticals in the aquatic environment: a review of recent toxicological studies and considerations for toxicity testing

Elorriaga, Y.; Marino, Dán.J.; Carriquiriborde, P.; Ronco, A.E., 2013:
Human pharmaceuticals in wastewaters from urbanized areas of Argentina

Caminada, D.; Zaja, R.; Smital, T.; Fent, K., 2008:
Human pharmaceuticals modulate P-gp1 (ABCB1) transport activity in the fish cell line PLHC-1

Hu, Y.; Wu, M.; Nishimura, T.; Zheng, M.; Peltz, G., 2013:
Human pharmacogenetic analysis in chimeric mice with 'humanized livers'

Polimanti, R.; Iorio, A.; Piacentini, S.; Manfellotto, D.; Fuciarelli, M., 2015:
Human pharmacogenomic variation of antihypertensive drugs: from population genetics to personalized medicine

Mathis, G.A.; Toggenburger, A.; Pokorny, R.; Autzen, S.; Ibanez, R.; Romeis, P.; Bachmann, H., 2014:
Human pharmacokinetic profile of 1,25-dihydroxyvitamin D3-glycoside of herbal origin

Fields, B.A.; Reeve, J.; Bartholomaeus, A.; Mueller, U., 2015:
Human pharmacokinetic study of tutin in honey; a plant-derived neurotoxin

Patel, H.; Andresen, A.; Vente, A.; Heilmann, H-Dietrich.; Stubbings, W.; Seiberling, M.; Lopez-Lazaro, L.; Pokorny, R.; Labischinski, H., 2012:
Human pharmacokinetics and safety profile of finafloxacin, a new fluoroquinolone antibiotic, in healthy volunteers

Klickovic, U.; Doberer, D.; Gouya, G.; Aschauer, S.; Weisshaar, S.; Storka, A.; Bilban, M.; Wolzt, M., 2014:
Human pharmacokinetics of high dose oral curcumin and its effect on heme oxygenase-1 expression in healthy male subjects

Schaller, G.; Dittrich, P.; Felizeter, M.; Gouya, G.; Leuchten, N.; Kapiotis, S.; Vcelar, B.; Vorauer-Uhl, K.; Wolzt, M., 2012:
Human pharmacokinetics of intravenous recombinant human Cu/Zn superoxide dismutase

Melilli, B.; Piazza, C.; Vitale, D.Cristina.; Marano, M.Rosa.; Pecori, A.; Mattana, P.; Volsi, V.Li.; Iuculano, C.; Cardì, F.; Drago, F., 2011:
Human pharmacokinetics of the muscle relaxant, eperisone hydrochloride by liquid chromatography-electrospray tandem mass spectrometry

Legette, L.; Karnpracha, C.; Reed, R.L.; Choi, J.; Bobe, G.; Christensen, J.Mark.; Rodriguez-Proteau, R.; Purnell, J.Q.; Stevens, J.F., 2014:
Human pharmacokinetics of xanthohumol, an antihyperglycemic flavonoid from hops

Burmeister Getz, E.; Fisher, D.M.; Fuller, R., 2009:
Human pharmacokinetics/pharmacodynamics of an interleukin-4 and interleukin-13 dual antagonist in asthma

Peiró, A.M.; Farré, M.; Roset, P.N.; Carbó, M.; Pujadas, M.; Torrens, M.; Camí, J.; de la Torre, R., 2013:
Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart

Ritter, J.M., 2010:
Human pharmacology of hydrogen sulfide, putative gaseous mediator

Jasinski, D.R.; Krishnan, S., 2008:
Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers

Gao, Z.; Kang, Y.; Yu, J.; Ren, L., 2014:
Human pharyngeal microbiome may play a protective role in respiratory tract infections

St Hilaire, M.A.; Gooley, J.J.; Khalsa, S.Bir.S.; Kronauer, R.E.; Czeisler, C.A.; Lockley, S.W., 2013:
Human phase response curve to a 1 h pulse of bright white light

Rüger, M.; St Hilaire, M.A.; Brainard, G.C.; Khalsa, S-Bir.S.; Kronauer, R.E.; Czeisler, C.A.; Lockley, S.W., 2013:
Human phase response curve to a single 6.5 h pulse of short-wavelength light

Revell, V.L.; Molina, T.A.; Eastman, C.I., 2013:
Human phase response curve to intermittent blue light using a commercially available device

Burgess, H.J.; Revell, V.L.; Molina, T.A.; Eastman, C.I., 2010:
Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg

Ciovacco, W.A.; Raskind, W.H.; Kacena, M.A., 2008:
Human phenotypes associated with GATA-1 mutations

Runager, K.; Basaiawmoit, R.V.; Deva, T.; Andreasen, M.; Valnickova, Z.; Sørensen, C.S.; Karring, H.; Thøgersen, I.B.; Christiansen, G.; Underhaug, J.; Kristensen, T.; Nielsen, N.Chr.; Klintworth, G.K.; Otzen, D.E.; Enghild, J.J., 2011 :
Human phenotypically distinct TGFBI corneal dystrophies are linked to the stability of the fourth FAS1 domain of TGFBIp

Boonyapiwat, B.; Panaretou, B.; Forbes, B.; Mitchell, S.C.; Steventon, G.B., 2009:
Human phenylalanine monooxygenase and thioether metabolism

Mast, T.G.; Samuelsen, C.L., 2009:
Human pheromone detection by the vomeronasal organ: unnecessary for mate selection?

Meyer, B.T.; Jürgens, T.; Wesker, T.; Brand, T.; Kollmeier, B., 2011:
Human phoneme recognition depending on speech-intrinsic variability

Qiu, J.; Yang, G.; Lin, A.; Shen, Z.; Wang, D.; Ding, L., 2015:
Human phosphatidylethanolamine-binding protein 4 promoted the radioresistance of human rectal cancer by activating Akt in an ROS-dependent way

Liu, H.; Qiu, J.; Li, N.; Chen, T.; Cao, X., 2010:
Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src

Fan, J.; Teng, X.; Liu, L.; Mattaini, K.R.; Looper, R.E.; Vander Heiden, M.G.; Rabinowitz, J.D., 2016:
Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate

Kusano, S.; Eizuru, Y., 2012:
Human phospholipid scramblase 1 interacts with and regulates transactivation of HTLV-1 Tax

Sutherland, J.C.; Sutherland, B.M., 1975:
Human photoreactivating enzyme action spectrum and safelight conditions

Abràmoff, M.D.; Mullins, R.F.; Lee, K.; Hoffmann, J.M.; Sonka, M.; Critser, D.B.; Stasheff, S.F.; Stone, E.M., 2013:
Human photoreceptor outer segments shorten during light adaptation

Renner, R., 2000:
Human phthalate study changes exposure picture

Scanni, G., 2012:
Human phthiriasis. Can dermoscopy really help dermatologists? Entodermoscopy: a new dermatological discipline on the edge of entomology

Richardson, G.S., 2008:
Human physiological models of insomnia

Grocott, M.P.W., 2008:
Human physiology in extreme environments: lessons from life at the limits?

Wübben, Y., 2010:
Human physiology: images and practices of the reflex

Natochin, I.V., 2010:
Human physiology: kidney

Dixson, B.J.; Dixson, A.F.; Bishop, P.J.; Parish, A., 2010:
Human physique and sexual attractiveness in men and women: a New Zealand-U.S. comparative study

Lukic, S.; Chen, K., 2012:
Human piRNAs are under selection in Africans and repress transposable elements

van Leeuwen, M.; Williams, M.M.W.; Koraka, P.; Simon, J.H.; Smits, S.L.; Osterhaus, A.D.M.E., 2010:
Human picobirnaviruses identified by molecular screening of diarrhea samples

Arianayagam, S.; Ryan, T.J., 2014:
Human pigmentation: A side effect adapted from a primitive organism's survival, acting through cell attachment with an affinity for the keratinocyte and for elastin: Part I

Arianayagam, S.; Ryan, T.J., 2014:
Human pigmentation: A side effect adapted from a primitive organism's survival. Part 2: The melanocyte as mentor of the keratinocye

Joosten, E.R.M.; Neri, P., 2013:
Human pitch detectors are tuned on a fine scale, but are perceptually accessed on a coarse scale

Hook, V.; Funkelstein, L.; Toneff, T.; Mosier, C.; Hwang, S-Rong., 2009:
Human pituitary contains dual cathepsin L and prohormone convertase processing pathway components involved in converting POMC into the peptide hormones ACTH, alpha-MSH, and beta-endorphin

Solov'ev, G.S.; Bogdanov, A.V.; Panteleev, S.M.; Ianin, V.L., 2007:
Human pituitary embryonic morphogenesis

Bárcena, A.; Muench, M.O.; Kapidzic, M.; Gormley, M.; Goldfien, G.A.; Fisher, S.J., 2012:
Human placenta and chorion: potential additional sources of hematopoietic stem cells for transplantation

Pigatto, P.D.; Minoia, C.; Ronchi, A.; Guzzi, G., 2013:
Human placenta and markers of heavy metals exposure

Esteban-Vasallo, Mía.D.; Aragonés, N.; Pollan, M.; López-Abente, G.; Perez-Gomez, B., 2013:
Human placenta and markers of heavy metals exposure: Esteban-Vasallo et al. Respond

Oliveira Magaldi, M.; Nicolato, A.; Godinho, J.V.; Santos, M.; Prosdocimi, A.; Malheiros, J.A.; Lei, T.; Belykh, E.; Almefty, R.O.; Almefty, K.K.; Preul, M.C.; Spetzler, R.F.; Nakaji, P., 2015:
Human placenta aneurysm model for training neurosurgeons in vascular microsurgery

Kwok, J.Ching.Kwong.; Huang, W.; Leung, W-Cheong.; Chan, S-Ki.; Chan, K-Yau.; Leung, K-Ming.; Chu, A.Chi.Ho.; Lam, A.Kar.Ngai., 2014:
Human placenta as an ex vivo vascular model for neurointerventional research

Hedlund, M.; Stenqvist, A-Christin.; Nagaeva, O.; Kjellberg, L.; Wulff, M.; Baranov, V.; Mincheva-Nilsson, L., 2009:
Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function

Robin, C.; Bollerot, K.; Mendes, S.; Haak, E.; Crisan, M.; Cerisoli, F.; Lauw, I.; Kaimakis, P.; Jorna, R.; Vermeulen, M.; Kayser, M.; van der Linden, R.; Imanirad, P.; Verstegen, M.; Nawaz-Yousaf, H.; Papazian, N.; Steegers, E.; Cupedo, T.; Dzierzak, E., 2009:
Human placenta is a potent hematopoietic niche containing hematopoietic stem and progenitor cells throughout development

Kang, S-Seong.; Woo, S.Su.; Im, J.; Yang, J.Seung.; Yun, C-Heui.; Ju, H.Ran.; Son, C.Gue.; Moon, E-Yi.; Han, S.Hyun., 2007:
Human placenta promotes IL-8 expression through activation of JNK/SAPK and transcription factors NF-kappaB and AP-1 in PMA-differentiated THP-1 cells

Milovanov, A.P.; Erofeeva, L.M.; Aleksandrovich, N.V.; Zolotukhina, I.A., 2013:
Human placenta structure in II and III trimesters of physiological pregnancy

Shehadah, A.; Chen, J.; Pal, A.; He, S.; Zeitlin, A.; Cui, X.; Zacharek, A.; Cui, Y.; Roberts, C.; Lu, M.; Hariri, R.; Chopp, M., 2014:
Human placenta-derived adherent cell treatment of experimental stroke promotes functional recovery after stroke in young adult and older rats

Li, X.; Ling, W.; Pennisi, A.; Wang, Y.; Khan, S.; Heidaran, M.; Pal, A.; Zhang, X.; He, S.; Zeitlin, A.; Abbot, S.; Faleck, H.; Hariri, R.; Shaughnessy, J.D.; van Rhee, F.; Nair, B.; Barlogie, B.; Epstein, J.; Yaccoby, S., 2011:
Human placenta-derived adherent cells prevent bone loss, stimulate bone formation, and suppress growth of multiple myeloma in bone

Kim, S.Jin.; Song, C.Hee.; Sung, H.Jung.; Yoo, Y.Do.; Geum, D.Ho.; Park, S.Hwa.; Yoo, J.Hyun.; Oh, J.Hyun.; Shin, H.Jin.; Kim, S.Haeng.; Kim, J.Suk.; Kim, B.Soo., 2007:
Human placenta-derived feeders support prolonged undifferentiated propagation of a human embryonic stem cell line, SNUhES3: comparison with human bone marrow-derived feeders

Martini, M.Maria.; Jeremias, T.da.Silva.; Kohler, M.Cecília.; Marostica, L.Lourenço.; Trentin, Aéa.Gonçalves.; Alvarez-Silva, M., 2013:
Human placenta-derived mesenchymal stem cells acquire neural phenotype under the appropriate niche conditions

Kadam, S.; Muthyala, S.; Nair, P.; Bhonde, R., 2011:
Human placenta-derived mesenchymal stem cells and islet-like cell clusters generated from these cells as a novel source for stem cell therapy in diabetes

Jung, J.; Choi, J.Ho.; Lee, Y.; Park, J-Wan.; Oh, I-Hoan.; Hwang, S-Gyu.; Kim, K-Soo.; Kim, G.Jin., 2014:
Human placenta-derived mesenchymal stem cells promote hepatic regeneration in CCl4 -injured rat liver model via increased autophagic mechanism

Li, F.; Chen, Y-Zhen.; Miao, Z-Ning.; Zheng, S-Ying.; Jin, J., 2012:
Human placenta-derived mesenchymal stem cells with silk fibroin biomaterial in the repair of articular cartilage defects

Amendola, D.; Nardella, M.; Guglielmi, L.; Cerquetti, L.; Carico, E.; Alesi, V.; Porru, M.; Leonetti, C.; Bearzi, C.; Rizzi, R.; D'Agnano, I.; Stigliano, A.; Novelli, G.; Bucci, B., 2015:
Human placenta-derived neurospheres are susceptible to transformation after extensive in vitro expansion

Suciu, L.; Popescu, L.M.; Gherghiceanu, M., 2007:
Human placenta: de visu demonstration of interstitial Cajal-like cells

von Versen-Höynck, F.; Rajakumar, A.; Bainbridge, S.A.; Gallaher, M.J.; Roberts, J.M.; Powers, R.W., 2009:
Human placental adenosine receptor expression is elevated in preeclampsia and hypoxia increases expression of the A2A receptor

Balmayor, E.Rosado.; Flicker, M.; Käser, T.; Saalmüller, A.; Erben, R.G., 2013:
Human placental alkaline phosphatase as a tracking marker for bone marrow mesenchymal stem cells

Yang, Y.; Wang, K.; Li, W.; Adelstein, S.James.; Kassis, A.I., 2012:
Human placental alkaline phosphatase-mediated hydrolysis correlates tightly with the electrostatic contribution from tail group

Florio, P.; Petraglia, F., 2012:
Human placental corticotropin-releasing factor (CRF) in the adaptive response to pregnancy

Lu, G-hui.; Yong, W-shi.; Xu, Z-min.; Ke, Y-quan.; Jiang, X-dan.; Zhang, S-zhong., 2012:
Human placental decidua basalis-derived mesenchymal stem cells differentiate into dopamine neuron-like cells with no response to long-term culture in vitro

Takemoto, Y.; Kawata, H.; Soeda, T.; Imagawa, K.; Somekawa, S.; Takeda, Y.; Uemura, S.; Matsumoto, M.; Fujimura, Y.; Jo, J-ichiro.; Kimura, Y.; Tabata, Y.; Saito, Y., 2009:
Human placental ectonucleoside triphosphate diphosphohydrolase gene transfer via gelatin-coated stents prevents in-stent thrombosis

Sharma, K.; Mukherjee, C.; Roy, S.; De, D.; Bhattacharyya, D., 2014:
Human placental extract mediated inhibition of proteinase K: implications of heparin and glycoproteins in wound physiology

Kim, B-Young.; Park, H.Rim.; Shin, J-Hyeon.; Kim, S.Won.; Kim, S.Whan., 2014:
Human placental extract reduces allergic inflammation in a murine allergic rhinitis model

Shimokobe, H.; Sumida, Y.; Tanaka, S.; Mori, K.; Kitamura, Y.; Fukumoto, K.; Kakutani, A.; Ohno, T.; Kanemasa, K.; Imai, S.; Hibino, S.; Yoshikawa, T., 2014:
Human placental extract treatment for non-alcoholic steatohepatitis non-responsive to lifestyle intervention: A pilot study

Obolenskaya, M.Yu.; Teplyuk, N.M.; Divi, R.L.; Poirier, M.C.; Filimonova, N.B.; Zadrozna, M.; Pasanen, M.J., 2010:
Human placental glutathione S-transferase activity and polycyclic aromatic hydrocarbon DNA adducts as biomarkers for environmental oxidative stress in placentas from pregnant women living in radioactivity- and chemically-polluted regions

Zamudio, S.; Wu, Y.; Ietta, F.; Rolfo, A.; Cross, A.; Wheeler, T.; Post, M.; Illsley, N.P.; Caniggia, I., 2007 :
Human placental hypoxia-inducible factor-1alpha expression correlates with clinical outcomes in chronic hypoxia in vivo

Lombardo, M.F.; De Angelis, F.; Bova, L.; Bartolini, B.; Bertuzzi, F.; Nano, R.; Capuani, B.; Lauro, R.; Federici, M.; Lauro, D.; Donadel, G., 2012:
Human placental lactogen (hPL-A) activates signaling pathways linked to cell survival and improves insulin secretion in human pancreatic islets

Zepiridis, L.; Zafrakas, M.; Theodoridis, T.D.; Assimakopoulos, E.; Tzevelekis, P.; Athanatos, D.; Bontis, J.N.; Tarlatzis, B.C., 2010:
Human placental lactogen and color Doppler in predicting expulsion of retained adherent placenta: a new clinical observation

Lee, J.Kyung.; Chung, H.Jin.; Fischer, L.; Fischer, J.; Gonzalez, F.J.; Jeong, H., 2014:
Human placental lactogen induces CYP2E1 expression via PI 3-kinase pathway in female human hepatocytes

Robertson, A.; Sprecher, H., 1967:
Human placental lipid metabolism. III. Synthesis and hydrolysis of phospholipids

Evsen, M.Siddik.; Kalkanli, S.; Deveci, E.; Sak, M.Erdal.; Ozler, A.; Baran, O.; Erdem, E.; Seker, Uğur., 2014:
Human placental macrophages (Hofbauer cells) in severe preeclampsia complicated by HELLP syndrome: immunohistochemistry of chorionic villi

Tissot van Patot, M.C.; Murray, A.J.; Beckey, V.; Cindrova-Davies, T.; Johns, J.; Zwerdlinger, L.; Jauniaux, E.; Burton, G.J.; Serkova, N.J., 2010:
Human placental metabolic adaptation to chronic hypoxia, high altitude: hypoxic preconditioning

Maier, C.L.; Pober, J.S., 2011:
Human placental pericytes poorly stimulate and actively regulate allogeneic CD4 T cell responses

Malek, A.; Bersinger, N.A., 2012:
Human placental stem cells: biomedical potential and clinical relevance

Sedlmeier, E-Maria.; Brunner, S.; Much, D.; Pagel, P.; Ulbrich, S.E.; Meyer, H.Hd.; Amann-Gassner, U.; Hauner, H.; Bader, B.L., 2015:
Human placental transcriptome shows sexually dimorphic gene expression and responsiveness to maternal dietary n-3 long-chain polyunsaturated fatty acid intervention during pregnancy

Knöfler, M.; Pollheimer, Jürgen., 2013:
Human placental trophoblast invasion and differentiation: a particular focus on Wnt signaling

Delorme-Axford, E.; Donker, R.B.; Mouillet, J-Francois.; Chu, T.; Bayer, A.; Ouyang, Y.; Wang, T.; Stolz, D.B.; Sarkar, S.N.; Morelli, A.E.; Sadovsky, Y.; Coyne, C.B., 2013:
Human placental trophoblasts confer viral resistance to recipient cells

Lanoix, D.; Beghdadi, H.; Lafond, J.; Vaillancourt, C., 2008:
Human placental trophoblasts synthesize melatonin and express its receptors

Yuen, R.K.C.; Avila, L.; Peñaherrera, M.S.; von Dadelszen, P.; Lefebvre, L.; Kobor, M.S.; Robinson, W.P., 2010:
Human placental-specific epipolymorphism and its association with adverse pregnancy outcomes

Ben Ari, T.; Gershunov, A.; Gage, K.L.; Snäll, T.; Ettestad, P.; Kausrud, K.L.; Stenseth, N.Chr., 2008:
Human plague in the USA: the importance of regional and local climate

Yin, J.X.; Dong, X.Q.; Liang, Y.; Wang, P.; Siriarayaporn, P.; Thaikruea, L., 2008:
Human plague outbreak in two villages, Yunnan Province, China, 2005

Pupek, Młgorzata.; Lemańska-Perek, A.; Jasonek, J.; Kątnik-Prastowska, I., 2011:
Human plasma and cerebrospinal fibronectins differ in the accessibility of the epitopes on the N-terminal domains

Mandagini, G.; Subramanian, S.P.; Vasantha, K.; Appukuttan, P.Sankunni., 2014:
Human plasma anti-α-galactoside antibody forms immune complex with autologous lipoprotein(a)

Na, K.; Lee, E-Young.; Lee, H-Joo.; Kim, K-Youl.; Lee, H.; Jeong, S-Ki.; Jeong, A-Sung.; Cho, S.Yun.; Kim, S.A.; Song, S.Young.; Kim, K.Sik.; Cho, S.Won.; Kim, H.; Paik, Y-Ki., 2009:
Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma

Xu, W.; Narayanan, P.; Kang, N.; Clayton, S.; Ohne, Y.; Shi, P.; Herve, M-Cecile.; Balderas, R.; Picard, C.; Casanova, J-Laurent.; Gorvel, J-Pierre.; Oh, S.; Pascual, V.; Banchereau, J., 2014:
Human plasma cells express granzyme B

van Greevenbroek, M.M.J.; Jacobs, M.; van der Kallen, C.J.H.; Blaak, E.E.; Jansen, E.H.J.M.; Schalkwijk, C.G.; Feskens, E.J.M.; Stehouwer, C.D.A., 2012:
Human plasma complement C3 is independently associated with coronary heart disease, but only in heavy smokers (the CODAM study)

Yamashita, M.; Suemizu, H.; Murayama, N.; Nishiyama, S.; Shimizu, M.; Yamazaki, H., 2015:
Human plasma concentrations of herbicidal carbamate molinate extrapolated from the pharmacokinetics established in in vivo experiments with chimeric mice with humanized liver and physiologically based pharmacokinetic modeling

Dreissigacker, U.; Suchy, M-Theresia.; Maassen, N.; Tsikas, D., 2010:
Human plasma concentrations of malondialdehyde (MDA) and the F2-isoprostane 15(S)-8-iso-PGF(2alpha) may be markedly compromised by hemolysis: evidence by GC-MS/MS and potential analytical and biological ramifications

O'Nuallain, B.; Acero, L.; Williams, A.D.; Koeppen, H.P.McWilliams.; Weber, A.; Schwarz, H.P.; Wall, J.S.; Weiss, D.T.; Solomon, A., 2008:
Human plasma contains cross-reactive Abeta conformer-specific IgG antibodies

El Balkhi, S.; Poupon, Jël.; Trocello, J-Marc.; Massicot, F.; Woimant, F.; Laprévote, O., 2010:
Human plasma copper proteins speciation by size exclusion chromatography coupled to inductively coupled plasma mass spectrometry. Solutions for columns calibration by sulfur detection

Cardile, A.P.; Sanchez, C.J.; Samberg, M.E.; Romano, D.R.; Hardy, S.K.; Wenke, J.C.; Murray, C.K.; Akers, K.S., 2015:
Human plasma enhances the expression of Staphylococcal microbial surface components recognizing adhesive matrix molecules promoting biofilm formation and increases antimicrobial tolerance In Vitro

Kekwick, R.A., 2018:
Human plasma fractionation

Pivac, N.; Knezević, A.; Gornik, O.; Pucić, M.; Igl, W.; Peeters, H.; Crepel, A.; Steyaert, J.; Novokmet, M.; Redzić, I.; Nikolac, M.; Hercigonja, V.Novković.; Curković, K.Dodig.; Curković, M.; Nedić, G.; Muck-Seler, D.; Borovecki, F.; Rudan, I.; Lauc, G., 2011:
Human plasma glycome in attention-deficit hyperactivity disorder and autism spectrum disorders

Bryant, J.W.; Shariat-Madar, Z., 2009:
Human plasma kallikrein-kinin system: physiological and biochemical parameters

Martins da Fonseca, Cíque.Silveira.; Pimenta Filho, A.Almeida.; dos Santos, B.Santana.; da Silva, César.Augusto.; Domingues, A.Lúcia.Coutinho.; Owen, J.Stuart.; Lima, V.Lúcia.de.Menezes., 2016:
Human plasma lipid modulation in schistosomiasis mansoni depends on apolipoprotein E polymorphism

Bellis, C.; Kulkarni, H.; Mamtani, M.; Kent, J.W.; Wong, G.; Weir, J.M.; Barlow, C.K.; Diego, V.; Almeida, M.; Dyer, T.D.; Göring, H.H.H.; Almasy, L.; Mahaney, M.C.; Comuzzie, A.G.; Williams-Blangero, S.; Meikle, P.J.; Blangero, J.; Curran, J.E., 2015:
Human plasma lipidome is pleiotropically associated with cardiovascular risk factors and death

Ansa-Addo, E.A.; Lange, S.; Stratton, D.; Antwi-Baffour, S.; Cestari, I.; Ramirez, M.I.; McCrossan, M.V.; Inal, J.M., 2010:
Human plasma membrane-derived vesicles halt proliferation and induce differentiation of THP-1 acute monocytic leukemia cells

Antwi-Baffour, S.; Kholia, S.; Aryee, Y.K-D.; Ansa-Addo, E.A.; Stratton, D.; Lange, S.; Inal, J.M., 2010:
Human plasma membrane-derived vesicles inhibit the phagocytosis of apoptotic cells--possible role in SLE

Mehdi, M.Murtaza.; Rizvi, S.Ibrahim., 2013:
Human plasma paraoxonase 1 (PON1) arylesterase activity during aging: correlation with susceptibility of LDL oxidation

Vinante, M.; Digregorio, G.; Lunelli, L.; Forti, S.; Musso, S.; Vanzetti, L.; Lui, A.; Pasquardini, L.; Giorcelli, M.; Tagliaferro, A.; Anderle, M.; Pederzolli, C., 2009:
Human plasma protein adsorption on carbon-based materials

Tsai, I.Y.; Tomczyk, N.; Eckmann, J.I.; Composto, R.J.; Eckmann, D.M., 2011:
Human plasma protein adsorption onto dextranized surfaces: a two-dimensional electrophoresis and mass spectrometry study

Delanghe, J.; Speeckaert, M.; De Buyzere, M.L.; Langlois, M.; Torck, M., 2013:
Human plasma protein polymorphisms and the persistence of cultural diversity

Alvarez, J-Claude.; Charbit, B.; Grassin-Delyle, S.; Demolis, J-Louis.; Funck-Brentano, C.; Abe, E., 2011:
Human plasma quantification of droperidol and ondansetron used in preventing postoperative nausea and vomiting with a LC/ESI/MS/MS method

Ribot, Mégane.; Polito, A.; Grassin-Delyle, S.; Annane, D.; Alvarez, J-Claude., 2013:
Human plasma quantification of fludrocortisone using liquid chromatography coupled with atmospheric pressure chemical ionization mass spectrometry after low-dosage administration

Pinto, J.; Domingues, M.Rosário.M.; Galhano, Eália.; Pita, C.; Almeida, M.do.Céu.; Carreira, I.M.; Gil, A.M., 2014:
Human plasma stability during handling and storage: impact on NMR metabolomics

Queiroz, K.C.S.; Tio, R.A.; Zeebregts, C.J.; Bijlsma, M.F.; Zijlstra, F.; Badlou, B.; de Vries, M.; Ferreira, C.V.; Spek, C.Arnold.; Peppelenbosch, M.P.; Rezaee, F., 2011:
Human plasma very low density lipoprotein carries Indian hedgehog

Berntorp, E., 2007:
Human plasma von Willebrand factor/factor VIII complex (Haemate P/Humate-P) in von Willebrand disease and haemophilia A: a viewpoint by Eric Berntorp

Carter, N.J.; Scott, L.J., 2007:
Human plasma von Willebrand factor/factor VIII complex (Haemate P/Humate-P): in von Willebrand disease and haemophilia A

Merrill, M.H., 2018:
Human plasma, surplus dried; its distribution in California

Lee, K.; Hoots, W.K., 2011:
Human plasma-derived concentrates: preventing thrombosis and controlling haemorrhage

Longet, Séphanie.; Miled, S.; Lötscher, M.; Miescher, S.M.; Zuercher, A.W.; Corthésy, B., 2013:
Human plasma-derived polymeric IgA and IgM antibodies associate with secretory component to yield biologically active secretory-like antibodies

Huang, B.; Tang, S.; Desai, A.; Cheng, X-min.; Kotlyar, A.; Van Der Spek, A.; Thomas, T.P.; Baker, J.R., 2009:
Human plasma-mediated hypoxic activation of indolequinone-based naloxone pro-drugs

Liao, A.P.; Salajegheh, M.; Morehouse, C.; Nazareno, R.; Jubin, R.G.; Jallal, B.; Yao, Y.; Greenberg, S.A., 2010:
Human plasmacytoid dendritic cell accumulation amplifies their type 1 interferon production

Piccioli, D.; Sammicheli, C.; Tavarini, S.; Nuti, S.; Frigimelica, E.; Manetti, A.G.O.; Nuccitelli, A.; Aprea, S.; Valentini, S.; Borgogni, E.; Wack, A.; Valiante, N.M., 2009:
Human plasmacytoid dendritic cells are unresponsive to bacterial stimulation and require a novel type of cooperation with myeloid dendritic cells for maturation

Sandgren, K.J.; Smed-Sörensen, A.; Forsell, M.N.; Soldemo, M.; Adams, W.C.; Liang, F.; Perbeck, L.; Koup, R.A.; Wyatt, R.T.; Karlsson Hedestam, G.B.; Loré, K., 2013:
Human plasmacytoid dendritic cells efficiently capture HIV-1 envelope glycoproteins via CD4 for antigen presentation

Tel, J.; Schreibelt, G.; Sittig, S.P.; Mathan, T.S.M.; Buschow, S.I.; Cruz, L.J.; Lambeck, A.J.A.; Figdor, C.G.; de Vries, I.Jolanda.M., 2013 :
Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets

Morita, R.; Fujita, T.; Uchiyama, T.; Hori, T., 2009:
Human plasmacytoid dendritic cells express an atrial natriuretic peptide receptor, guanylyl cyclase-A

Hong, J.; Li, Y.; Gong, Z-jiong., 2011:
Human plasmacytoid dendritic cells from patients with chronic hepatitis B induce the generation of CD4+CD25+Treg in vitro

Boor, P.P.C.; Metselaar, H.J.; Jonge, S.de.; Mancham, S.; van der Laan, L.J.W.; Kwekkeboom, J., 2011:
Human plasmacytoid dendritic cells induce CD8⁺ LAG-3⁺ Foxp3⁺ CTLA-4⁺ regulatory T cells that suppress allo-reactive memory T cells

De Filippo, A.; Binder, R.J.; Camisaschi, C.; Beretta, V.; Arienti, F.; Villa, A.; Della Mina, P.; Parmiani, G.; Rivoltini, L.; Castelli, C., 2008:
Human plasmacytoid dendritic cells interact with gp96 via CD91 and regulate inflammatory responses

Tel, J.; Lambeck, A.J.A.; Cruz, L.J.; Tacken, P.J.; de Vries, I.Jolanda.M.; Figdor, C.G., 2010:
Human plasmacytoid dendritic cells phagocytose, process, and present exogenous particulate antigen

Chao, Y.; Kaliaperumal, N.; Chretien, A-Sophie.; Tang, S.; Lee, B.; Poidinger, M.; Fairhurst, A-Marie.; Connolly, J.E., 2015:
Human plasmacytoid dendritic cells regulate IFN-α production through activation-induced splicing of IL-18Rα

Wieland, S.F.; Takahashi, K.; Boyd, B.; Whitten-Bauer, C.; Ngo, N.; de la Torre, J-C.; Chisari, F.V., 2014:
Human plasmacytoid dendritic cells sense lymphocytic choriomeningitis virus-infected cells in vitro

Yu, C-Feng.; Peng, W-Ming.; Oldenburg, J.; Hoch, J.; Bieber, T.; Limmer, A.; Hartmann, G.; Barchet, W.; Eis-Hübinger, A.Maria.; Novak, N., 2010:
Human plasmacytoid dendritic cells support Th17 cell effector function in response to TLR7 ligation

Mathan, T.S.M.Manuel.; Figdor, C.G.; Buschow, S.I., 2013:
Human plasmacytoid dendritic cells: from molecules to intercellular communication network

Cho, C-Fong.; Chen, P-Ku.; Chang, P-Chiao.; Wu, H-Lin.; Shi, G-Yueh., 2014:
Human plasminogen kringle 1-5 inhibits angiogenesis and induces thrombomodulin degradation in a protein kinase A-dependent manner

Chang, P.C.; Wu, H.L.; Lin, H.C.; Wang, K.C.; Shi, G.Y., 2010:
Human plasminogen kringle 1-5 reduces atherosclerosis and neointima formation in mice by suppressing the inflammatory signaling pathway

Christen, M.T.; Frank, P.; Schaller, J.; Llinás, M., 2010:
Human plasminogen kringle 3: solution structure, functional insights, phylogenetic landscape

Aleem, A.M.; Wells, L.; Jankun, J.; Walther, M.; Kühn, H.; Reinartz, J.; Skrzypczak-Jankun, E., 2010:
Human platelet 12-lipoxygenase: naturally occurring Q261/R261 variants and N544L mutant show altered activity but unaffected substrate binding and membrane association behavior

Huang, Z-Yu.; Chien, P.; Indik, Z.K.; Schreiber, A.D., 2011:
Human platelet FcγRIIA and phagocytes in immune-complex clearance

Al-Jafari, A.A.; Shakil, S.; Reale, M.; Kamal, M.A., 2012:
Human platelet acetylcholinesterase inhibition by cyclophosphamide: a combined experimental and computational approach

Mousa, S.S.; Davis, F.B.; Davis, P.J.; Mousa, S.A., 2011:
Human platelet aggregation and degranulation is induced in vitro by L-thyroxine, but not by 3,5,3'-triiodo-L-thyronine or diiodothyropropionic acid (DITPA)

Al-Subaie, A.M.; Fawaz, N.A.; Mahdi, N.; Al-Absi, I.K.; Al-Ola, K.; Ameen, G.; Almawi, W.Y., 2010:
Human platelet alloantigens (HPA) 1, HPA2, HPA3, HPA4, and HPA5 polymorphisms in sickle cell anemia patients with vaso-occlusive crisis

Abboud, N.; Ghazouani, L.; Ben-Hadj-Khalifa, S.; Anabi, F.; Added, F.; Khalfallah, A.; Nsiri, B.; Almawi, W.Y.; Mahjoub, T., 2010:
Human platelet alloantigens HPA-1, HPA-2, and HPA-3 polymorphisms associated with extent of severe coronary artery disease

Jackson, D.J.; Eastlake, J.L.; Kumpel, B.M., 2014:
Human platelet antigen (HPA)-1a peptides do not reliably suppress anti-HPA-1a responses using a humanized severe combined immunodeficiency (SCID) mouse model

Allen, D.L.; Abrahamsson, S.; Murphy, M.F.; Roberts, D.J., 2012:
Human platelet antigen 1a epitopes are dependent on the cation-regulated conformation of integrin α(IIb)β(3) (GPIIb/IIIa)

Xu, X.; Liu, Y.; Ying, Y.; Tao, S.; Hong, X.; Zhu, F.; Lv, H.; Yan, L., 2012:
Human platelet antigen allele frequencies and new mutations on platelet glycoprotein genes in the Chinese Han population

Brouk, H.; Halle, L.; Bertrand, G.; Neche, F.Z.; Ouelaa, H.; Kaplan, C., 2010:
Human platelet antigen allele frequencies in different Algerian populations

Pai, S-Chung.; Burnouf, T.; Chen, J-Wei.; Lin, L-In., 2014:
Human platelet antigen alleles in 998 Taiwanese blood donors determined by sequence-specific primer polymerase chain reaction

Hwang, S.Mee.; Kim, M.Jung.; Chang, H.Eun.; Hong, Y.Ji.; Kim, T.Soo.; Song, E.Young.; Park, K.Un.; Song, J.; Han, K-Sup., 2013:
Human platelet antigen genotyping and expression of CD109 (human platelet antigen 15) mRNA in various human cell types

Bhatti, F.A.; Uddin, M.; Ahmed, A.; Bugert, P., 2010:
Human platelet antigen polymorphisms (HPA-1, -2, -3, -4, -5 and -15) in major ethnic groups of Pakistan

Lemnrau, A.G.; Cardoso, S.; Creary, L.E.; Brown, C.; Miretti, M.; Girdlestone, J.; Navarrete, C.V., 2009:
Human platelet antigen typing of neonatal alloimmune thrombocytopenia patients using whole genome amplified DNA and a 5'-nuclease assay

Gentile, I.; Meola, M.; Buonomo, A.Riccardo.; Minei, G.; Coppola, N.; Foggia, M.; Ferruzzi, F.; Fratellanza, G.; Scarpato, N.; Borgia, G., 2014:
Human platelet antigen-3 genotype predicts platelet count in patients with HCV infection

Curtis, B.R.; McFarland, J.G., 2014:
Human platelet antigens - 2013

Gorgi, Y.; Sfar, I.; Ben Aabdallah, T.; Aouadi, H.; Abderrahim, E.; Bardi, R.; Jendoubi-Ayed, S.; Ayed, K., 2008:
Human platelet antigens polymorphisms and susceptibility of thrombosis in hemodialysis patients

Edelblute, C.M.; Donate, A.L.; Hargrave, B.Y.; Heller, L.C., 2015:
Human platelet gel supernatant inactivates opportunistic wound pathogens on skin

Shanskii, Y.D.; Sergeeva, N.S.; Sviridova, I.K.; Kirakozov, M.S.; Kirsanova, V.A.; Akhmedova, S.A.; Antokhin, A.I.; Chissov, V.I., 2014:
Human platelet lysate as a promising growth-stimulating additive for culturing of stem cells and other cell types

Walenda, G.; Hemeda, H.; Schneider, R.K.; Merkel, R.; Hoffmann, B.; Wagner, W., 2013:
Human platelet lysate gel provides a novel three dimensional-matrix for enhanced culture expansion of mesenchymal stromal cells

Hofbauer, P.; Riedl, S.; Witzeneder, K.; Hildner, F.; Wolbank, S.; Groeger, M.; Gabriel, C.; Redl, H.; Holnthoner, W., 2015:
Human platelet lysate is a feasible candidate to replace fetal calf serum as medium supplement for blood vascular and lymphatic endothelial cells

Govindasamy, V.; Ronald, V.Sainik.; Abdullah, A.Naim.Binti.; Ganesan Nathan, K.R.; Aziz, Z.Adura.Che.Abdul.; Abdullah, M.; Zain, R.Binti.; Kasim, N.Hayaty.Abu.; Musa, S.; Bhonde, R.R., 2012:
Human platelet lysate permits scale-up of dental pulp stromal cells for clinical applications

Griffiths, S.; Baraniak, P.R.; Copland, I.B.; Nerem, R.M.; McDevitt, T.C., 2014:
Human platelet lysate stimulates high-passage and senescent human multipotent mesenchymal stromal cell growth and rejuvenation in vitro

Xia, W.; Li, H.; Wang, Z.; Xu, R.; Fu, Y.; Zhang, X.; Ye, X.; Huang, Y.; Xiang, A.Peng.; Yu, W., 2011:
Human platelet lysate supports ex vivo expansion and enhances osteogenic differentiation of human bone marrow-derived mesenchymal stem cells

Xu, R.; Xia, W-jie.; Rong, X.; Ye, X.; Shao, Y.; Wang, M.; Luo, G-ping.; Fu, Y-shui., 2013:
Human platelet lysates promotes the proliferation of mesenchymal stem cells in vitro

Simon, L.M.; Edelstein, L.C.; Nagalla, S.; Woodley, A.B.; Chen, E.S.; Kong, X.; Ma, L.; Fortina, P.; Kunapuli, S.; Holinstat, M.; McKenzie, S.E.; Dong, J-Fei.; Shaw, C.A.; Bray, P.F., 2014:
Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics

Van Geet, C.; Izzi, B.; Labarque, V.; Freson, K., 2009:
Human platelet pathology related to defects in the G-protein signaling cascade

Badr Eslam, R.; Lang, I.M.; Kaider, A.; Panzer, S., 2013:
Human platelet protease-activated receptor-1 responsiveness to thrombin related to P2Y12 inhibition

Parizi, A.Meimandi.; Oryan, A.; Shafiei-Sarvestani, Z.; Bigham, A.S., 2012:
Human platelet rich plasma plus Persian Gulf coral effects on experimental bone healing in rabbit model: radiological, histological, macroscopical and biomechanical evaluation

Krüger, J.Philipp.; Ketzmar, A-Katharina.; Endres, M.; Pruss, A.; Siclari, A.; Kaps, C., 2014:
Human platelet-rich plasma induces chondrogenic differentiation of subchondral progenitor cells in polyglycolic acid-hyaluronan scaffolds

Takeuchi, M.; Kamei, N.; Shinomiya, R.; Sunagawa, T.; Suzuki, O.; Kamoda, H.; Ohtori, S.; Ochi, M., 2012:
Human platelet-rich plasma promotes axon growth in brain-spinal cord coculture

Demidova-Rice, T.N.; Wolf, L.; Deckenback, J.; Hamblin, M.R.; Herman, I.M., 2012:
Human platelet-rich plasma- and extracellular matrix-derived peptides promote impaired cutaneous wound healing in vivo

De La Vega Elena, C.D.; Nogués, N.; Fernández Montoya, A.; Chialina, S.; Blanzaco, P.D.; Theiller, E.; Raillon, M.A.; Arancegui, N.; Solis, E.; Oyonarte, S.; Crespo Ferrer, V.; Campos Muñoz, A.; Muñiz-Díaz, E., 2008:
Human platelet-specific antigens frequencies in the Argentinean population

Basu, S.S.; Deutsch, E.C.; Schmaier, A.A.; Lynch, D.R.; Blair, I.A., 2014:
Human platelets as a platform to monitor metabolic biomarkers using stable isotopes and LC-MS

Jones, M.; Peden, A.H.; Yull, H.; Wight, D.; Bishop, M.T.; Prowse, C.V.; Turner, M.L.; Ironside, J.W.; MacGregor, I.R.; Head, M.W., 2008:
Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrP) associated with variant Creutzfeldt-Jakob disease

Berthet, J.; Damien, P.; Hamzeh-Cognasse, H.; Arthaud, C-Antoine.; Eyraud, M-Ange.; Zéni, F.; Pozzetto, B.; McNicol, A.; Garraud, O.; Cognasse, F., 2013:
Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion

Newman, P.J.; Aster, R.; Boylan, B., 2007:
Human platelets circulating in mice: applications for interrogating platelet function and survival, the efficacy of antiplatelet therapeutics, and the molecular basis of platelet immunological disorders

Meyer, T.; Amaya, M.; Desai, H.; Robles-Carrillo, L.; Hatfield, M.; Francis, J.L.; Amirkhosravi, A., 2011:
Human platelets contain and release TWEAK

Sarabia, S.F.; Raya, J.L.; Hoogeveen, R.C.; Bray, P.F., 2008:
Human platelets differentially concentrate estradiol, estrone and testosterone

Østerud, B.; Olsen, J.Ole., 2014:
Human platelets do not express tissue factor

Gupalo, E.; Buriachkovskaia, L.; Othman, M., 2012:
Human platelets express CAR with localization at the sites of intercellular interaction

Anabel, A-Santos.; Eduardo, Pérez-Campos.; Pedro Antonio, Hández-Cruz.; Carlos, Sórzano-Mata.; Juana, Náez-Morales.; Honorio, T-Aguilar.; Nicolás, V-Sepúlveda.; Sergio Roberto, A-Ruiz., 2015:
Human platelets express Toll-like receptor 3 and respond to poly I:C

Romaniuk, M.Albertina.; Tribulatti, M.Virginia.; Cattaneo, V.; Lapponi, M.Jose.; Molinas, F.Concepcion.; Campetella, O.; Schattner, M., 2011:
Human platelets express and are activated by galectin-8

Catani, M.V.; Gasperi, V.; Catanzaro, G.; Baldassarri, S.; Bertoni, A.; Sinigaglia, F.; Avigliano, L.; Maccarrone, M., 2011:
Human platelets express authentic CB₁ and CB₂ receptors

Schedel, A.; Thornton, S.; Schloss, P.; Klüter, H.; Bugert, P., 2011:
Human platelets express functional alpha7-nicotinic acetylcholine receptors

Wang, B.; Peng, Y.; Dong, J.; Lin, J.; Wu, C.; Su, Y.; Fang, H.; Wang, L.; Huang, K.; Li, D., 2014:
Human platelets express functional thymic stromal lymphopoietin receptors: a potential role in platelet activation in acute coronary syndrome

Niessen, J.; Jedlitschky, G.; Grube, M.; Bien, S.; Schwertz, Hörg.; Ohtsuki, S.; Kawakami, H.; Kamiie, J.; Oswald, S.; Starke, K.; Strobel, U.; Siegmund, W.; Rosskopf, D.; Greinacher, A.; Terasaki, T.; Kroemer, H.K., 2009:
Human platelets express organic anion-transporting peptide 2B1, an uptake transporter for atorvastatin

Aldrovandi, M.; Hammond, V.J.; Podmore, H.; Hornshaw, M.; Clark, S.R.; Marnett, L.J.; Slatter, D.A.; Murphy, R.C.; Collins, P.W.; O'Donnell, V.B., 2014:
Human platelets generate phospholipid-esterified prostaglandins via cyclooxygenase-1 that are inhibited by low dose aspirin supplementation

Takahashi, K.; Murata, S.; Fukunaga, K.; Ohkohchi, N., 2014:
Human platelets inhibit liver fibrosis in severe combined immunodeficiency mice

Novokmet, S.; Jakovljevic, V.Lj.; Jankovic, S.; Davidovic, G.; Andjelkovic, N.; Milanovic, Z.; Djuric, D.M., 2010:
Human platelets perfusion through isolated guinea-pig heart: the effects on coronary flow and oxidative stress markers

Salles, I.I.; Thijs, T.; Brunaud, C.; De Meyer, S.F.; Thys, J.; Vanhoorelbeke, K.; Deckmyn, H., 2010:
Human platelets produced in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice upon transplantation of human cord blood CD34(+) cells are functionally active in an ex vivo flow model of thrombosis

Petersen, H.J.; Keane, C.; Jenkinson, H.F.; Vickerman, M.Margaret.; Jesionowski, A.; Waterhouse, J.C.; Cox, D.; Kerrigan, S.W., 2010:
Human platelets recognize a novel surface protein, PadA, on Streptococcus gordonii through a unique interaction involving fibrinogen receptor GPIIbIIIa

Neumann, K.; Farías, G.; Slachevsky, A.; Perez, P.; Maccioni, R.B., 2012:
Human platelets tau: a potential peripheral marker for Alzheimer's disease

Qiu, M-hua.; Qiu, M-de., 2010:
Human plerocercoidosis and sparganosis: I. A historical review on aetiology

Qiu, M-Hua.; Qiu, M-De., 2010:
Human plerocercoidosis and sparganosis: II. A historical review on pathology, clinics, epidemiology and control

Schierloh, P.; Landoni, Vónica.; Balboa, L.; Musella, R.M.; Castagnino, J.; Moraña, E.; de Casado, G.C.; Palmero, D.; Sasiain, Mía.C., 2014:
Human pleural B-cells regulate IFN-γ production by local T-cells and NK cells in a Mycobacterium tuberculosis-induced delayed hypersensitivity reaction

Rampalli, S.; Bhatia, M., 2012:
Human pluripotency: a difficult state to make smart choices

Simões, P.D.; Ramos, T., 2007:
Human pluripotent embryonal carcinoma NTERA2 cl.D1 cells maintain their typical morphology in an angiomyogenic medium

Wataya, T.; Muguruma, K.; Sasai, Y., 2008:
Human pluripotent stem cell and neural differentiation

Chen, K.G.; Mallon, B.S.; McKay, R.D.G.; Robey, P.G., 2014:
Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics

Aigner, S.; Heckel, T.; Zhang, J.D.; Andreae, L.C.; Jagasia, R., 2014:
Human pluripotent stem cell models of autism spectrum disorder: emerging frontiers, opportunities, and challenges towards neuronal networks in a dish

Davidson, K.C.; Guymer, R.H.; Pera, M.F.; Pébay, A., 2014:
Human pluripotent stem cell strategies for age-related macular degeneration

Nicoleau, C.; Viegas, P.; Peschanski, M.; Perrier, A.L., 2012:
Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges

Poon, E.; Kong, C-Wing.; Li, R.A., 2012:
Human pluripotent stem cell-based approaches for myocardial repair: from the electrophysiological perspective

Acimovic, I.; Vilotic, A.; Pesl, M.; Lacampagne, A.; Dvorak, P.; Rotrekl, V.; Meli, A.C., 2014:
Human pluripotent stem cell-derived cardiomyocytes as research and therapeutic tools

Chow, M.; Boheler, K.R.; Li, R.A., 2015:
Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives

Sheng, X.; Reppel, M.; Nguemo, F.; Mohammad, F.Ibrahem.; Kuzmenkin, A.; Hescheler, Jürgen.; Pfannkuche, K., 2013:
Human pluripotent stem cell-derived cardiomyocytes: response to TTX and lidocain reveals strong cell to cell variability

Parvini, M.; Satarian, L.; Parivar, K.; Javan, M.; Tondar, M.; Ahmad, S.; Baharvand, H., 2015:
Human pluripotent stem cell-derived retinal pigmented epithelium in retinal treatment: from bench to bedside

Hibaoui, Y.; Feki, A., 2014:
Human pluripotent stem cells as alternative models to study trophoblast development

Chicha, L.; Feki, A.; Boni, A.; Irion, O.; Hovatta, O.; Jaconi, M., 2011:
Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34- and CD34+ progenitors with distinct characteristics

Maury, Y.; Gauthier, M.; Peschanski, M.; Martinat, Cécile., 2012:
Human pluripotent stem cells for disease modelling and drug screening

Gauthier, M.; Maury, Y.; Peschanski, M.; Martinat, Cécile., 2012:
Human pluripotent stem cells for genetic disease modeling and drug screening

Lin, B.; Gupta, D.; Heinen, C.D., 2015:
Human pluripotent stem cells have a novel mismatch repair-dependent damage response

Laustriat, D.; Gide, J.; Peschanski, M., 2010:
Human pluripotent stem cells in drug discovery and predictive toxicology

Viswanathan, P.; Gaskell, T.; Moens, N.; Culley, O.J.; Hansen, D.; Gervasio, M.K.R.; Yeap, Y.J.; Danovi, D., 2014:
Human pluripotent stem cells on artificial microenvironments: a high content perspective

Ni, Z.; Knorr, D.A.; Clouser, C.L.; Hexum, M.K.; Southern, P.; Mansky, L.M.; Park, I-Hyun.; Kaufman, D.S., 2011:
Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms

Zhu, Z.; Huangfu, D., 2013:
Human pluripotent stem cells: an emerging model in developmental biology

Hibaoui, Y.; Feki, A., 2012:
Human pluripotent stem cells: applications and challenges in neurological diseases

Kao, C-Fu.; Chuang, C-Yu.; Chen, C-Hong.; Kuo, H-Chih., 2009:
Human pluripotent stem cells: current status and future perspectives

Li, W.; Ding, S., 2011:
Human pluripotent stem cells: decoding the naïve state

Ramirez, J-Marie.; Bai, Q.; Dijon-Grinand, M.; Assou, S.; Gerbal-Chaloin, S.; Hamamah, S.; De Vos, J., 2011:
Human pluripotent stem cells: from biology to cell therapy

Maury, Y.; Gauthier, M.; Peschanski, M.; Martinat, Cécile., 2011:
Human pluripotent stem cells: opening key for pathological modeling

Sherman, S.P.; Alva, J.A.; Thakore-Shah, K.; Pyle, A.D., 2011 :
Human pluripotent stem cells: the development of high-content screening strategies

Borza, C.M.; Borza, D-Bogdan.; Pedchenko, V.; Saleem, M.A.; Mathieson, P.W.; Sado, Y.; Hudson, H.M.; Pozzi, A.; Saus, J.; Abrahamson, D.R.; Zent, R.; Hudson, B.G., 2008:
Human podocytes adhere to the KRGDS motif of the alpha3alpha4alpha5 collagen IV network

Dobrinskikh, E.; Okamura, K.; Kopp, J.B.; Doctor, R.Brian.; Blaine, J., 2014:
Human podocytes perform polarized, caveolae-dependent albumin endocytosis

Chamandi, S.Chucrallah.; Kallab, K.; Mattar, H.; Nader, E., 2009:
Human poisoning after ingestion of puffer fish caught from Mediterranean Sea

David, D.; Prabhakar, A.; Peter, J.Victor.; Pichamuthu, K., 2008:
Human poisoning with hexastar: a hexaconazole-containing agrochemical fungicide

Chen, H-Hsiang.; Lin, J-Liang.; Yen, T-Hai.; Lin, W-Ran., 2014:
Human poisoning with prochloraz imidazole fungicide

Su, T-Yi.; Lin, J-Liang.; Lin-Tan, D-Tzu.; Tseng, H-Hui.; Yen, T-Hai., 2012:
Human poisoning with spinosad and flonicamid insecticides

Agrawal, N.; Banerjee, R., 2009:
Human polycomb 2 protein is a SUMO E3 ligase and alleviates substrate-induced inhibition of cystathionine beta-synthase sumoylation

Esposito, C.I.; Oliver, R.A.; Campbell, P.A.; Yu, Y.; Walter, W.L.; Walter, W.K.; Walsh, W.R., 2014:
Human polyethylene granuloma tissues inhibit bone healing in a novel xenograft animal model

Robinson, A.K.; Leal, B.Z.; Nanyes, D.R.; Kaur, Y.; Ilangovan, U.; Schirf, V.; Hinck, A.P.; Demeler, B.; Kim, C.A., 2012:
Human polyhomeotic homolog 3 (PHC3) sterile alpha motif (SAM) linker allows open-ended polymerization of PHC3 SAM

Höltje, M.; Richartz, A.; Zdrazil, B.; Schwanke, A.; Dugovic, B.; Murruzzu, C.; Reissig, H-Ulrich.; Korting, H.Christian.; Kleuser, B.; Höltje, H-Dieter.; Schäfer-Korting, M., 2010:
Human polymerase alpha inhibitors for skin tumors. Part 2. Modeling, synthesis and influence on normal and transformed keratinocytes of new thymidine and purine derivatives

Mukherjee, P.; Lahiri, I.; Pata, J.D., 2013:
Human polymerase kappa uses a template-slippage deletion mechanism, but can realign the slipped strands to favour base substitution mutations over deletions

Moore, E.E.; Moore, F.A.; Fabian, T.C.; Bernard, A.C.; Fulda, G.J.; Hoyt, D.B.; Duane, T.M.; Weireter, L.J.; Gomez, G.A.; Cipolle, M.D.; Rodman, G.H.; Malangoni, M.A.; Hides, G.A.; Omert, L.A.; Gould, S.A., 2009:
Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial

Davies, S.M.; Dickinson, A.; Miller, J.S., 2008:
Human polymorphism and variable outcomes of cancer chemotherapy and transplantation

Keyhani, A.; Riazi-Rad, F.; Pakzad, S.Reza.; Ajdary, S., 2014:
Human polymorphonuclear leukocytes produce cytokines in response to Leishmania major promastigotes

Chanchamroen, S.; Kewcharoenwong, C.; Susaengrat, W.; Ato, M.; Lertmemongkolchai, G., 2008:
Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects

Riegel, A.; Maurer, T.; Prior, B.; Stegmaier, S.; Heppert, V.; Wagner, C.; Hänsch, G.Maria., 2012:
Human polymorphonuclear neutrophils express RANK and are activated by its ligand, RANKL

Sokhi, U.K.; Das, S.K.; Dasgupta, S.; Emdad, L.; Shiang, R.; DeSalle, R.; Sarkar, D.; Fisher, P.B., 2014:
Human polynucleotide phosphorylase (hPNPaseold-35): should I eat you or not--that is the question?

Das, S.K.; Sokhi, U.K.; Bhutia, S.K.; Azab, B.; Su, Z-Zhong.; Sarkar, D.; Fisher, P.B., 2010:
Human polynucleotide phosphorylase selectively and preferentially degrades microRNA-221 in human melanoma cells

Saribas, A.Sami.; Mun, S.; Johnson, J.; El-Hajmoussa, M.; White, M.K.; Safak, M., 2014:
Human polyoma JC virus minor capsid proteins, VP2 and VP3, enhance large T antigen binding to the origin of viral DNA replication: evidence for their involvement in regulation of the viral DNA replication

Boothpur, R.; Brennan, D.C., 2010:
Human polyoma viruses and disease with emphasis on clinical BK and JC

Ho, J.; Jedrych, J.J.; Feng, H.; Natalie, A.A.; Grandinetti, L.; Mirvish, E.; Crespo, M.M.; Yadav, D.; Fasanella, K.E.; Proksell, S.; Kuan, S-Fan.; Pastrana, D.V.; Buck, C.B.; Shuda, Y.; Moore, P.S.; Chang, Y., 2015:
Human polyomavirus 7-associated pruritic rash and viremia in transplant recipients

van der Meijden, E.; Wunderink, H.F.; van der Blij-de Brouwer, C.S.; Zaaijer, H.L.; Rotmans, J.I.; Bavinck, J.Nico.Bouwes.; Feltkamp, M.C.W., 2015:
Human polyomavirus 9 infection in kidney transplant patients

Chapagain, M.L.; Nerurkar, V.R., 2010:
Human polyomavirus JC (JCV) infection of human B lymphocytes: a possible mechanism for JCV transmigration across the blood-brain barrier

Bellizzi, A.; Nardis, C.; Anzivino, E.; Rodìo, D..M.; Fioriti, D.; Mischitelli, M.; Chiarini, F.; Pietropaolo, V., 2013:
Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies

Huijskens, E.G.W.; van Erkel, A.J.M.; Peeters, M.F.; Rossen, J.W.A., 2011:
Human polyomavirus KI and WU in adults with community acquired pneumonia in The Netherlands, 2008-2009

Sauvage, V.; Foulongne, V.; Cheval, J.; Ar Gouilh, M.; Pariente, K.; Dereure, O.; Manuguerra, J.Claude.; Richardson, J.; Lecuit, M.; Burguière, A.; Caro, Vérie.; Eloit, M., 2011:
Human polyomavirus related to African green monkey lymphotropic polyomavirus

Duncavage, E.J.; Pfeifer, J.D., 2012:
Human polyomaviruses 6 and 7 are not detectable in Merkel cell polyomavirus-negative Merkel cell carcinoma

Wieland, U.; Silling, S.; Hellmich, M.; Potthoff, A.; Pfister, H.; Kreuter, A., 2014:
Human polyomaviruses 6, 7, 9, 10 and Trichodysplasia spinulosa-associated polyomavirus in HIV-infected men

Machado, D.Maria.; Fink, M.Cristina.; Pannuti, Cáudio.Sérgio.; Succi, R.Célia.de.Menezes.; Machado, A.Aparecida.; Carmo, F.Bononi.do.; Gouvêa, Aída.de.Fátima.Barbosa.; Urbano, P.Roberto.; Beltrão, S.Vasconcelos.; Santos, I.Cristina.Lopes.dos.; Machado, C.Martins., 2012:
Human polyomaviruses JC and BK in the urine of Brazilian children and adolescents vertically infected by HIV

Moens, U.; Johannessen, M., 2008:
Human polyomaviruses and cancer: expanding repertoire

Siebrasse, E.A.; Bauer, I.; Holtz, L.R.; Le, B-minh.; Lassa-Claxton, S.; Canter, C.; Hmiel, P.; Shenoy, S.; Sweet, S.; Turmelle, Y.; Shepherd, R.; Wang, D., 2013:
Human polyomaviruses in children undergoing transplantation, United States, 2008-2010

Moens, U.; Ludvigsen, M.; Van Ghelue, M., 2011:
Human polyomaviruses in skin diseases

Anonymous, 2009:
Human polyvalent immunoglobulin: new indication. Multifocal motor neuropathy: slightly more muscle strength. Improvement in muscle strength, but frequent hypersensitivity reactions

Caretti, V.; Sewing, A.Charlotte.P.; Lagerweij, T.; Schellen, P.; Bugiani, M.; Jansen, M.H.A.; van Vuurden, D.G.; Navis, A.C.; Horsman, I.; Vandertop, W.Peter.; Noske, D.P.; Wesseling, P.; Kaspers, G.J.L.; Nazarian, J.; Vogel, H.; Hulleman, E.; Monje, M.; Wurdinger, T., 2015:
Human pontine glioma cells can induce murine tumors

Xu, S., 2012:
Human population admixture in Asia

Keinan, A.; Reich, D., 2010:
Human population differentiation is strongly correlated with local recombination rate

Garte, S., 2010:
Human population genetic diversity as a function of SNP type from HapMap data

Spuhler, J.N., 1966:
Human population genetics

Yilmaz, S.; Toy, Süleyman.; Demircioglu Yildiz, N.; Yilmaz, H., 2008:
Human population growth and temperature increase along with the increase in urbanisation, motor vehicle numbers and green area amount in the sample of Erzurum city, Turkey

Bongaarts, J., 2010:
Human population growth and the demographic transition

Bradshaw, C.J.A.; Brook, B.W., 2015:
Human population reduction is not a quick fix for environmental problems

Novembre, J.; Han, E., 2012:
Human population structure and the adaptive response to pathogen-induced selection pressures

Campbell, H.; Rudan, I.; Bittles, A.H.; Wright, A.F., 2009:
Human population structure, genome autozygosity and human health

Ceppi, M.; Biasotti, B.; Fenech, M.; Bonassi, S., 2010:
Human population studies with the exfoliated buccal micronucleus assay: statistical and epidemiological issues

Crawford, M.H., 1977:
Human population study

Eichner, M.; Ferrari, V., 2013:
Human pose co-estimation and applications

Lin, J.Feng-Shun.; Kulić, D., 2015:
Human pose recovery for rehabilitation using ambulatory sensors

Lin, J.F.S.; Kulić, D., 2013:
Human pose recovery using wireless inertial measurement units

Lee, M.Wai.; Nevatia, R., 2008:
Human pose tracking in monocular sequence using multilevel structured models

Chen, L.; Du, C.; Wang, L.; Yang, C.; Zhang, J-rui.; Li, N.; Li, Y.; Xie, X-Dong.; Gao, G-dong., 2015:
Human positive coactivator 4 (PC4) is involved in the progression and prognosis of astrocytoma

Das, C.; Gadad, S.S.; Kundu, T.K., 2010:
Human positive coactivator 4 controls heterochromatinization and silencing of neural gene expression by interacting with REST/NRSF and CoREST

Bernier, P-Michel.; Grafton, S.T., 2011:
Human posterior parietal cortex flexibly determines reference frames for reaching based on sensory context

Lindner, A.; Iyer, A.; Kagan, I.; Andersen, R.A., 2010:
Human posterior parietal cortex plans where to reach and what to avoid

Shah, S.N.; Eckert, K.A., 2009:
Human postmeiotic segregation 2 exhibits biased repair at tetranucleotide microsatellite sequences

Sin, H-Su.; Ichijima, Y.; Koh, E.; Namiki, M.; Namekawa, S.H., 2012:
Human postmeiotic sex chromatin and its impact on sex chromosome evolution

Laszczyńska, M.; Brodowska, A.; Starczewski, A.; Masiuk, M.; Brodowski, J., 2007:
Human postmenopausal ovary--hormonally inactive fibrous connective tissue or more?

Lemons, J.; Brott, B.; Eberhardt, A., 2011:
Human postmortem device retrieval and analysis--orthopaedic, cardiovascular, and dental systems

Ramaswami, M.; Gautam, M.; Kamb, A.; Rudy, B.; Tanouye, M.A.; Mathew, M.K., 1990:
Human potassium channel genes: Molecular cloning and functional expression

Anbazhagan, K.; Rabbind Singh, A.; Isabelle, P.; Stella, I.; Céline, A-De.Martel.; Bissac, E.; Bertrand, B.; Rémy, N.; Naomi, T.; Vincent, F.; Rochette, J.; Lassoued, Kïss., 2014:
Human pre-B cell receptor signal transduction: evidence for distinct roles of PI3kinase and MAP-kinase signalling pathways

Niakan, K.K.; Han, J.; Pedersen, R.A.; Simon, C.; Pera, R.A.Reijo., 2012:
Human pre-implantation embryo development

Zimmermann, M.; Armeanu, S.; Smirnow, I.; Kupka, S.; Wagner, S.; Wehrmann, M.; Rots, M.G.; Groothuis, G.M.M.; Weiss, T.S.; Königsrainer, A.; Gregor, M.; Bitzer, M.; Lauer, U.M., 2009:
Human precision-cut liver tumor slices as a tumor patient-individual predictive test system for oncolytic measles vaccine viruses

Darimont, C.T.; Carlson, S.M.; Kinnison, M.T.; Paquet, P.C.; Reimchen, T.E.; Wilmers, C.C., 2009:
Human predators outpace other agents of trait change in the wild

van Schaik, P.; Kusev, P.; Juliusson, A., 2011:
Human preferences and risky choices

Trapp, S.; Shenhav, A.; Bitzer, S.; Bar, M., 2016:
Human preferences are biased towards associative information

Scott, I.M.; Clark, A.P.; Josephson, S.C.; Boyette, A.H.; Cuthill, I.C.; Fried, R.L.; Gibson, M.A.; Hewlett, B.S.; Jamieson, M.; Jankowiak, W.; Honey, P.Lynne.; Huang, Z.; Liebert, M.A.; Purzycki, B.G.; Shaver, J.H.; Snodgrass, J.Josh.; Sosis, R.; Sugiyama, L.S.; Swami, V.; Yu, D.W.; Zhao, Y.; Penton-Voak, I.S., 2015:
Human preferences for sexually dimorphic faces may be evolutionarily novel

Evans, D.W.; Orr, P.T.; Lazar, S.M.; Breton, D.; Gerard, J.; Ledbetter, D.H.; Janosco, K.; Dotts, J.; Batchelder, H., 2012:
Human preferences for symmetry: subjective experience, cognitive conflict and cortical brain activity

Sörgjerd, K.Margareta.; Zako, T.; Sakono, M.; Stirling, P.C.; Leroux, M.R.; Saito, T.; Nilsson, P.; Sekimoto, M.; Saido, T.C.; Maeda, M., 2014:
Human prefoldin inhibits amyloid-β (Aβ) fibrillation and contributes to formation of nontoxic Aβ aggregates

Teffer, K.; Semendeferi, K., 2012:
Human prefrontal cortex: evolution, development, and pathology

Shah, M.; Nunes, M.Raquel.; Stearns, V., 2018:
CDK4/6 Inhibitors: Game Changers in the Management of Hormone Receptor–Positive Advanced Breast Cancer?

Hönger, G.; Cardinal, H.; Dieudé, Mélanie.; Buser, A.; Hösli, I.; Dragun, D.; Hébert, M-Josée.; Schaub, S., 2015:
Human pregnancy and generation of anti-angiotensin receptor and anti-perlecan antibodies

Pérez-López, F.R.; Blackwell, S.C.; Funai, E.F.; Jiang, S-Wen.; Keirse, M.J.N.C.; Voto, L.S., 2010:
Human pregnancy and parturition clinical management

Krackow, S., 1998:
Human pregnancy filtering: yesterday's news?

Ha, C.T.; Wu, J.A.; Irmak, S.; Lisboa, F.A.; Dizon, A.M.; Warren, J.W.; Ergun, S.; Dveksler, G.S., 2010:
Human pregnancy specific beta-1-glycoprotein 1 (PSG1) has a potential role in placental vascular morphogenesis

Zhao, J.; Lei, Z.; Liu, Y.; Li, B.; Zhang, L.; Fang, H.; Song, C.; Wang, X.; Zhang, G-Mei.; Feng, Z-Hua.; Huang, B., 2009:
Human pregnancy up-regulates Tim-3 in innate immune cells for systemic immunity

Valdés S, G., 2012:
Human pregnancy, a biological paradigm of tolerance and adaptation

Duniec-Dmuchowski, Z.; Fang, H-Lin.; Strom, S.C.; Ellis, E.; Runge-Morris, M.; Kocarek, T.A., 2009:
Human pregnane X receptor activation and CYP3A4/CYP2B6 induction by 2,3-oxidosqualene:lanosterol cyclase inhibition

Lau, A.Jiang.; Yang, G.; Rajaraman, G.; Baucom, C.C.; Chang, T.K.H., 2011:
Human pregnane X receptor agonism by Ginkgo biloba extract: assessment of the role of individual ginkgolides

Conde, I.; Lobo, Mía.V.T.; Zamora, J.; Pérez, J.; González, F.J.; Alba, E.; Fraile, B.; Paniagua, R.; Arenas, Mía.I., 2008:
Human pregnane X receptor is expressed in breast carcinomas, potential heterodimers formation between hPXR and RXR-alpha

Xu, Y.; Zhang, Y.; Zhou, F.; Zheng, Y.; Zhu, X., 2012:
Human pregnane X receptor-mediated transcriptional regulation of CYP3A4 by extracts of 7 traditional Chinese medicines

Rathod, V.; Jain, S.; Nandekar, P.; Sangamwar, A.T., 2014:
Human pregnane X receptor: a novel target for anticancer drug development

Barnicot, N.A., 1949:
Human prehistory

Trigger, B.G., 1983:
Human prehistory legitimated

Rowley-Conwy, P., 2010:
Human prehistory: Hunting for the earliest farmers

Summers, M.C.; Bird, S.; Mirzai, F.Mirzazadeh.; Thornhill, A.; Biggers, J.D., 2014:
Human preimplantation embryo development in vitro: a morphological assessment of sibling zygotes cultured in a single medium or in sequential media

Kornysheva, K.; Diedrichsen, Jörn., 2015:
Human premotor areas parse sequences into their spatial and temporal features

Hussain, S.; Ram, M.Subramanian.; Kumar, A.; Shivaji, S.; Umapathy, G., 2014:
Human presence increases parasitic load in endangered lion-tailed macaques (Macaca silenus) in its fragmented rainforest habitats in Southern India

Liu, F.; Qi, H., 2012:
Human preterm amnion cells cultured in three-dimensional collagen I matrix

Meijer, K.; de Vries, M.; Al-Lahham, S.; Bruinenberg, M.; Weening, Dée.; Dijkstra, M.; Kloosterhuis, N.; van der Leij, R.Jan.; van der Want, H.; Kroesen, B-Jan.; Vonk, R.; Rezaee, F., 2011:
Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages

Karlsen, T.A.; Shahdadfar, A.; Brinchmann, J.E., 2011:
Human primary articular chondrocytes, chondroblasts-like cells, and dedifferentiated chondrocytes: differences in gene, microRNA, and protein expression and phenotype

Da Costa, S.; van der Zwaag, W.; Marques, J.P.; Frackowiak, R.S.J.; Clarke, S.; Saenz, M., 2011:
Human primary auditory cortex follows the shape of Heschl's gyrus

Ekstrand-Hammarström, B.; Akfur, C.M.; Andersson, P.Ola.; Lejon, C.; Osterlund, L.; Bucht, A., 2012:
Human primary bronchial epithelial cells respond differently to titanium dioxide nanoparticles than the lung epithelial cell lines A549 and BEAS-2B

Bérubé, K.; Prytherch, Zë.; Job, C.; Hughes, T., 2011:
Human primary bronchial lung cell constructs: the new respiratory models

Diercke, K.; König, A.; Kohl, A.; Lux, C.J.; Erber, R., 2012:
Human primary cementoblasts respond to combined IL-1β stimulation and compression with an impaired BSP and CEMP-1 expression

Nakamura, A.; Ueno, T.; Yagi, Y.; Okuda, K.; Ogata, T.; Nakamura, T.; Torimura, T.; Iwamoto, H.; Ramadoss, S.; Sata, M.; Tsutsumi, V.; Yasuda, K.; Tomiyasu, Y.; Obayashi, K.; Tashiro, K.; Kuhara, S., 2011:
Human primary cultured hepatic stellate cells can be cryopreserved

Zahn, S.; Kirschsiefen, P.; Jonuleit, H.; Steinbrink, K.; Von Stebut, E., 2011:
Human primary dendritic cell subsets differ in their IL-12 release in response to Leishmania major infection

Wong, T.; Yeung, J.; Hildebrand, K.J.; Junker, A.K.; Turvey, S.E., 2014:
Human primary immunodeficiencies causing defects in innate immunity

Zeitvogel, J.; Dalpke, A.; Eiz-Vesper, B.; Kracht, M.; Dittrich-Breiholz, O.; Werfel, T.; Wittmann, M., 2012:
Human primary keratinocytes show restricted ability to up-regulate suppressor of cytokine signaling (SOCS)3 protein compared with autologous macrophages

Ray, B.; Chopra, N.; Long, J.M.; Lahiri, D.K., 2015:
Human primary mixed brain cultures: preparation, differentiation, characterization and application to neuroscience research

Hari, R.; Bourguignon, M.; Piitulainen, H.; Smeds, E.; De Tiège, X.; Jousmäki, V., 2014:
Human primary motor cortex is both activated and stabilized during observation of other person's phasic motor actions

Boukhechba, F.; Balaguer, T.; Michiels, J-François.; Ackermann, K.; Quincey, D.; Bouler, J-Michel.; Pyerin, W.; Carle, G.F.; Rochet, N., 2010:
Human primary osteocyte differentiation in a 3D culture system

Hallum, L.E.; Landy, M.S.; Heeger, D.J., 2012:
Human primary visual cortex (V1) is selective for second-order spatial frequency

Cho, K.Ho.; Rodríguez-Vázquez, J.Francisco.; Han, E.Hyeog.; Verdugo-López, S.; Murakami, G.; Cho, B.Hwan., 2010:
Human primitive meninges in and around the mesencephalic flexure and particularly their topographical relation to cranial nerves

Kee, K.; Flores, M.; Cedars, M.I.; Reijo Pera, R.A., 2010:
Human primordial germ cell formation is diminished by exposure to environmental toxicants acting through the AHR signaling pathway

Teng, Y.; Chen, B.; Tao, M., 2009:
Human primordial germ cell-derived progenitors give rise to neurons and glia in vivo

Møllgård, K.; Jespersen, A.; Lutterodt, M.C.; Yding Andersen, C.; Høyer, P.E.; Byskov, A.G., 2010:
Human primordial germ cells migrate along nerve fibers and Schwann cells from the dorsal hind gut mesentery to the gonadal ridge

Ye, J.; Han, J.; Shi, Q.; Zhang, B-Yun.; Wang, G-Rong.; Tian, C.; Gao, C.; Chen, J-Min.; Li, C-Jiang.; Liu, Z.; Li, X-Zhang.; Zhang, L-Zhong.; Dong, X-Ping., 2008:
Human prion disease with a G114V mutation and epidemiological studies in a Chinese family: a case series

Bradford, B.M.; Piccardo, P.; Ironside, J.W.; Mabbott, N.A., 2015:
Human prion diseases and the risk of their transmission during anatomical dissection

Jansen, C.; Parchi, P.; Capellari, S.; Ibrahim-Verbaas, C.A.; Schuur, M.; Strammiello, R.; Corrado, P.; Bishop, M.T.; van Gool, W.A.; Verbeek, M.M.; Baas, F.; van Saane, W.; Spliet, W.G.M.; Jansen, G.H.; van Duijn, C.M.; Rozemuller, A.J.M., 2012:
Human prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects

Holman, R.C.; Belay, E.D.; Christensen, K.Y.; Maddox, R.A.; Minino, A.M.; Folkema, A.M.; Haberling, D.L.; Hammett, T.A.; Kochanek, K.D.; Sejvar, J.J.; Schonberger, L.B., 2010:
Human prion diseases in the United States

Sikorska, B.; Liberski, P.P., 2014:
Human prion diseases: from Kuru to variant Creutzfeldt-Jakob disease

Head, M.W., 2014:
Human prion diseases: molecular, cellular and population biology

Zerr, I., 2013:
Human prion diseases: progress in clinical trials

Kovács, Gábor.Géza.; Bakos, A.; Mitrova, E.; Minárovits, János.; László, L.; Majtényi, K., 2008:
Human prion diseases: the Hungarian experience

Hizume, M.; Kobayashi, A.; Teruya, K.; Ohashi, H.; Ironside, J.W.; Mohri, S.; Kitamoto, T., 2009:
Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection

Costantini, S.; Facchiano, A.M., 2009:
Human prion protein helices: studying their stability by molecular dynamics simulations

Xu, K.; Wang, X.; Shi, Q.; Chen, C.; Tian, C.; Li, X-Li.; Zhou, R-Min.; Chu, Y-Lie.; Dong, X-Ping., 2011:
Human prion protein mutants with deleted and inserted octarepeats undergo different pathways to trigger cell apoptosis

Giles, K.; Glidden, D.V.; Patel, S.; Korth, C.; Groth, D.; Lemus, A.; DeArmond, S.J.; Prusiner, S.B., 2010:
Human prion strain selection in transgenic mice

Exley, C.; House, E.; Patel, T.; Wu, L.; Fraser, P.E., 2011:
Human pro-islet amyloid polypeptide (ProIAPP(1-48)) forms amyloid fibrils and amyloid spherulites in vitro

Awong, Génève.; Singh, J.; Mohtashami, M.; Malm, M.; La Motte-Mohs, R.N.; Benveniste, P.M.; Serra, P.; Herer, E.; van den Brink, M.R.; Zúñiga-Pflücker, J.Carlos., 2014:
Human proT-cells generated in vitro facilitate hematopoietic stem cell-derived T-lymphopoiesis in vivo and restore thymic architecture

Moreira, L.A.; Saig, E.; Turley, A.P.; Ribeiro, Jé.M.C.; O'Neill, S.L.; McGraw, E.A., 2010:
Human probing behavior of Aedes aegypti when infected with a life-shortening strain of Wolbachia

Hatch, T.F., 1949:
Human problems in industrial machine design

Bronk, D.W., 2018:
Human problems in military aviation

Heymann, M.C.; Winkler, S.; Luksch, H.; Flecks, S.; Franke, M.; Ruß, S.; Ozen, S.; Yilmaz, E.; Klein, C.; Kallinich, T.; Lindemann, D.; Brenner, S.; Ganser, G.; Roesler, J.; Rösen-Wolff, A.; Hofmann, S.R., 2014:
Human procaspase-1 variants with decreased enzymatic activity are associated with febrile episodes and may contribute to inflammation via RIP2 and NF-κB signaling

Nahum, L.; Gabriel, D.; Schnider, A., 2011:
Human processing of behaviorally relevant and irrelevant absence of expected rewards: a high-resolution ERP study

Kawalec, Mł.; Sitkowska, A.; Sobota, Mł.; Sieroń, A.L.; Komar, P.; Kurcok, P., 2015:
Human procollagen type I surface-modified PHB-based non-woven textile scaffolds for cell growth: preparation and short-term biological tests

Classen, H.G., 1961:
Human procreation in civilized society

Ramalho-Santos, Jão., 2011:
Human procreation in unchartered territory: new twists in ethical discussions

Lee, K-Won.; Johnson, N.R.; Gao, J.; Wang, Y., 2014:
Human progenitor cell recruitment via SDF-1α coacervate-laden PGS vascular grafts

Bayes-Genis, A.; Soler-Botija, C.; Farré, J.; Sepúlveda, P.; Raya, A.; Roura, S.; Prat-Vidal, C.; Gálvez-Montón, C.; Montero, Jé.Anastasio.; Büscher, D.; Izpisúa Belmonte, J.Carlos., 2011:
Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents

Hess, D.A.; Bonde, J.; Craft, T.P.; Craft, T.C.; Wirthlin, L.; Hohm, S.; Lahey, R.; Todt, L.M.; Dipersio, J.F.; Devine, S.M.; Nolta, J.A., 2007:
Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor

Zhou, P.; Hohm, S.; Olusanya, Y.; Hess, D.A.; Nolta, J., 2009:
Human progenitor cells with high aldehyde dehydrogenase activity efficiently engraft into damaged liver in a novel model

Thebaud, Nélie.B.; Bareille, R.; Remy, M.; Bourget, C.; Daculsi, R.; Bordenave, L., 2011:
Human progenitor-derived endothelial cells vs. venous endothelial cells for vascular tissue engineering: an in vitro study

Cifarelli, V.; Luppi, P.; Tse, H.M.; He, J.; Piganelli, J.; Trucco, M., 2008:
Human proinsulin C-peptide reduces high glucose-induced proliferation and NF-kappaB activation in vascular smooth muscle cells

Zhou, J.; Guo, S-Y.; Zhang, Y.; Li, C-Q., 2014:
Human prokinetic drugs promote gastrointestinal motility in zebrafish

Adamson, A.D.; Friedrichsen, S.; Semprini, S.; Harper, C.V.; Mullins, J.J.; White, M.R.H.; Davis, J.R.E., 2007:
Human prolactin gene promoter regulation by estrogen: convergence with tumor necrosis factor-alpha signaling

Lupi, A.; Tenni, R.; Rossi, A.; Cetta, G.; Forlino, A., 2008:
Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations

Karbanová, J.; Laco, J.; Marzesco, A-Marie.; Janich, P.; Voborníková, M.; Mokrý, J.; Fargeas, C.A.; Huttner, W.B.; Corbeil, D., 2015:
Human prominin-1 (CD133) is detected in both neoplastic and non-neoplastic salivary gland diseases and released into saliva in a ubiquitinated form

Hernández, A.; Villegas, A.; Anguita, E., 2010:
Human promoter mutations unveil Oct-1 and GATA-1 opposite action on Gfi1b regulation

Pérez, O.; Batista-Duharte, A.; González, E.; Zayas, C.; Balboa, J.; Cuello, M.; Cabrera, O.; Lastre, M.; Schijns, V.E.J.C., 2013:
Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations

Fletcher, R., 1883:
Human proportion

Davis, J.R.; Horslen, B.C.; Nishikawa, K.; Fukushima, K.; Chua, R.; Inglis, J.Timothy.; Carpenter, M.G., 2012:
Human proprioceptive adaptations during states of height-induced fear and anxiety

Ian McCloskey, D., 1994:
Human proprioceptive sensation

Morales, R.; Watier, Y.; Böcskei, Z., 2012:
Human prorenin structure sheds light on a novel mechanism of its autoinhibition and on its non-proteolytic activation by the (pro)renin receptor

Ross, M.; Lanyon, L.J.; Viswanathan, J.; Manoach, D.S.; Barton, J.J.S., 2012:
Human prosaccades and antisaccades under risk: effects of penalties and rewards on visual selection and the value of actions

Ramkissoon, A.; Wells, P.G., 2011:
Human prostaglandin H synthase (hPHS)-1 and hPHS-2 in amphetamine analog bioactivation, DNA oxidation, and cytotoxicity

Ramkissoon, A.; Wells, P.G., 2011:
Human prostaglandin H synthase (hPHS)-1- and hPHS-2-dependent bioactivation, oxidative macromolecular damage, and cytotoxicity of dopamine, its precursor, and its metabolites

Ronquist, K.Göran.; Ronquist, G.; Carlsson, L.; Larsson, A., 2009:
Human prostasomes contain chromosomal DNA

Tarazona, R.; Delgado, E.; Guarnizo, M.C.; Roncero, R.G.; Morgado, S.; Sánchez-Correa, B.; Gordillo, J.J.; Dejulián, J.; Casado, J.G., 2011:
Human prostasomes express CD48 and interfere with NK cell function